Molecular Characterization of the Dbf4/Drf1-Dependent Kinase (DDK) and the DNA Replication Checkpoint Mediator Claspin in Xenopus Egg Extracts by Gold, Daniel A.
Molecular Characterization of the Dbf4/Drf1-
Dependent Kinase (DDK) and the DNA Replication 
Checkpoint Mediator Claspin in Xenopus Egg 
Extracts 
Thesis by 
Daniel A. Gold 
 
In Partial Fulfillment of the Requirements 
for the Degree of 
Doctor of Philosophy  
 
California Institute of Technology 
Pasadena, CA 
2010 
(Defended September 23, 2009) 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2010 
Daniel A. Gold 
All Rights Reserved 
iii 
 
To my family. 
  
iv 
 
Acknowledgements 
 
I would like to thank my thesis advisor, Bill Dunphy, for his unwavering 
commitment to performing the most rigorous science possible; a commitment 
that I hope has been instilled in me.  I am also thankful for his support over the 
years that I have been in graduate school.  I would also like to thank the 
members of my thesis committee who have been supportive of me over a long 
period: Judy Campbell, Bruce Hay, David Chan and Paul Sternberg.  In 
particular, I want to thank David Chan for standing behind me under adverse 
circumstances that arose when I taught a discussion section for his course.  I 
would like to acknowledge Akiko Kumagai for her endless technical and strategic 
advice, as well as for providing an excellent scientific role model for me.  I am 
indebted to my labmates, past and present, who have provided advice and 
comradeship: Hae Yong Yoo, Stephanie Yanow, Esther Bae, Soo-Mi Kim, 
Seong-Yun Jeong, Jianghai Wang, Wenhui Li, Jason DeHart, Joon Lee, Sanjay 
Kumar, and Zheng Meng.  I want to extend a gratitude that I truly do not have the 
appropriate words to express to Juanse Ramírez-Lugo, without whom I doubt I 
would have finished my degree with any measure of sanity (not to mention his 
scientific and technical advice over the years). 
I am also grateful for many personal relationships that have been invaluable for a 
multitude of reasons over my graduate career: Johannes Graumann for being 
both my fiercest critic and strongest ally, Anna Maria Salazar for giving me a 
much finer appreciation of the gradations of the color black not to mention being 
v 
 
a kindred soul, David Walker for career, relationship, and cultural advice, Scott 
Detmer for his contagious prideful exuberance, Ofer Mazor for teaching me how 
to be strong as an Ox, Ben Rubin for his soundness of advice and endless ideas, 
most of which I wish I could have thought of, Melanie Lee for her sharp wit, Tim 
Lebestky for his irreverent humor and ambitious drive, Ernie, Sumi, and Tai for 
caloric and soulful sustenance, Nina Tang Sherwood for her sly humor and good 
cheer, Allan Wong for his passion for science, Baris Bingol for his singular style, 
Wulf Haubensack for being, well, Wulf, Michael Reiser for being a friend and co-
conspirator since I was 15 years old, and Stijn Cassanaer who has made me 
look forward to the end of nearly every week I have been at Caltech.  Special 
mention should be also paid to Kate Chabarek, Pankaj Mehta, Matt Levin, Nina 
Gutin and Yan Michael Wang who have given me balance in very different ways.  
Kate also provided unexpected but most welcome help with proofreading and 
formatting this document. 
Lastly, I thank my parents for their love, support, and encouragement.
vi 
 
Abstract 
Maintaining the integrity of DNA replication control and checkpoint mechanisms 
is essential for cellular viability and preventing tumorigenesis.  Replication 
initiation is catalyzed by the S-phase Cyclin-dependent kinase (S-CDK) and the 
Drf1/Dbf4-dependent kinase (DDK) that mediate the unwinding of the replication 
fork and loading of DNA polymerases onto chromatin.  Genotoxic stress that 
affects cells specifically in S-phase is detected by a discrete replication 
checkpoint pathway.  Replication blockages activate the ATR kinase which, in 
turn, activates the downstream effector kinase Chk1 through the mediator 
protein, Claspin.  Chk1 facilitates downstream checkpoint functions including 
arresting cell cycle progression and inhibiting replication firing.   
Claspin has two broadly defined roles, one to mediate Chk1 activation and the 
other as a component of the replication fork.  Our studies have attempted to 
address the linkage between these two facets of Claspin function.  Here, we 
show that Claspin associates with several core replication fork proteins in 
Xenopus egg extracts.  We identified a replication fork-interacting domain on 
Claspin that associates with these replication fork proteins and is required for 
Claspin association with chromatin.  However, chromatin binding-deficient 
Claspin proteins can still mediate Chk1 activation in Claspin-depleted extracts, 
albeit with reduced efficiency.  Thus, the localization of Claspin at the replication 
fork is not required for its role in mediation of Chk1 activation but it does 
potentiate this process. 
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Another focus of this study, DDK, is composed of the catalytic subunit Cdc7 and 
one of two distinct adaptor proteins, Drf1 or Dbf4.  Drf1 forms a stable, active 
complex with Cdc7, even after replication arrest in egg extracts.  Accumulation of 
Drf1 on chromatin in the presence of replication blocks is dependent upon ATR 
and Claspin but not Chk1.  We also show that, in the presence of the DNA 
polymerase inhibitor aphidicolin, inhibition of the replication checkpoint by 
caffeine leads to modest DNA replication initiation in both somatic cells and egg 
extracts.  This coincides with our observation that DDK remains active in the 
presence of aphidicolin, and thus may be responsible for initiating origins or 
stabilizing stalled replication forks against collapse even under conditions of 
replication stress.  
Based on our finding that Drf1 accumulation on chromatin was Claspin-
dependent, we further investigated the relationship between these proteins.  We 
characterized Xenopus Claspin as a kinase substrate of DDK which forms a 
stable nuclear complex with Cdc7 and Drf1 under both arrested and unperturbed 
replication conditions.  Moreover, we identified a region of Claspin required for 
association with DDK that lies within the Chk1-binding domain, which contains a 
series of repeat sequences.  This DDK-associating region is the first, but not the 
second of these repeat sequences.  Furthermore, we have identified two 
evolutionarily conserved residues within this region required for DDK interaction.   
Claspin mutant proteins unable to interact with DDK are still able to bind to Chk1 
and rescue Chk1 activation in Claspin-depleted extracts.  Therefore, we conclude 
that DDK regulates a largely checkpoint-independent role of Claspin function.  
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Chapter 1 
Introduction 
Accurately and completely replicating the genome is of fundamental importance 
to every organism.  To this end, eukaryotes have evolved conserved 
mechanisms to promote the orderly assembly of replication components that 
span the exit of M-phase through the completion of S-phase.  Besides the proper 
control of replication initiation and elongation, cells also have processes to 
ensure protection against both intrinsic and extrinsic genotoxic stress in order to 
maintain the integrity of the genome.  This is accomplished through a set of 
checkpoints that prevent continuing replication and entry into mitosis in the 
presence of DNA damage and stalled replication forks, allowing time for repair or 
a commitment to enter into apoptosis.  The breakdown of these checkpoints, 
either through accrued mutation in the genome or inheritance can lead to 
unchecked proliferation of cells, a hallmark of cancer. 
1.1 Replication Initiation  
The mechanisms underlying eukaryotic DNA replication initiation are becoming 
increasingly well understood (reviewed in (Arias and Walter, 2007; Bell and 
Dutta, 2002; Takeda and Dutta, 2005)).  Briefly, the assembly of replication 
factors begins with the loading of a set of proteins known as the prereplicative 
complex (pre-RC) onto chromatin in late M-phase (figure 1.1).  These factors 
assemble in a stepwise fashion starting with the binding of the origin recognition 
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complex (ORC) onto DNA replication origins.  ORC then recruits the initiation 
factors Cdc6 and Cdt1 to replication origins and in turn, Cdc6 and Cdt1 are 
required for the loading of the minichromosome maintenance complex, MCM2-7.  
The MCM2-7 complex is thought to be the eukaryotic replicative helicase, but it is 
inactive at this point in the cell cycle.  Together, ORC, Cdt1, Cdc6, and MCM2-7 
comprise the pre-RC and are distributed at potential replication origins 
throughout the chromosome in M-phase.  Only a subset of chromatin-loaded pre-
RCs is actually converted into active replication forks during S-phase.  The 
conversion of pre-RCs into active replication forks is catalyzed by the concerted 
actions of two S-phase kinase complexes, S-phase Cyclin-dependent kinase (S-
CDK) and the Drf1/Dbf4-dependent kinase (DDK).  These kinases recruit a set of 
initiation factors including Cdc45, GINS, and Dpb11/TopBP11 which lead to the 
activation of the MCM2-7 helicase and subsequent unwinding of the replication 
fork, allowing the association of DNA polymerases and other replication 
elongation factors.
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Figure 1.1. Summary of requirements for binding of Claspin to 
chromatin.    
Reprinted from Lee, J., et al. (2003) Molecular Cell 11, 329–340, with permission 
from Elsevier. 
4 
 
 
The molecular details regarding DDK will be extensively reviewed later in this 
introduction.  The role of S-CDK in replication initiation has only recently become 
apparent in yeast.  The essential step in replication initiation involving this kinase 
that has been described is the S-CDK mediated phosphorylation of two proteins, 
Sld2 and Sld3, leading to their association with a third protein, Dpb11, and their 
subsequent loading onto chromatin (Masumoto et al., 2000; Tanaka et al., 
2007b; Zegerman and Diffley, 2007).  Yeast strains containing suppressing 
mutations that bypass the requirement of S-CDK in budding yeast for replication 
initiation still require DDK activity, demonstrating that S-CDK and DDK regulate 
parallel pathways (Tanaka et al., 2007b; Zegerman and Diffley, 2007).  The role 
of S-CDK in higher eukaryotes is still under investigation.  TopBP11 has been 
identified as the homologue of Dpb11 in higher eukaryotes but homologues of 
Sld2 and Sld3 have yet to be identified (Tanaka et al., 2007a). 
1.1.1 Characterization of DDK as an essential S-phase kinase 
The cdc7 allele was originally identified in the Hartwell screen for temperature-
sensitive cell division mutants in S. cerevisiae (budding yeast) and was found to 
be required for the initiation of S-phase (Hartwell, 1971, 1973).   The Cdc7 gene 
was subsequently cloned and predicted to be a serine/threonine kinase based on 
sequence analysis and was thereafter demonstrated to be an active kinase 
(Patterson et al., 1986; Yoon and Campbell, 1991).  Subsequently, Cdc7 
homologues in the fission yeast, S. pombe (Hsk1), human and Xenopus (both 
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called Cdc7) were also identified (Jiang and Hunter, 1997; Masai et al., 1995; 
Sato et al., 1997).  The kinase domains of Cdc7 share approximately 60% 
identity between fission and budding yeasts and mammalian Cdc7 kinase 
domain shares nearly 45% identity with yeast Cdc7 (Masai and Arai, 2002).  
Genetic analyses in a variety of systems also provided evidence that Cdc7 is a 
key regulator of DNA replication initiation.  Firstly, the phenotype for the null 
mutant of S. pombe Hsk1 is premature entry into mitosis and an inability to 
initiate DNA replication (Masai et al., 1995).  Secondly, several studies revealed 
that antibody competition against or immunodepletion of Cdc7 from Xenopus egg 
extracts prevents DNA replication from occurring (Jares et al., 2000; Roberts et 
al., 1999; Walter, 2000).  Additionally, Cdc7 null knockout mice were found to be 
embryonic lethal at E3.5–6.5 (Kim et al., 2002).  Further investigation revealed 
that conditional Cdc7 allele knockout mouse ES (embryonic stem) cells display 
an arrest of DNA replication that leads to activation of the replication checkpoint 
and entry into apoptosis (Kim et al., 2002; Kim et al., 2003).    Interestingly, 
despite its role at the beginning of S-phase, the Cdc7 protein is stable and 
expressed in a constitutive manner throughout the cell cycle (Sato et al., 1997; 
Takeda et al., 1999).  These data supported the assertion that Cdc7 was an 
evolutionarily conserved kinase essential for initiation of replication in studied 
eukaryotes. 
Investigations concerning another gene in yeast, Dbf4, gave further insight into 
the regulation of Cdc7.  The dbf4 (dumbbell former) mutant was isolated in a 
screen to identify factors that would arrest S. cerevisiae strains in a characteristic 
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dumbbell shape, which was considered to be a hallmark of failure to initiate DNA 
replication (Johnston and Thomas, 1982).  Genetic linkage to Cdc7 was 
demonstrated when multiple copies of DBF4 were later found capable of 
suppressing the temperature sensitive cdc7 allele in budding yeast (Kitada et al., 
1992).  Additionally, the kinase activity of Cdc7 was determined to be dependent 
upon the presence of Dbf4 (Yoon et al., 1993).  It was also observed that Cdc7 
and Dbf4 directly interact with each other (Dowell et al., 1994; Hardy and Pautz, 
1996).  A model then emerged where Dbf4 acts as a Cdc7 adaptor protein, 
required for activating the Cdc7 kinase.  Supporting this, the S. pombe 
homologue of Dbf4 (Dfp1 or Him1) was identified and found to be defective in 
DNA replication (Brown and Kelly, 1998, 1999; Takeda et al., 1999).  In contrast 
to the steady cell cycle expression of Cdc7, the expression profile of the DBF4 
protein in budding yeast varies in a cell cycle–dependent fashion where protein 
abundance increases in G1, peaks in S-phase and decreases in G2/M 
(Chapman and Johnston, 1989).  The human homologue of Dbf4 was identified 
by two separate yeast 2-hybrid screens using human Cdc7 as the bait and was 
named ASK (activator of S-phase kinase) and Dbf4 respectively (Jiang et al., 
1999; Kumagai et al., 1999).  ASK/Dbf4 was subsequently determined to be 
necessary for human Cdc7 activation in vitro (Masai et al., 2000).  The Xenopus 
homologue of Dbf4 was cloned several years later (Jares et al., 2004).  
ASK/Dbf4 conditional knockout ES cells displayed a phenotype similar to Cdc7 
conditional knockout cells where DNA replication is compromised and the cells 
eventually enter into apoptosis (Yamashita et al., 2005). 
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There are three conserved sequence motifs of Dbf4 that are called N, M, and C 
in order from the N-termini to C-termini of the protein (Masai and Arai, 2002).  
The M and C motifs comprise a bipartite domain required for binding to and 
activating the Cdc7 kinase (Masai and Arai, 2002; Ogino et al., 2001).  The N 
motif contains sequences loosely related to BRCA1 C-terminal (BRCT) repeats 
which, in tandem, are involved in binding phosphopeptides involved in DNA 
damage repair and checkpoint signaling (Manke et al., 2003; Masai and Arai, 
2002). In budding yeast, the Dbf4 N motif contains additional sequences besides 
the BRCT motif that are conserved amongst Dbf4 homologues but distinct from 
BRCT-containing proteins and called the BRDF (BRCT and Dbf4 similarity) motif 
(Gabrielse et al., 2006). The BRDF sequence is required for budding yeast to 
respond normally to DNA damage (Gabrielse et al., 2006).  This coincides with 
the data that N motif deletions in fission yeast are sensitive to DNA damaging 
agents (Fung et al., 2002; Ogino et al., 2001).    
A second adaptor protein for Cdc7 was identified using a bioinformatic approach 
to find genes similar to Dbf4 in the human genome and was named Drf1 (Dbf4-
related factor 1) (Montagnoli et al., 2002).  Human Drf1 physically interacts with 
Cdc7 and stimulates its kinase activity in vitro in a similar fashion to Dbf4 
(Montagnoli et al., 2002).  Moreover, Drf1 is expressed in mammalian somatic 
cells along with Dbf4 and exhibits a similar cell cycle-dependent regulation of 
expression where the protein levels increase in G1, peak in S-phase and 
decrease in G2/M (Montagnoli et al., 2002).  Using overexpressed epitope-
tagged recombinant proteins in immunoprecipitation experiments, it was 
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determined that Cdc7 forms distinct complexes with Drf1 and Dbf4 (Montagnoli et 
al., 2002).  Shortly thereafter, the Xenopus homologue of Drf1 was isolated and 
subsequent immunoprecipitation experiments in Xenopus egg extracts with anti-
Dbf4 and anti-Drf1 antibodies confirmed that Cdc7 exists in distinct complexes 
with each adaptor protein (chapter 2) (Takahashi and Walter, 2005; Yanow et al., 
2003).  Additional studies using Xenopus egg extracts showed that the Drf1/Cdc7 
complex was in greater abundance than Dbf4/Cdc7 and that Drf1 but not Dbf4 
was required for replication initiation in the extract (Silva et al., 2006; Takahashi 
and Walter, 2005).  This situation persists until gastrulation in the embryo when 
Drf1 protein levels decline and Dbf4 levels increase, demonstrating that Drf1 
drives Cdc7 activity in early embryonic cell cycles (Silva et al., 2006; Takahashi 
and Walter, 2005).  Both human and Xenopus Drf1 homologues have the 
characteristic N, M, and C motifs in common with Dbf4, suggesting they are in 
the same gene family (chapter 2) (Montagnoli et al., 2002; Yanow et al., 2003).   
There are several similarities between Cyclin-dependent kinases (Cdk(s)) and 
Cdc7, since like Cdk(s), Cdc7 is stable and expressed throughout the cell cycle 
and its activity is regulated by the binding of an adaptor protein that is expressed 
in a cell cycle–dependent manner.  Therefore, the Cdc7 is referred to as DDK 
(Dbf4-dependent kinase or sometimes Drf1/Dbf-dependent kinase) by analogy to 
Cdk(s) (Johnston et al., 1999).  The major physiological substrate for DDK is 
thought to be the minichromosome maintenance complex, MCM2-7.  Other 
known substrates of DDK include the replication fork unwinding factor, Cdc45, in 
yeast (Nougarede et al., 2000), DNA polymerase α in yeast (Weinreich and 
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Stillman, 1999), the polo box domain (PBD) of Cdc5 in yeast (Miller et al., 2009), 
the cohesin loading protein Scc2 in Xenopus  (Takahashi et al., 2008), the p150 
subunit of the histone deposition protein, CAF-1 (Gerard et al., 2006), and the 
checkpoint mediator protein Claspin in mammalian cells (Kim et al., 2008). 
1.1.2 The role of DDK in replication initiation 
Several subunits of the MCM2-7 complex including MCM2, MCM4, and MCM6 
are substrates of Cdc7 (Kihara et al., 2000; Sato et al., 1997; Sheu and Stillman, 
2006; Weinreich and Stillman, 1999).  Cdc7 and MCM2 interact genetically and 
MCM2 is phosphorylated in a Cdc7-dependent manner in vivo in several systems 
(Jares et al., 2000; Lei et al., 1997; Snaith et al., 2000; Takeda et al., 2001). 
Several physiologically relevant phosphorylation sites have been identified on 
mammalian MCM2, however a consensus target sequence has yet to be 
elucidated (Montagnoli et al., 2006).  The most important piece of initial data 
linking the MCM complex as the key target of Cdc7 came from genetic analysis 
in budding yeast.  A genetic screen for suppressors that mediated the DNA 
replication bypass of the temperature sensitive allele of Cdc7 in S. cerevisiae 
identified bob1 as one such allele (Jackson et al., 1993).  The bob1 suppressor 
was subsequently revealed to be a mutation of MCM5 that can suppress null 
mutants of both Cdc7 and Dbf4, therefore suggesting that the MCM complex 
plays an important role in DDK function (Hardy et al., 1997; Jackson et al., 1993).   
There is extensive research supporting the idea that the MCM2-7 complex is the 
main replicative helicase (reviewed in detail in (Arias and Walter, 2007; Bell and 
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Dutta, 2002; Takahashi et al., 2005; Takeda and Dutta, 2005)).  Briefly, MCM2-7 
proteins form a hexameric ring complex in which each MCM molecule contains a 
characteristic AAA+ helicase motif.  The MCM2-7 complex has ATP-dependent 
helicase activity and travels with the replisome.  Further insight into the role of 
the MCM2-7 complex comes from studies involving several mutants and 
inhibitors of the helicase activity that block DNA replication at the replication 
origin unwinding step.  More recent work has suggested that the actual helicase 
activity of MCM2-7 is thought to be stimulated by the binding of the unwinding 
factor Cdc45 and the GINS (Go, Ichi, Nii, and San) complex which has been 
referred to as the CMG (Cdc45, MCM, and GINS) complex (Gambus et al., 2006; 
Kubota et al., 2003; Masuda et al., 2003; Moyer et al., 2006).   Cdc45 and GINS 
lack ATPase motifs but they associate with active replication forks and are 
required for fork progression (Aparicio et al., 1997; Pacek et al., 2006; Takayama 
et al., 2003; Tercero et al., 2000).  Importantly, DDK activity is required for Cdc45 
association with the replication fork (Walter, 2000; Zou and Stillman, 2000).  
Further investigations revealed that phosphorylation of MCM2 and MCM4 by 
DDK stimulate binding of Cdc45 to chromatin (Masai et al., 2006; Sheu and 
Stillman, 2006; Tsuji et al., 2006).  Thus, the prevailing model is that DDK activity 
helps convert inactive pre-RC complexes into active DNA replication forks by 
phosphorylating components of the MCM2-7 complex, thus stimulating MCM 
helicase activity by promoting the formation of the Cdc45, MCM, and GINS 
complex on chromatin (figure 1.1).   
11 
 
Besides enzymatic regulation of Cdc7 kinase activity, subnuclear localization is 
thought to provide a key layer of regulation of the DDK complex. There are 
several pieces of data that suggest that the DDK complex must be localized to 
replication origins in order to effectively initiate DNA replication.  First, Cdc7 
activity is required throughout S-phase for initiation of both early and late firing 
origins (Bousset and Diffley, 1998; Donaldson et al., 1998).  Second, DDK is 
ratelimiting for origin firing in budding yeast, and tethering Hsk1-Dfp1 to DNA 
sequences near an origin makes firing at that origin more efficient (Patel et al., 
2008).  Third, DDK phosphorylates a stable MCM2-7/Cdc45 complex on 
chromatin exclusively in S-phase (Sheu and Stillman, 2006).  Fourth, DDK 
associates with replication origins in a pre-RC-dependent manner in yeast and 
Xenopus egg extracts (Dowell et al., 1994; Edwards et al., 2002; Jares et al., 
2000; Jares et al., 2004).  Finally, efficient phosphorylation, in vitro, of MCM2-7 
requires a stable interaction of those factors and DDK with preferentially 
phosphorylated MCM complexes that were associated with origin DNA (Francis 
et al., 2009).  These reports suggest that DDK phosphorylates MCM2-7 after 
association with chromatin and directly at origins of replication.  Thus, chromatin 
interaction of DDK is essential for its activity. 
1.2 The replication checkpoint 
Different types of genotoxic stress can adversely affect cell viability through 
fundamentally distinct mechanisms.  In order to mount an appropriate response 
to varied classes of stress, cells have evolved multiple signaling pathways that 
are activated according to the type of challenge encountered (reviewed in (Bartek 
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and Lukas, 2007; Kastan and Bartek, 2004; Melo and Toczyski, 2002; Sancar et 
al., 2004)).  Damage induced by insults such as ionizing radiation (IR) or free 
radicals leads to the formation of DNA double-strand breaks (DSBs) which 
activate the DNA damage checkpoint pathway.  Stress that affects cells 
specifically during S-phase and culminates in the arrest of replication forks, such 
as ultraviolet radiation, is responded to by a pathway known as the replication 
checkpoint.  These checkpoints respond to genotoxic stress by ensuring that cell 
cycle progression is arrested until the damage can be repaired and failing that, 
enter the cell into the programmed cell death pathway.  Both the DNA damage 
and replication checkpoints are organized in similar fashion, with sensor 
molecules that detect damage and activate a sensor phosphatidylinositol 3-
kinase (PI3K)-like protein kinase that controls the initial activation of the pathway.  
Ataxia telangiecstasia mutated (ATM) is the apical (PI3K)-like kinase atop the 
DNA damage checkpoint pathway and ATM- and Rad3-related (ATR) is its 
counterpart kinase regulating the replication checkpoint pathway.  The next class 
of organization is made up of checkpoint mediators or adaptor proteins, which 
cooperate with the sensor kinases to activate downstream effector kinases that 
regulate the cell cycle arrest, DNA repair, and apoptotic pathways.  For the 
purpose of brevity, the main focus of the below discussion will be on the 
replication checkpoint in higher eukaryotes. 
The prevailing model for the mechanism of activation of the replication 
checkpoint is that abnormal stretches of single-stranded DNA (ssDNA) are 
generated by stalled replication forks and this is the key signal recognized by the 
13 
 
checkpoint senor machinery (reviewed in (Bartek and Lukas, 2007; Kastan and 
Bartek, 2004; Sancar et al., 2004)).  RPA (replication protein A), a single-
stranded DNA binding protein, coats the ssDNA generated by the arrested fork 
and recruits ATR and its binding partner ATRIP to that site.  In addition to 
ATR/ATRIP, the sliding clamp complex of Rad9-Rad1-Hus1 (9-1-1) is loaded by 
the clamp-loading Rad17 complex onto the ssDNA site.  The chromatin-loaded 9-
1-1 complex is required for the activation of ATR.  The main target for ATR in this 
context is the downstream effector kinase, Chk1, whose phosphorylation by ATR 
is mediated by the adaptor protein Claspin.  ATR-activated Chk1 kinase 
transduces the replication checkpoint signal to various factors that effect the 
arrest of cell cycle progression, inhibit DNA synthesis, late origin firing and if 
necessary, activation of the programmed cell death pathway.     
1.2.1 Claspin as a mediator of the replication checkpoint 
Claspin was first identified in our laboratory as a novel protein that bound to 
recombinant Chk1 protein isolated from checkpoint-stimulated Xenopus egg 
extracts and was subsequently determined to be required for the activation of 
Chk1 in response to arrested replication forks (Kumagai and Dunphy, 2000).  
Claspin is evolutionarily conserved amongst higher eukaryotes and the human 
homologue shares 49% identity with Xenopus Claspin (Kumagai and Dunphy, 
2000).  Functional yeast homologues were identified and named MRC1 
(mediator of replication checkpoint) but these proteins contain little sequence 
similarity to Claspin (Alcasabas et al., 2001; Tanaka and Russell, 2001).  Claspin 
is a large, acidic (pI = 4.5) protein which contains no shared protein motifs except 
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between other Claspin homologues in other organisms (Kumagai and Dunphy, 
2000).  Human Claspin is also required for activation of Chk1 in response to 
replication stress (Chini and Chen, 2004; Lin et al., 2004).  Further investigation 
into the mechanism of Chk1 activation mediated by Xenopus Claspin revealed 
that an evolutionarily conserved 57 amino acid region of Claspin, called the 
CKBD (Chk1 binding domain), is required for Chk1 binding and activation 
(Kumagai and Dunphy, 2003).  However a somewhat larger,129 amino acid 
region (called the CKAD, Chk1 activating domain) is needed to rescue Chk1 
activation after the depletion of Claspin in egg extracts (chapter 3) (Lee et al., 
2005).  The CKBD protein region is composed of two amino acid repeat 
sequences, each containing conserved serines that are phosphorylated by an as 
yet unidentified kinase in response to replication arrest and these 
phosphoserines are essential for binding to and activating Chk1 (Kumagai and 
Dunphy, 2003).  The human Claspin CKBD is phosphorylated in a similar fashion 
to the Xenopus homologue.  However, it contains three repeat sequences (as do 
several Claspin homologues in other organisms) but only two are required for 
Chk1 activation (Chini and Chen, 2006; Clarke and Clarke, 2005).  These 
checkpoint-induced phosphoserines of Claspin bind the catalytic domain of Chk1, 
mediating Chk1 activation by ATR/ATRIP, and culminate in the release of 
activated Chk1 (Guo et al., 2000; Jeong et al., 2003; Kumagai et al., 2004).  
1.2.2 The role of Claspin on the replication fork 
In addition to its role in mediating Chk1 activation in response to replication 
stress, a number of studies have demonstrated that Claspin also has a role in 
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replication.  Claspin was found to associate with the replication fork during S-
phase in Xenopus egg extracts (Lee et al., 2003).  This association was 
dependent upon Cdc45 and S-CDK, but not RPA, implying that Claspin loads 
onto chromatin at the DNA unwinding step of replication initiation, which is similar 
to the time that DNA polymerase ε (Pol ε) is loaded onto chromatin (figure 1.1) 
(Lee et al., 2003).  Claspin interacts with replication fork proteins such as Cdc45, 
RFC (replication factor C), RPA, and Pol ε (Lee et al., 2005; Lee et al., 2003; Lin 
et al., 2004; Sar et al., 2004).  Moreover, Claspin is required for a normal rate of 
DNA replication (Lee et al., 2003; Lin et al., 2004; Petermann et al., 2008).    The 
budding yeast homologue of Claspin, Mrc1, also was found to associate with the 
replication fork, is required for a normal rate of replication, and interacts with 
replication fork proteins (Hodgson et al., 2007; Katou et al., 2003; Lou et al., 
2008; Osborn and Elledge, 2003; Szyjka et al., 2005; Tourriere et al., 2005). 
Subnuclear spatial dynamics are thought to be important for many aspects of 
replication checkpoint signaling.  Claspin is involved in stabilizing replication forks 
after replication arrest and Claspin accumulates onto replication-arrested 
chromatin (Lee et al., 2005; Lee et al., 2003; Lin et al., 2004).  The subcellular 
localization of Claspin is exclusively nuclear (Chini and Chen, 2003; Liu et al., 
2006).  However, despite its accumulation onto chromatin in response to 
replication stress, no subnuclear change is observed by immunofluoresence in 
cells under those conditions (Chini and Chen, 2003; Liu et al., 2006).  Chk1 is 
nucleoplasmic and very mobile, which is thought to be important for its role in 
mediating signaling between the site of a replication fork arrest and its targets of 
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checkpoint arrest such as preventing the firing of other replication origins 
(Bekker-Jensen et al., 2006).  Claspin displays spatial properties and dynamics 
similar to Chk1 in response to damage (Liu et al., 2006). One question that arises 
from these observations is whether Claspin is required to be associated with the 
replication fork in order to mediate Chk1 activation.  To answer this question, a 
truncated form of Xenopus Claspin that has a compromised ability to bind to 
replication forks was generated and was found capable of activating Chk1 in 
response to replication arrest in Claspin depleted extracts but with a significantly 
reduced efficiency (chapter 3) (Lee et al., 2005).  This suggests that Claspin 
association with stalled replication forks is not strictly required to mediate Chk1 
activation but the stalled fork binding does increase the efficiency of the process.   
Recent investigations have implicated Claspin with another complex of proteins 
on the replication fork.  A study in mammalian cells found that the protein TIM 
(timeless) interacts with Chk1, ATR, and ATRIP in an replication checkpoint-
stimulated manner (Unsal-Kacmaz et al., 2005).  Furthermore, siRNA-mediated 
knockdown of TIM led to reduced activation of Chk1 after replication arrest 
(Unsal-Kacmaz et al., 2005).  TIM has a stable binding partner named TIPIN, 
which was found to interact with Claspin in mammalian cells (Gotter et al., 2007).  
TIPIN also interacts with Claspin in Xenopus egg extracts and is required for 
Chk1 activation and chromatin accumulation of Claspin in response to arrested 
replication in the extract (Errico et al., 2007).  Moreover, TIM and TIPIN interact 
with several replication fork proteins such as RPA and components of the MCM2-
7 complex (Chou and Elledge, 2006; Gotter et al., 2007; Unsal-Kacmaz et al., 
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2007).  Depletion of TIM or TIPIN by siRNA in mammalian cells leads to an 
increased sensitivity to genotoxic stress in the cells as well as down-regulation of 
the intra-S-phase checkpoint that results in damage resistant DNA synthesis 
(Chou and Elledge, 2006; Gotter et al., 2007; Unsal-Kacmaz et al., 2007; Unsal-
Kacmaz et al., 2005; Yoshizawa-Sugata and Masai, 2007).  Interestingly, 
depletion of TIM in mammalian cells leads to a reduced rate of replication fork 
progression in unperturbed cells but depletion of TIPIN in mammalian cells and 
Xenopus egg extracts had no such effect (Errico et al., 2007; Unsal-Kacmaz et 
al., 2007).  However, depletion of TIPIN in the egg extract abated replication fork 
recovery after removal of the DNA polymerase inhibitor aphidicolin, perhaps due 
to the inability of Claspin to load onto chromatin under these conditions (Errico et 
al., 2007).  Finally, depletion of Chk1, Claspin, or TIM prevents the mono-
ubiquitinylation of PCNA in response to replication stress, which is thought to 
recruit translesion DNA polymerases to repair damaged chromatin (Yang et al., 
2008). Taken together, the data demonstrate that Claspin exists in a replication 
monitoring complex consisting of TIM, TIPIN, ATR, and ATRIP that is involved in 
ensuring fork stability and restart after replication arrest. 
1.2.3 Claspin is required for deactivation of the replication checkpoint 
Other recent studies have characterized the involvement of Claspin in turning off 
the replication checkpoint response.  In mammalian cells, Claspin levels are high 
in S-phase but low in G2, M-phase and G1, suggesting possible regulation by 
ubiquitin-mediated proteolysis (Mailand et al., 2006; Mamely et al., 2006).  Using 
a candidate approach, depletion of β-TRCP (β-transducin repeat containing 
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protein), the substrate adaptor for the E3 ubiquitin ligase SCF β-TRCP 
(Skp1/Cul1/F-box protein), led to a increase of Claspin protein levels in G2, when 
it is normally present at low levels (Mailand et al., 2006; Mamely et al., 2006; 
Peschiaroli et al., 2006).  Also, Claspin was found to interact with β-TRCP 
(Peschiaroli et al., 2006).  In G1, Claspin is degraded by a distinct E3 ubiquitin 
ligase, the APC (anaphase promoting complex) and siRNA knockdown of SCFβ -
TRCP had no effect on Claspin stability in this cell cycle phase (Faustrup et al., 
2009; Gao et al., 2009).  The deubiquitylating enzyme USP7 was found to 
counteract SCFβ -TRCP to maintain Claspin stability but had no effect on APC-
mediated ubiquitylation (Faustrup et al., 2009).   Plk1 (pololike kinase) was found 
to be required for Claspin degredation in G2 and promoted Claspin ubiquitylation 
by SCFβ-TRCP in vitro (Mailand et al., 2006; Mamely et al., 2006; Peschiaroli et al., 
2006).  Cells expressing nondegradable Claspin, lacking the SCFβ -TRCP 
ubiquitylation site, exhibit delayed entry into the cell cycle after replication stress 
due to prolonged activation of Chk1 (Mailand et al., 2006; Mamely et al., 2006; 
Peschiaroli et al., 2006).  This coincides with data demonstrating that Plk1 is 
required for recovery after DNA damage and its kinase activity is inhibited in 
response to DNA damage (Smits et al., 2000; van Vugt et al., 2004).  The finding 
also complements earlier work showing that Plx1 (the Xenopus homologue of 
Plk1) was found to interact with and phosphorylate Claspin in Xenopus egg 
extracts (Yoo et al., 2004).  Extracts where Claspin has been depleted and 
replaced by a recombinant Claspin protein incapable of interacting with or being 
phosphorylated by Plx1 are defective in their ability to adapt to aphidicolin-
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induced replication stress (Yoo et al., 2004).  Specifically, under these conditions 
Chk1 is not down-regulated and Claspin remains associated with chromatin at 
high levels (Yoo et al., 2004).  Thus, Claspin plays key roles in mediating both 
activation and deactivation of the replication checkpoint. 
1.3 The role of DDK in the replication and DNA damage checkpoints 
1.3.1 Evidence in yeast for the involvement of DDK in replication checkpoint 
Experiments in budding and fission yeasts suggest a role for DDK in the 
replication and DNA damage checkpoints.  Several laboratories have 
demonstrated that budding yeast Dbf4, fission yeast Dfp1/Him1, and Hsk1 are 
hyperphosphorylated in a Rad53/Cds1-dependent manner in response to the S-
phase inhibitor hydroxyurea (HU) (Brown and Kelly, 1999; Snaith et al., 2000; 
Takeda et al., 1999; Weinreich and Stillman, 1999).  There was also a reduction 
in budding yeast Cdc7 kinase activity observed in response to HU treatment, 
which reduces the cellular pool of dNTPs (Weinreich and Stillman, 1999).  
Additionally, the S. cerevisiae Cdc7/Dbf4 complex dissociates from replication 
origins after treatment with HU (Duncker et al., 2002; Pasero et al., 1999).  This 
coincides with the finding that in vitro phosphorylation of budding yeast Dbf4 by 
the Rad53 checkpoint effector kinase inactivates Cdc7-Dbf4 kinase activity 
(Kihara et al., 2000).  However, another report showed that the budding yeast 
Cdc7 kinase remained active even after HU treatment (Oshiro et al., 1999).  As 
mentioned previously, the N-terminal domain of Dbf4, which is not required for 
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replication, is required for the viability of budding yeast cells in response to HU 
(Gabrielse et al., 2006; Varrin et al., 2005).  
In fission yeast, a temperature sensitive allele of Hsk1 (hsk1-89) is 
hypersensitive to HU and the DNA damaging alkylating agent methyl 
methanesulfate (MMS) (Takeda et al., 2001).  Moreover, the normally HU-
activated kinase Cds1 has its activity compromised after HU treatment in the 
hsk1-89 genetic background in both permissive and non-permissive temperature 
regimes (Takeda et al., 2001).  It was also found that N motif deletions in fission 
yeast Dfp1 conferred sensitivity to UV irradiation, HU, ionizing radiation (IR) and 
MMS (Fung et al., 2002).  Further work has defined that Hsk1 acts in a complex 
with the replication mediator MRC1 (Claspin) and replication fork stability 
proteins Swi1 (TIM) and Swi3 (TIPIN) in response to a variety of replication 
stresses in S. pombe (Matsumoto et al., 2005; Shimmoto et al., 2009; 
Sommariva et al., 2005). 
1.3.2 The role of DDK in replication checkpoint in higher eukaryotes 
There are several conflicting reports regarding the regulation of DDK complex 
dynamics under conditions of genotoxic stress in higher eukaryotes.  A challenge 
in characterizing the role of DDK under these conditions is differences that have 
been observed between the Cdc7-Dbf4 and the Cdc7-Drf1 complexes.  Drf1-
Cdc7 kinase activity was found to be invariant in response to the DNA 
polymerase inhibitor aphidicolin, nor to induced double-strand breaks (DSBs) in 
Xenopus egg extracts (chapter 2) (Petersen et al., 2006; Yanow et al., 2003).  
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Similar results were seen in mammalian cells in response to HU or etoposide 
treatment (Tenca et al., 2007; Tsuji et al., 2008). However, the topoisomerase II 
inhibitor, etoposide, which induces double-stranded DNA breaks in S-phase 
causes the dissociation of Dbf4 from Cdc7 and inhibition of the Cdc7 kinase in 
Xenopus egg extracts (Costanzo and Gautier, 2003).  This Dbf4-Cdc7 
dissociation was also observed in response to etoposide in leukemia cells 
(Dierov et al., 2004).  In contrast, later investigations by two laboratories working 
with Xenopus egg extracts disputed the earlier Xenopus report by showing that 
Cdc7 remains active and in a stable complex with both Dbf4 and Drf1 in 
response to aphidicolin and etoposide (Silva et al., 2006; Tsuji et al., 2008).  Also 
in contradiction to this earlier report, other laboratories found that Drf1-Cdc7 and 
Dbf4-Cdc7 complexes were stable in response to HU or etoposide treatment in 
HeLa cells and in response to etoposide treatment in two different hematopoietic 
cell lines, a leukemia cell line and a colon cancer cell line (Tenca et al., 2007; 
Tsuji et al., 2008). It was suggested by the authors of this study that the Cdc7 
antibody used by Dierov et al., (2004) failed to immunoprecipitate native Cdc7-
Dbf4 in their laboratory (Tenca et al., 2007).  It would seem that an accumulating 
body of evidence indicates that DDK remains stable and active under conditions 
of genotoxic stress although there may be some cell-type-specific conditions 
where the kinase is inhibited.  Thus, there seems to be a divergence between 
checkpoint regulation of DDK between yeasts and higher eukaryotes. 
There are reports that DDK association with chromatin may be a mode of 
regulation for DDK since this interaction is crucial for its role in activating 
22 
 
replication origins.  Treatment with aphidicolin leads to the accumulation of Drf1 
on stalled replication forks in an ATR- and Claspin-dependent manner in 
Xenopus egg extracts (chapter 2) (Yanow et al., 2003).  Aphidicolin treatment as 
well as depletion of Drf1 (in both unperturbed and aphidicolin-treated extracts) 
results in a drastic reduction of Cdc45 binding to chromatin (chapter 2) (Yanow et 
al., 2003).  The aphidicolin-stimulated Drf1 chromatin accumulation and the 
Cdc45 chromatin suppression were also counteracted by treatment with caffeine, 
which is a PI3K-like kinase inhibitor (chapter 2) (Yanow et al., 2003).  This 
coincides with additional data that caffeine-mediated inhibition of the intra-S-
phase checkpoint results in some nascent DNA replication initiation in both 
Xenopus tissue culture (XTC) cells and egg extracts (chapter 2) (Yanow et al., 
2003).  More detailed analysis has shown that caffeine can lead to increased 
early origin firing even under unperturbed conditions as well as with low amounts 
of aphidicolin in Xenopus egg extracts (Marheineke and Hyrien, 2004; Shechter 
et al., 2004).  However, the aphidicolin-induced Drf1 accumulation was not 
observed in a later study with Xenopus egg extracts (Silva et al., 2006).  
However, my inspection of the published data that the authors claim supports 
their conclusion indicates that there is, in fact, a modest increase in chromatin-
bound Drf1 after aphidicolin treatment (Silva et al., 2006). The role of regulation 
of DDK chromatin association in replication and DNA damage checkpoints 
remains murky but the more recent investigations seem to suggest that DDK 
remains bound to replication forks under these conditions.   Taken together, the 
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body of evidence suggests that DDK is not a target for down-regulation by the 
DNA damage and replication checkpoints in higher eukaryotes.  
There are several preliminary indications that DDK may be an upstream regulator 
of the DNA damage and replication checkpoints in higher eukaryotes.  
Overexpression of Dbf4 in mammalian cells or ectopic addition of excess 
recombinant Dbf4-Cdc7 complexes in Xenopus egg extracts suppresses the 
activation of the ATR-Chk1 pathway, inhibition of late replication, and cell cycle 
progression in response to etoposide and other DNA damaging agents (Tsuji et 
al., 2008).  Phosphorylation of mammalian MCM4 induced by HU and etoposide 
was abated by siRNA-mediated knockdown of Cdc7 in HeLa cells (Tenca et al., 
2007).   Additionally, conditional null Cdc7 knockout mouse ES cells display a 
reduction in Chk1 activation in response to UV- and HU-induced replication 
stress but have no effect on Chk2 activation in response to IR treatment (Kim et 
al., 2008).  Similar results were observed in human cancer cells where Cdc7 was 
depleted by siRNA-mediated knockdown (Kim et al., 2008). These cells 
displayed other defects in checkpoint activation such as HU sensitivity and a loss 
of HU-induced phosphorylation and chromatin accumulation of Claspin (Kim et 
al., 2008).  One caveat to these experiments is that replication initiation is 
required for Chk1 activation in response to replication stress causing agents such 
as aphidicolin and HU (Lupardus et al., 2002; Michael et al., 2000; Stokes et al., 
2002).  By eliminating Cdc7 activity, the diminished Chk1 activation in response 
to HU in the mammalian Cdc7 depletion experiments may be a result of an 
overall reduction in the number of active replication forks rather than a direct 
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modulation of the ATR-Chk1 pathway by DDK.  However, the authors do observe 
that ATR still localizes to HU-induced foci under the Cdc7 depleted conditions, 
suggesting that some upstream replication checkpoint activity remains intact 
(Kim et al., 2008).  One candidate for direct modulation of the ATR-Chk1 
pathway is the replication checkpoint mediator, Claspin.  Adding credence to this 
hypothesis is the fact that Cdc7 interacts with and phosphorylates Claspin in 
mammalian cells (Kim et al., 2008).  However, this association and 
phosphorylation occurs independently of HU treatment (Kim et al., 2008).  We 
have confirmed the Claspin interaction with and phosphorylation by DDK in 
Xenopus egg extracts.  This interaction and phosphorylation is independent of 
aphidicolin and DNA damage checkpoint-inducing DNA templates in the extract 
(Gold, D.A., et al. unpublished data).  One possible model for the role of DDK in 
replication checkpoint signaling is that it may be required to maintain replication 
fork stability when the fork is stalled, allowing for possible replication restart if the 
damage is overcome. 
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Chapter 2 
 
Xenopus Drf1, a Regulator of Cdc7, Displays 
Checkpoint-Dependent Accumulation on Chromatin 
during an S-phase Arrest 
Stephanie K. Yanow, Daniel A. Gold, Hae Yong Yoo, and William G. Dunphy  
 
We have cloned a Xenopus Dbf4-related factor named Drf1 and characterized 
this protein by using Xenopus egg extracts. Drf1 forms an active complex with the 
kinase Cdc7. However, most of the Cdc7 in egg extracts is not associated with 
Drf1, which raises the possibility that some or all of the remaining Cdc7 is bound 
to another Dbf4-related protein. Immunodepletion of Drf1 does not prevent DNA 
replication in egg extracts. Consistent with this observation, Cdc45 can still 
associate with chromatin in Drf1-depleted extracts, albeit at significantly reduced 
levels. Nonetheless, Drf1 displays highly regulated binding to replicating 
chromatin. Treatment of egg extracts with aphidicolin results in a substantial 
accumulation of Drf1 on chromatin. This accumulation is blocked by addition of 
caffeine and by immunodepletion of either ATR or Claspin. These observations 
suggest that the increased binding of Drf1 to aphidicolin-treated chromatin is an 
active process that is mediated by a caffeine-sensitive checkpoint pathway 
containing ATR and Claspin. Abrogation of this pathway also leads to a large 
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increase in the binding of Cdc45 to chromatin. This increase is substantially 
reduced in the absence of Drf1, which suggests that regulation of Drf1 might be 
involved in the suppression of Cdc45 loading during replication arrest. We also 
provide evidence that elimination of this checkpoint causes resumed initiation of 
DNA replication in both Xenopus tissue culture cells and egg extracts. Taken 
together, these observations argue that Drf1 is regulated by an intra-S-phase 
checkpoint mechanism that down-regulates the loading of Cdc45 onto chromatin 
containing DNA replication blocks. 
2.1 Introduction 
In eukaryotes, DNA replication is initiated by a multistep process. Early in the G1-
phase, replication initiation factors are sequentially assembled onto replication 
origins to form prereplicative complexes (pre-RCs).  At the core of the pre-RC is 
the origin recognition complex, a six-subunit protein assembly which is required 
for the subsequent loading of other pre-RC components, including Cdc6/Cdc18, 
Cdt1, and the Mcms (Nishitani and Lygerou, 2002). The second phase of the 
initiation process involves the transition of the pre-RC to a pre-initiation complex 
(Zou and Stillman, 1998). A key determinant for this step is the loading of Cdc45 
onto pre-RCs (Aparicio et al., 1999; Zou and Stillman, 2000).  This binding 
requires the concerted actions of the Mcm10 and Mus101 proteins, and the 
activities of two types of kinases: the S-phase cyclin-dependent kinases (primarily 
cyclin E-Cdk2) and Dbf4-Cdc7 (Wohlschlegel et al., 2002; Zou and Stillman, 
1998, 2000) (Costanzo et al., 2000; Jares and Blow, 2000; Mimura and 
Takisawa, 1998; Van Hatten et al., 2002; Walter and Newport, 2000). It has been 
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proposed that the S-phase cyclin-dependent kinases act as global activators of 
S-phase onset, whereas Dbf4-Cdc7 functions at the level of the individual origins 
and is therefore required throughout S-phase (Bousset and Diffley, 1998; 
Donaldson et al., 1998).  
The Dbf4-Cdc7 kinase consists of a regulatory subunit, Dbf4, and a catalytic 
subunit, Cdc7. In yeast, the Cdc7 subunit is present at constant levels throughout 
the cell cycle, whereas the Dbf4 subunit accumulates only during the G1/S-phase 
and is then degraded by ubiquitin-mediated proteolysis (Brown and Kelly, 1998; 
Pasero et al., 1999; Takeda et al., 1999; Weinreich and Stillman, 1999). The 
activation of Cdc7 by Dbf4 leads to the phosphorylation of key substrates within 
the pre-RC. The best characterized substrate both in vitro and in vivo is the 
Mcm2 subunit of the Mcm complex (Brown and Kelly, 1998; Jiang et al., 1999; 
Lei et al., 1997; Masai et al., 2000). It has been suggested that phosphorylation 
of Mcm2 alters the structure of the pre-initiation complex to induce DNA 
unwinding (Geraghty et al., 2000). Mcm subcomplexes possess DNA helicase 
activity in vitro and may be involved in DNA unwinding during origin firing (Ishimi, 
1997; Lee and Hurwitz, 2001) 
In S-phase cells, the presence of stalled replication forks or damaged DNA 
invokes a checkpoint response that delays entry into mitosis until the defect has 
been repaired (Melo and Toczyski, 2002; O'Connell et al., 2000; Zhou and 
Elledge, 2000). These regulatory mechanisms are known as S-M checkpoints. 
The signal transduction cascades that underlie S-M checkpoints have been well 
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characterized in yeast model systems. A defect is recognized by various sensor 
proteins, which elicit activation of the effector kinases Chk1 or Cds1 (Rad53 in 
budding yeast), depending on the nature of the checkpoint-inducing DNA signal. 
These kinases then phosphorylate key targets within the cell cycle machinery to 
delay mitosis (O'Connell et al., 2000). In vertebrates, homologues of the Rad3 
protein include ATR and ATM, both members of the family of phosphatidylinositol 
3-kinase-like kinases (Abraham, 2001). Evidence suggests that ATR is involved 
in the detection of replication blocks, whereas ATM is activated in response to 
DNA damage, leading to activation of Chk1 and Chk2, respectively (Bartek et al., 
2001; Guo and Dunphy, 2000; Guo et al., 2000; Hekmat-Nejad et al., 2000; Liu et 
al., 2000; Zhao and Piwnica-Worms, 2001).  Another protein that has been 
implicated in the signaling in response to replication blocks is Claspin, which was 
discovered in Xenopus as a Chk1-binding protein that is essential for activation of 
Chk1 following induction of the replication checkpoint (Kumagai and Dunphy, 
2000).  
Recent studies in vertebrate systems have also identified a checkpoint pathway 
that prevents the onset of DNA replication in the presence of damaged DNA. In 
Xenopus, one of the targets of this checkpoint pathway is the Cdc45 protein. 
Reconstitution of the DNA damage checkpoint in a Xenopus cell-free system 
identified a pathway that activates ATM in response to DNA containing double-
strand breaks (Costanzo et al., 2000). ATM, in turn, down-regulates cyclin E-
Cdk2 activity, thus preventing the loading of Cdc45 onto chromatin and inhibiting 
DNA replication. Similarly, Cdc45 is a target of a checkpoint induced by treatment 
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with etoposide, a topoisomerase II inhibitor (Costanzo et al., 2003). Activation of 
this checkpoint, which is mediated by ATR, leads to the down-regulation of Cdc7-
associated kinase activity and inhibition of the binding of Cdc45 to chromatin.  
In yeast, similar pathways are involved in signaling a third checkpoint, the intra-
replication checkpoint. This checkpoint inhibits the firing of late replication origins 
in the presence of stalled replication forks or DNA damage that occurs during S-
phase. In budding yeast, both subunits of the Dbf4-Cdc7 kinase undergo Rad53-
dependent phosphorylation in response to treatment with hydroxyurea. This 
phosphorylation releases Dbf4-Cdc7 from chromatin, inhibits its kinase activity, 
and thereby prevents the loading of Cdc45 (Aparicio et al., 1999; Kihara et al., 
2000; Pasero et al., 1999; Weinreich and Stillman, 1999). In mammalian cells, a 
recent study showed that mice lacking Cdc7 are embryonic lethal, demonstrating 
that this kinase is essential for embryonic development (Kim et al., 2002). 
Furthermore, when Cdc7 was conditionally removed from an embryonic stem cell 
line, cells arrested within S-phase with partially replicated DNA. These results 
support a critical role for the Dbf4-Cdc7 kinase in ensuring the integrity of the 
DNA throughout the process of replication.  
In this study we have cloned a Xenopus member of the Dbf4 family, which we 
have named Xenopus Dbf4-related factor 1 (Drf1). The Drf1 protein is not 
essential for DNA replication or the recruitment of Cdc45 to chromatin during 
normal S-phase. However, Drf1 displays highly regulated binding to replicating 
chromatin. Unlike the scenario in yeast and the etoposide-induced pathway in 
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Xenopus, we have observed that, following replication fork arrest, Drf1 and Cdc7 
accumulate on chromatin. This binding is dependent upon ATR and Claspin, and 
is abrogated by treatment with caffeine. The loss of Drf1 from chromatin in the 
presence of caffeine correlates with an increase in Cdc45 loading, which is also 
observed in aphidicolin-treated extracts lacking ATR or Claspin. Caffeine is also 
capable of overriding an intra-S checkpoint that prevents further initiation events 
in the presence of aphidicolin, both in XTC cells and in egg extracts. We have 
established a biochemical assay for this checkpoint by using alkaline agarose 
gels and have observed a significant increase in the synthesis of small DNA 
fragments when extracts are treated with aphidicolin and caffeine. We 
hypothesize that activation of ATR by stalled replication forks leads to the 
accumulation of Drf1 on chromatin in a checkpoint-dependent manner. This 
checkpoint-dependent association of Drf1 with chromatin may play a role in 
preventing the binding of Cdc45 to chromatin during a replication arrest. 
2.2 Experimental Procedures 
2.2.1 Cloning of a Xenopus Drf1 Homologue—The following oligonucleotides 
were designed corresponding to sequences in a Xenopus expressed sequence 
tag (accession no. BG408573 [GenBank] ) from the EMBL sequence library: 
sense, 5'-gcagcaggacgatgaacccccattggcc-3'; antisense, 5'-
ccttccgttccgcagcctggatttgggac-3'. A polymerase chain reaction (PCR) using a 
Xenopus cDNA library generated with the Marathon RACE kit (Clontech) served 
as the template. The 270bp PCR product was subsequently biotinylated and 
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used as a probe to screen a Xenopus oocyte cDNA library in the pAX-NMT 
vector (Mueller et al., 1995) using the ClonCapture cDNA selection kit (Clontech). 
The same PCR fragment was radiolabeled and used to isolate the full-length 
cDNA from the pool of clones enriched for Drf1. Positive clones were verified by 
PCR, and sequencing of both strands was performed with an ABI model 373 
automated sequencer. The GenBank accession no. for Drf1 is AY328889 
[GenBank] .  
2.2.2 Antibodies—Xenopus Cdc7 was amplified by PCR with the following 
oligonucleotides: 5'-gggaattccatatgagttcgggcgataattcagg-3' and 5'-
actggggaattcctaccgcatgtttttaaacagagc-3' (Roberts et al., 1999). The RACE 
Xenopus cDNA library described above served as the template. The full-length 
Cdc7 coding sequence was cloned into the NdeI and EcoRI sites of the pET3-
His6X vector, and the resulting plasmid was transformed into Codon Plus 
Escherichia coli cells for expression and purification as described (Roberts et al., 
1999). Antibodies were affinity purified using standard methods with the antigen 
described above conjugated to CNBr-activated Sepharose 4B (Amersham 
Biosciences).  
Antibodies were raised against an N-terminal fragment of Drf1. The fragment was 
amplified by PCR using the following oligonucleotides: sense, 5'-
gggaattccatatgcagcaggacgatgaacc-3'; antisense, 5'-
gccaggtgaattcctatgtggggctcac-3'. The 1270bp fragment was cloned into the NdeI 
and EcoRI sites of the pET3-His6X vector and expressed in Codon Plus cells. 
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The fusion protein was purified from inclusion bodies as described above for 
Cdc7. Antibodies were affinity-purified as described above. Affinity-purified 
antibodies against Xenopus Claspin, Chk1, and ATR, and antisera against Orc2 
were described previously (Carpenter et al., 1996; Kumagai and Dunphy, 2000; 
Lee et al., 2003). Antisera against Xenopus Cdc45 were generously provided by 
J. Lee.  Monoclonal antibodies against human Mcm2 were obtained commercially 
(BM28, BD Biosciences). Antibodies recognizing Xenopus Mcm4 were kindly 
provided by J. Blow. Control rabbit IgG was obtained from Zymed Laboratories.  
2.2.3  Recombinant proteins- Xenopus GST-Mcm2 was cloned into pGEX4T2 
vector (Amersham Biosciences), expressed in Codon Plus cells, and purified with 
GST-agarose. Recombinant geminin was purified as described (Carpenter et al., 
1996; Kumagai and Dunphy, 2000; Lee et al., 2003).  
2.2.4 Egg Extracts—Xenopus egg extracts were prepared as described (Murray, 
1991). Egg extracts arrested in interphase because of the presence of 
unreplicated DNA routinely contained 3000 demembranated Xenopus sperm 
nuclei/µl of extract and 100 µg/ml aphidicolin. Caffeine was added to a final 
concentration of 5 mM from a 100 mM solution freshly dissolved in 10 mM 
PIPES-KOH (pH 7.5).  
2.2.5 Immunodepletion—Immunodepletions of Chk1 and Claspin from egg 
extracts were carried out with Affiprep-protein A beads (Bio-Rad) as described 
previously (Kumagai and Dunphy, 2000). For immunodepletion of Cdc7 and Drf1, 
100 µl of serum coupled to Affiprep-protein A beads was used per 100 µl of CSF-
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arrested extract, during two rounds of depletion. Pre-immune serum served as a 
control. For immunodepletion of ATR, 25 µg of antibody coated on protein A-
magnetic beads (Dynal) was incubated with extracts on ice for 1 h. The beads 
were removed with a magnet, and the procedure was repeated.  
2.2.6 Chromatin Isolation—Egg extracts (100 µl) containing 3,000 sperm nuclei/µl 
were overlaid on a 1-ml sucrose cushion containing chromatin isolation buffer 
(CIB; 20 mM HEPES-KOH (pH 7.6), 1 M sucrose, 80 mM KCl, 25 mM potassium 
gluconate, and 10 mM magnesium gluconate), and centrifuged at 6,100 × g for 5 
min. The pellets were washed twice with CIB + 0.5% Nonidet P-40, and 
centrifuged as above. The chromatin pellets were boiled in 2× SDS sample buffer 
and subjected to SDS-PAGE. To elute chromatin-associated proteins, chromatin 
pellets were prepared from 400 µl of extract by overlaying 200 µl on a 1ml 
sucrose cushion in duplicate. Samples were centrifuged at 6,100 × g for 5 min. 
Chromatin pellets were washed twice with CIB and then once with CIB + 0.5% 
Nonidet P-40. The supernatants were removed, and the chromatin pellets were 
resuspended in 100 µl of 1 M NaCl, 10 mM HEPES-KOH (pH 7.6). Samples were 
incubated on ice for 10 min and then centrifuged at 11,700 × g for 5 min. The 
supernatant contained the proteins eluted from chromatin.  
2.2.7 Replication Assays—To monitor DNA replication, egg extracts were 
incubated with sperm nuclei (1,000–3,000 sperm nuclei/µl), 0.4 mM CaCl2, 100 
µg/ml cycloheximide, and 1 µl of [α -32P]dATP for 90 min at room temperature. 
The reaction was terminated upon addition of an equal volume of 2× replication 
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stop buffer (80 mM Tris-HCl (pH 8), 8 mM EDTA, 0.13% phosphoric acid, 10% 
Ficoll, 5% SDS, and 0.2% bromophenol blue), and 1 mg/ml proteinase K, 
followed by incubation at 55°C for 1 h. Samples were run on 1% agarose gels, 
dried, and detected by a PhosphorImager (Amersham Biosciences).  
2.2.8 Immunoprecipitations and Kinase Assays—For immunoprecipitation of Drf1 
and Cdc7 from egg extracts, 100 µl of extract was diluted 3-fold with 10 mM 
HEPES-KOH (pH 7.6), 150 mM NaCl, 2.5 mM EGTA, 20 mM β-
glycerophosphate, and 0.5% Nonidet P-40, and centrifuged at 11,700 x g for 10 
min to pellet nuclei. Supernatants were removed and incubated with 5 µg of 
affinity-purified antibody bound to Affiprep-protein A beads for 1 h at 4°C with 
rotation. The beads were washed three times with buffer X (10 mM HEPES-KOH 
(pH 7.6), 80 mM NaCl, 2.5 mM EGTA, 20 mM β-glycerolphosphate, and 0.1% 
Nonidet P-40), then once with HBS (150 mM NaCl, 10 mM HEPES-KOH (pH 
7.6)). For immunoprecipitation of proteins eluted from chromatin, the supernatant 
was removed and diluted 8-fold with 50 mM NaCl, 10 mM HEPES-KOH (pH 7.6) 
and incubated with 5 µg of antibody bound to Affiprep-protein A beads for 1 h at 
4°C with rotation. The beads were washed three times with buffer X, and then 
once with HBS. For in vitro kinase assays, the beads were resuspended in HBS. 
One-half was boiled in 2× SDS sample buffer, subjected to SDS-PAGE, and 
immunoblotted for Drf1 and Cdc7. The other half was incubated with kinase 
buffer (50 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 1 mM dithiothreitol,
 and 50 µM 
ATP) containing [γ-32P]ATP and 1 µg of GST-Mcm2. Samples were incubated at 
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room temperature for 15 min with rotation, then boiled in 2× SDS sample buffer, 
subjected to SDS-PAGE, and detected by a PhosphorImager.  
2.2.9 Cell Culture and Immunofluorescence—XTC-2 cells were grown on poly-D-
lysine-coated coverslips in 61% Leibovitz's (L-15) medium supplemented with 
10% fetal calf serum and antibiotics. Caffeine-treated cells were incubated with 5 
mM caffeine 90 min prior to aphidicolin treatment, where applicable. The cells 
were then incubated with 100 µM BrdUrd and 5 µg/ml aphidicolin where 
indicated. At 5.5 h, cells were fixed with 3% paraformaldehyde, permeabilized 
with 0.1% Triton X-100, and subjected to indirect immunofluorescence. For 
BrdUrd visualization, cells were refixed with 0.1% formaldehyde and incubated 
for 10 min in 2 M HCl and 0.1% Triton X-100 at room temperature. The acid was 
washed away, and the immunofluorescence procedure was repeated with anti-
BrdUrd (Roche) as the primary antibody and Texas Red conjugated anti-mouse 
IgG (Jackson Laboratories) at a 1:500 dilution as the secondary antibody. The 
coverslips were washed (with 1 µg/ml Hoechst 33258 in the last wash) and 
mounted onto glass slides with Vectamount (Vector Laboratories). The samples 
were imaged with a SpotRT CCD camera (Diagnostic Instruments) and analyzed 
with Adobe Photoshop.  
2.2.10 Alkaline Gel Electrophoresis—Replication reactions (typically 40 µl of egg 
extract) were resuspended in 300 µl of StopN (20 mM Tris-HCl (pH 8), 200 mM 
NaCl, 5 mM EDTA, and 0.5% SDS) containing 2 µg/ml RNase, and digested for 
10 min at 37°C. Proteinase K (200 µg/ml) was added, and samples were 
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incubated for another 30 min at 37°C. DNA was extracted twice with 
phenol:chloroform:isoamyl alcohol (Sigma) and then precipitated with ethanol. 
Pellets were resuspended in 10 µl of 10 mM EDTA, and then diluted with an 
equal volume of 2× alkaline loading buffer (100 mM NaOH, 2 mM EDTA, 2.5% 
Ficoll, and 0.025% bromcresol green). Samples were loaded onto gels containing 
1% agarose in 50 mM NaCl and 1 mM EDTA, and run overnight in alkaline gel 
running buffer (50 mM NaOH, 1 mM EDTA). Gels were fixed with 7% 
trichloroacetic acid, dried, and autoradiographed. 
2.3 Results 
2.3.1 Identification of a cDNA Encoding Xenopus Drf1—A Xenopus homologue 
from the Dbf4 family was cloned by first amplifying a 270bp sequence with 
oligonucleotides designed to recognize a Xenopus expressed sequence tag with 
homology to Dbf4 proteins in other species. This fragment was then used to 
screen a Xenopus cDNA library to isolate the full-length open reading frame. 
Recently, a Xenopus Dbf4 sequence has been entered in the GenBank database 
(accession no. AB095983 [GenBank]). Our cloned protein shares significant 
sequence homology with this protein (28% identical) but represents a second, 
distinct Dbf4-like polypeptide (figure 2.1A). In humans, two Dbf4-like proteins 
have been identified, both of which activate Cdc7 (Jiang et al., 1999; Montagnoli 
et al., 2002). The cDNA that we have identified in Xenopus encodes a 772-amino 
acid protein that is homologous to both human proteins (32% and 26% identical 
to human Drf1 and ASK, respectively) but shares a higher identity with Drf1 
(figure 2.1A). In comparison with other vertebrate Dbf4 proteins, Xdrf1 shares 
37 
 
29% identity with the hamster Dbf4 and 30% identity with the mouse Dbf4. Based 
on the sequence and the experimental evidence presented below, we believe 
that we have cloned a Dbf4-related factor, and have named this protein Xdrf1 
(referred to hereafter as Drf1). 
Three distinct amino acid motifs have been described for the Dbf4 gene family: 
motifs N, M, and C (Masai and Arai, 2000). Motif N shares similarity to a BRCT-
like domain and may be functionally important for the replication and DNA 
damage checkpoints; mutations in this region of the fission yeast homologue, 
Dfp1/Him1, do not affect the replication functions of the kinase but cause 
hypersensitivity to drugs that block DNA replication or damage DNA (Ogino et al., 
2001). Motif M consists of a proline-rich region, and motif C resembles a CCHH-
type zinc finger motif (Masai and Arai, 2000). These two regions of Dfp1/Him1 
are both necessary and sufficient for full activation of the kinase (Ogino et al., 
2001). All three of these motifs are highly conserved in the Xenopus Drf1 protein 
(figure 2.1B and C). 
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Figure 2.1 Sequence analysis of Xenopus Drf1. 
(A) phylogenetic tree displaying the evolutionary relationships among the following Dbf4-like 
family members: Xenopus (XDrf1 and XDbf4), Saccharomyces cerevisiae (ScDbf4), human 
(HsDrf1 and HsASK), Schizosaccharomyces pombe (SpHsk1), mouse (MuDbf4), Chinese 
hamster (ChDbf4), Drosophila (Chiffon), and Aspergillus (nimO). (B) schematic of the 
Xenopus Drf1 protein illustrating the three motifs conserved in Dbf4-related proteins. 
Numbers correspond to amino acid position in the sequence of Drf1. (C) alignment of the 
motifs in B with those in other species. Numbers in parentheses correspond to amino acid 
positions in each respective protein. 
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2.3.2 Drf1 Is Dispensable for DNA Replication and Cdc45 Loading—We raised 
antibodies against an N-terminal fragment of the Xenopus Drf1 protein. This 
antibody efficiently detects the endogenous Drf1 protein by immunoblotting 
(figure 2.2A). Although the predicted molecular mass of Drf1 is 85 kDa, we found 
that the protein detected by two different antibodies raised against Drf1 migrated 
more slowly, at ~150 kDa. Upon removal of Drf1 with anti-Drf1 antibodies, we 
observed that a significant amount of Cdc7 remained in the Drf1-depleted extract. 
Possible explanations are that there is a pool of free Cdc7 or that a second Dbf4-
like protein may also form a complex with Cdc7, as is the case in human cells. To 
determine whether Drf1 is required for DNA synthesis, we depleted Drf1 from egg 
extracts and monitored the extent of DNA replication. We observed no defect in 
DNA replication in the absence of Drf1 compared with the mock-depleted or 
untreated extracts (figure 2.2B). This result contrasts with the nearly complete 
inhibition of replication that has been reported for depletion of the Xenopus Cdc7 
protein (Jares and Blow, 2000; Roberts et al., 1999). It is possible that our 
antibodies failed to completely deplete Drf1 from the extracts, thereby allowing 
some residual kinase to promote DNA replication. However, immunoprecipitation 
of Drf1 from a Drf1-depleted extract failed to detect any Drf1 protein (data not 
shown). Hence, our results suggest that either Drf1 is not the regulatory subunit 
of Cdc7 that is essential for DNA replication or, alternatively, that when Drf1 is 
depleted from extracts, the replication function of the kinase is performed by a 
Dbf4-Cdc7 complex.
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Figure 2.2  Drf1 forms an active kinase with Cdc7 but is not 
essential for DNA replication. 
(A) Western blot analysis of Drf1 and Cdc7 in untreated, Drf1-depleted, and mock-
depleted extracts. (B) sperm nuclei were incubated in interphase extracts from A 
in the presence of [α -32P]dATP for 90 min. DNA replication was determined as 
described under "Experimental Procedures." (C) sperm nuclei were incubated for 
60 min in mock-depleted and Drf1-depleted extracts. Chromatin fractions were 
isolated and immunoblotted with antibodies against Drf1, Cdc45, Claspin, Mcm2, 
and Orc2. (D) sperm nuclei were incubated in interphase extracts for 100 min in 
the absence or presence of 30 µM etoposide. Chromatin fractions were isolated 
and immunoblotted with antibodies against Drf1, Cdc7, Cdc45, and Orc2. (E) 
immunoprecipitation of Cdc7 and Drf1 from interphase extracts. Half of the 
immunoprecipitate was immunoblotted with antibodies against Drf1 and Cdc7. The 
other half was incubated with GST-Mcm2 and [γ-32P]ATP for in vitro kinase 
assays. 
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In yeast, both the Dbf4 and Cdc7 subunits are required for the loading of Cdc45 
onto chromatin. In Xenopus, a similar requirement has been shown for Cdc7 
(Walter, 2000). To determine whether depletion of Drf1 affects the ability of 
Cdc45 to bind to chromatin, we analyzed the chromatin fraction of Drf1-depleted 
extracts that had been incubated with sperm nuclei for 60 min (figure 2.2C). 
Although we observed a significant reduction in the levels of chromatin-bound 
Cdc45 in the Drf1-depleted extracts compared with the control extract, Cdc45 
was nonetheless still capable of binding to chromatin. Consistent with this 
observation, Claspin, which is dependent on Cdc45 for its recruitment to 
chromatin during interphase (Lee et al., 2003), was also bound to chromatin in 
the absence of Drf1, albeit at lower levels. As expected, the binding of 
components of the pre-RC, including Orc2 and Mcm2, was not dependent on 
Drf1. These results are consistent with the hypothesis that another member of the 
Dbf4 family must contribute to the replication function of the Cdc7 kinase.  
A recent report identified a Xenopus Dbf4 protein as the target of an etoposide-
induced checkpoint (Costanzo et al., 2003). In the presence of etoposide, it was 
observed that Dbf4 failed to bind to chromatin, resulting in the loss of Cdc45 
loading. We tested whether we could also detect the loss of chromatin binding of 
Drf1 in the presence of etoposide (figure 2.2D). Although etoposide efficiently 
inhibited DNA replication (data not shown), we failed to observe any change in 
the chromatin binding of Drf1. However, the chromatin binding of Cdc45 was 
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inhibited by etoposide, consistent with the published results. Collectively, these 
results support the conclusion that Drf1 constitutes a second member of the Dbf4 
family in Xenopus laevis.  
Given the different properties of Xenopus Dbf4 and Drf1, we verified that Drf1 is 
indeed a regulatory subunit of the Cdc7 kinase. Using Drf1 and Cdc7 antibodies, 
we tested whether these proteins could be coimmunoprecipitated with each other 
from Xenopus egg extracts (figure 2.2E, upper panel). We found that Drf1 and 
Cdc7 formed a stable complex that could be immunoprecipitated with antibodies 
against either subunit. This complex also formed an active kinase that readily 
phosphorylated GST-Mcm2 in vitro (figure 2.2E, bottom panel). These results 
confirm that the Drf1-Cdc7 complex has kinase activity.
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Figure 2.3   Drf1 is a chromatin-binding protein. 
 (A) whole-egg extract and chromatin fractions isolated at various times 
(minutes) following addition of sperm chromatin to interphase extracts were 
immunoblotted with antibodies against Drf1, Cdc7, Cdc45, Mcm2, and Orc2. 
The second lane depicts a mock chromatin fraction from an extract lacking 
DNA. (B) mock-depleted, Drf1-depleted, and Cdc7-depleted extracts were 
incubated with sperm nuclei for 100 min. Subsequently, chromatin fractions 
were immunoblotted with antibodies against Drf1, Cdc7, and Mcm2. (C) 
sperm nuclei were incubated in egg extracts in the absence and presence of 
aphidicolin (Aph) and geminin, as indicated. After 100 min, chromatin 
fractions were immunoblotted with antibodies against Drf1, Cdc7, Mcm4, 
and Orc2. 
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 2.3.3 Drf1 Binds to Chromatin in a Regulated Manner—We next characterized 
the binding of Drf1 to chromatin. As was reported for Cdc7 (Jares and Blow, 
2000), Drf1 binds to chromatin after Mcm2 and around the same time as Cdc45 
(figure 2.3A). Because both Drf1 and Cdc7 bind to chromatin at the onset of S-
phase, we tested whether each subunit requires the other to bind to chromatin 
(figure 2.3B). In Drf1-depleted extracts, Cdc7 binding was barely detectable. 
Likewise, in Cdc7-depleted extracts, we failed to observe any chromatin-bound 
Drf1. These observations suggest that Drf1 and Cdc7 bind to chromatin as a 
complex or indirectly stabilize each other on chromatin. Furthermore, when 
extracts were treated with geminin, an inhibitor of Cdt1-dependent Mcm loading 
(McGarry, 2002), the binding of both Drf1 and Cdc7 to chromatin was strongly 
inhibited (figure 2.3C). This finding indicates that binding of Drf1 and Cdc7 is 
dependent upon the pre-RC. 
2.3.4 Chromatin Binding of Drf1 and Cdc7 following Aphidicolin Treatment Is 
Checkpoint regulated—Because Cdc7 and Dbf4 are regulated by the DNA 
replication checkpoint in Xenopus and in yeast, we tested whether Drf1 may also 
have a checkpoint-specific function. In the presence of aphidicolin, which induces 
a block to replication, it has been reported that the binding of Cdc7 to chromatin 
is increased (McGarry, 2002). We observed a similar increase in the levels of 
Drf1 following incubation of sperm nuclei in extracts in which the replication 
checkpoint was activated by aphidicolin (figure 2.4A). This increase is also 
sensitive to geminin, which is consistent with a requirement for initiation to occur 
to establish the replication checkpoint induced by aphidicolin (figure 2.3C). 
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However, the increase in Drf1 and Cdc7 binding to chromatin could simply be a 
consequence of the increased number of replication forks that stall in response to 
aphidicolin. In this case, we would predict that the chromatin binding of Drf1 and 
Cdc7 would be independent of the checkpoint-signaling pathways. To test this 
possibility, we treated extracts with aphidicolin and caffeine, an inhibitor of ATM 
and ATR, to determine whether inhibition of checkpoint-signaling affects the 
levels of Drf1 and Cdc7 on chromatin. We found that the levels of both Drf1 and 
Cdc7 on chromatin were significantly reduced in the presence of caffeine (figure 
2.4A). This behavior is in stark contrast to the regulation of Cdc45. A slight 
increase in chromatin binding of Cdc45 was observed in the presence of 
aphidicolin, but the association of Cdc45 with chromatin was dramatically up-
regulated upon addition of caffeine (figure 2.4A). This observation suggests that 
Cdc45 loading may be suppressed by a checkpoint pathway that is activated by a 
replication block.
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Figure 2.4  Regulation of the binding of Drf1 and Cdc7 to chromatin. 
 (A) sperm nuclei were incubated for 100 min in interphase extracts with no drug, 
aphidicolin (Aph), or aphidicolin plus caffeine. Chromatin fractions were immunoblotted for 
Drf1, Cdc7, Cdc45, Mcm2, and Orc2. (B) untreated, mock-depleted, ATR-depleted, 
Claspin-depleted, and Chk1-depleted extracts were immunoblotted with anti-ATR, anti-
Claspin, and anti-Chk1 antibodies. (C) the extracts described in B were incubated with 
sperm nuclei in the presence of no drug, aphidicolin, or aphidicolin plus caffeine for 100 
min. Chromatin was isolated and immunoblotted with antibodies against Xenopus Drf1, 
Cdc7, and Cdc45. (D) interphase, Drf1-depleted, and mock-depleted extracts were 
incubated with sperm nuclei and either no drug, aphidicolin, or aphidicolin plus caffeine for 
100 min. Chromatin fractions were immunoblotted with antibodies against Drf1, Cdc7, 
Cdc45, and Orc2. 
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To characterize further the checkpoint-dependent chromatin binding of Drf1 and 
Cdc7, we tested whether this binding requires specific components of the 
checkpoint-signaling pathway. For this purpose, we depleted ATR, Claspin, or 
Chk1 from egg extracts (figure 2.4B). Sperm nuclei and aphidicolin were added to 
these depleted extracts, and chromatin fractions were immunoblotted for Drf1 
and Cdc7. In both the ATR-depleted and Claspin-depleted extracts, we found that 
Drf1 and Cdc7 levels were reduced as compared with the mock-depleted controls 
and were very similar to the levels observed in extracts treated with both 
aphidicolin and caffeine (figure 2.4C). In contrast, when Chk1 was depleted, 
there was no effect on the chromatin binding of either Drf1 or Cdc7. These results 
suggest that upstream components of the replication checkpoint pathway are 
required for the recruitment or stability of Drf1 and Cdc7 on chromatin following 
aphidicolin treatment, yet the chromatin binding of Drf1 and Cdc7 is not 
dependent on the effector kinase Chk1. Another significant finding involves the 
effect of ATR and Claspin depletion on Cdc45. When extracts were treated with 
aphidicolin in the absence of ATR or Claspin, Cdc45 levels on chromatin 
increased significantly, similar to those observed in the presence of both 
aphidicolin and caffeine (figure 2.4A and C). In contrast, depletion of Chk1 had no 
effect on Cdc45. From these results we conclude that the regulated chromatin 
binding of Drf1, Cdc7, and Cdc45 during a replication block is dependent upon 
ATR and Claspin.
48 
 
  
Figure 2.5  The kinase activity of Drf1-Cdc7 is not affected by 
aphidicolin treatment.  
Interphase extracts were incubated without aphidicolin, with aphidicolin, and 
with aphidicolin plus caffeine. The extracts (A) and chromatin fractions isolated 
from these extracts (B) were immunoprecipitated (IP) with control, anti-Cdc7, 
and anti-Drf1 antibodies. The immunoprecipitates were then probed for Cdc7 
and Drf1 by immunoblotting. (C) the kinase activity of immunoprecipitates from 
A was tested in vitro using GST-Mcm2 as a substrate. 
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 These findings suggest that a replication checkpoint pathway may respond to 
stalled replication forks by suppressing further loading of Cdc45 at these forks or 
at other origins. To test whether Drf1 plays a role in preventing additional Cdc45 
from binding to chromatin, we depleted Drf1 from egg extracts and then 
examined the levels of chromatin-bound Cdc45 in these extracts in the presence 
of no drug, aphidicolin, or aphidicolin and caffeine (figure 2.4D). In mock-depleted 
extract, low levels of Cdc45 were detected in the absence and presence of 
aphidicolin, whereas a significant increase in Cdc45 loading was observed in the 
presence of both aphidicolin and caffeine. However, only a small increase in the 
binding of Cdc45 occurred in Drf1-depleted extracts that were treated with both 
aphidicolin and caffeine. These findings imply that Drf1 is involved in regulating 
Cdc45 loading during a replication block. 
2.3.5 Regulation of Drf1-Cdc7 Kinase Activity during the Replication Block—In 
Xenopus egg extracts, treatment with the DNA damaging agent etoposide 
disrupts the interaction between Dbf4 and Cdc7. This treatment therefore 
inactivates the kinase and prevents the binding of Cdc45 to chromatin (Costanzo 
et al., 2003). To determine whether Drf1 and Cdc7 are regulated in a similar 
fashion in response to aphidicolin, we tested whether both subunits could be 
coimmunoprecipitated with each other in the extract and on chromatin. In both 
fractions, Drf1 and Cdc7 coimmunoprecipitated with each other in the presence 
of aphidicolin (figure 2.5A and B). This observation suggests that the Drf1-Cdc7 
complex is maintained during a replication block. 
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We next measured the kinase activity associated with Drf1 that had been 
immunoprecipitated from either the extract or chromatin fractions, using GST-
Mcm2 as a substrate. In the extract, no obvious change in the kinase activity was 
observed in response to aphidicolin or aphidicolin plus caffeine (figure 2.5C). 
Similar results were observed when the kinase activity of the chromatin-eluted 
Drf1-Cdc7 complex was measured (data not shown). Taken together, these 
results indicate that the aphidicolin-induced checkpoint does not lead to a readily 
discernible inhibition of the kinase activity of Drf1-Cdc7 under these assay 
conditions.  
2.3.6 A Caffeine-sensitive Checkpoint Inhibits Replication in XTC Cells during 
Aphidicolin Arrest—Our chromatin binding data suggest that an aphidicolin-
induced, caffeine-sensitive checkpoint regulates the binding of Drf1 and Cdc7 to 
chromatin. The aphidicolin-dependent increase in the chromatin binding 
correlates with a suppression of Cdc45 that is reversed upon abrogation of the 
checkpoint with caffeine. These observations suggest that Drf1 is a target of an 
intra-S checkpoint that regulates the loading of Cdc45. To investigate whether an 
intra-S checkpoint exists in Xenopus cells, we treated Xenopus tadpole cells 
(XTC cells) with BrdUrd and monitored its incorporation in asynchronous cells 
after a 5.5 hour incubation with aphidicolin or with aphidicolin and caffeine. 
Treatment with caffeine alone or Me2SO served as controls. We then counted the 
percentage of the total number of cells that exhibited punctate BrdUrd staining, 
an indicator that these cells were in S-phase. As expected, we observed a 
dramatic decrease in the number of BrdUrd-positive S-phase cells after treatment 
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with aphidicolin (figure 2.6A and B). When caffeine was added together with 
aphidicolin, the percentage of cells increased significantly (p < 0.01), 
approximately to levels observed in untreated cells or cells treated with caffeine 
alone. Similar results were recorded when we calculated the percentage of 
punctate BrdUrd cells over the total number of BrdUrd-positive cells (data not 
shown). However, the intensity of the BrdUrd labeling in the nuclei of cells treated 
with both caffeine and aphidicolin was strongly reduced compared with untreated 
S-phase cells (figure 2.6A, compare left and right panels). These observations 
indicate that caffeine mostly does not reverse the inhibitory effect of aphidicolin 
on DNA polymerase activity to allow extensive elongation and completion of DNA 
synthesis. Instead, the enhanced incorporation of BrdUrd in the presence of 
caffeine may reflect the abrogation of a checkpoint that suppresses origin 
unwinding and early events associated with the initiation of DNA replication.
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Figure 2.6  Caffeine induces some BrdUrd (BrdU) incorporation in 
aphidicolin (Aph)-treated XTC cells.  
(A) immunofluorescence of BrdUrd-labeled XTC cells treated with Me2SO, aphidicolin 
alone, or aphidicolin and caffeine for 5.5 h. BrdUrd incorporation was visualized using an 
anti-BrdUrd antibody (upper panels), and Hoechst dye was used for nuclear DNA 
staining (lower panels). (B) quantification of cells in A expressed as the percentage of 
cells with punctate BrdUrd staining over the total number of cells. 
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2.3.7 Caffeine-sensitive Inhibition of Nascent Strand DNA Synthesis in Xenopus 
Extracts—We next sought a biochemical assay to determine whether an 
analogous intra-S checkpoint may operate in Xenopus egg extracts. It has been 
reported that in the presence of lower doses of aphidicolin (10 µg/ml), small DNA 
fragments ranging in size from 0.1 to 1 kb accumulate during a replication block. 
These fragments can be detected in alkaline agarose gels (Mahbubani et al., 
1997). Using this dose of aphidicolin, we were able to detect a low level of DNA 
fragments that accumulated within this same size range (figure 2.7A). We 
hypothesized that, if a checkpoint functions to suppress origin firing in the 
presence of aphidicolin, perhaps this checkpoint may be reversed by caffeine, 
thereby allowing more synthesis of these small DNA fragments. Indeed, in 
extracts treated with both aphidicolin and caffeine, we observed a significant 
increase in the accumulation of these small fragments compared with treatment 
with aphidicolin alone (figure 2.7A). Although some of the fragments appeared 
longer than in the aphidicolin-blocked sample, the bulk of DNA synthesized in the 
presence of caffeine remained within the same size range. This observation 
suggests that aphidicolin still prevents elongation in the presence of caffeine, but 
some aspect of initiation is under checkpoint control. 
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Figure 2.7  Caffeine-sensitive accumulation of nascent DNA during 
replication arrest.  
DNA from untreated extracts (control, lane 1) or extracts treated for 100 min with 
10µg/ml aphidicolin (Aph, lane 2) or aphidicolin and 5 mM caffeine (lane 3) was 
isolated and run on a 1% agarose gel under alkaline conditions. M, 32P-labeled 1-kb 
DNA marker. For the first lane, one tenth as much sample was electrophoresed as in 
the other lanes. 
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2.4 Discussion 
In this work, we have cloned and characterized Xenopus Drf1, a member of the 
Dbf4 family of proteins. Based on published results that describe another Dbf4-
related homologue in Xenopus  (Costanzo et al., 2003) and its reported 
sequence, Drf1 represents a second, distinct protein. Thus, Xenopus is the 
second vertebrate species, after humans, to have two Dbf4 homologues. In 
fission yeast, two Dbf4-like complexes have also been identified: Dfp1-Hsk1 and 
Spo6-Spo4. Both complexes form active kinases, but their functions are quite 
divergent. Dfp1-Hsk1, which is most analogous to mammalian Dbf4-Cdc7, is 
essential for DNA replication (Jares and Blow, 2000; Masai et al., 1995; Takeda 
et al., 1999), whereas Spo6-Spo4 is involved in progression through the second 
meiotic division (Nakamura et al., 2002). In humans, the two Dbf4-like proteins 
(ASK and Drf1) regulate the same catalytic partner, Cdc7. Both complexes are 
activated during S-phase. Although ASK-Cdc7 is essential for DNA replication 
(Jares and Blow, 2000; Kumagai et al., 1999), it is not known what role human 
Drf1-Cdc7 plays during this phase of the cell cycle.  
We have found that the Xenopus Drf1 homologue is dispensable for DNA 
replication and loading of Cdc45 onto chromatin. It is possible that both Drf1-
Cdc7 and Dbf4-Cdc7 complexes contribute to Cdc45 loading, and therefore a 
defect in replication would be observed only by depleting both regulatory 
subunits. This possibility would be consistent with our findings that Cdc45 levels 
on chromatin are reduced in Drf1-depleted extracts, and published results that 
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depletion of the Cdc7 subunit is sufficient to block DNA replication and Cdc45 
loading (Jares and Blow, 2000; Roberts et al., 1999).  Although Drf1 may not be 
essential for DNA replication in Xenopus, it does bind to chromatin in a highly 
regulated manner. In particular, it associates with chromatin at S-phase onset at 
around the same time as Cdc7 and Cdc45. The binding of Drf1 to chromatin is 
sensitive to geminin, as was shown previously for Cdc7 (McGarry, 2002), 
implying that binding of Drf1 and Cdc7 occurs once the Mcm complex has been 
recruited to the pre-RC. Although the exact function of chromatin-bound Drf1 and 
Cdc7 is not known, the two subunits form a complex on chromatin that exhibits 
kinase activity toward Mcm2 in vitro.  
Upon further characterization of Drf1, we found that the chromatin binding 
properties of this protein are regulated during a replication block. Whereas 
treatment with hydroxyurea causes the budding yeast Dbf4-Cdc7 complex to 
dissociate from chromatin (Pasero et al., 1999), a replication block induced by 
aphidicolin results in the accumulation of both Xenopus Drf1 and Cdc7 on 
chromatin. This binding is sensitive to caffeine and diminished in extracts lacking 
ATR or Claspin. These observations argue against the model that Drf1 and Cdc7 
remain on chromatin simply because of the presence of stalled replication forks. 
Instead, these results suggest that Drf1 and Cdc7 are either actively recruited to 
or stabilized on chromatin by signaling components of the caffeine-sensitive 
replication checkpoint. Importantly, we found that depletion of Drf1 substantially 
reduced the effect of caffeine on Cdc45 loading, suggesting that, although Cdc45 
can bind to chromatin in a Drf1-depleted extract to allow normal replication to 
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proceed, the suppression of Cdc45 by checkpoint activation involves Drf1. One 
possible model is that the Drf1-Cdc7 kinase on chromatin phosphorylates 
different targets under checkpoint conditions than during DNA replication, 
resulting in the inhibition of further Cdc45 loading. Alternatively, Drf1 and Cdc7 
may simply be sequestered on chromatin in a manner that contributes to the lack 
of Cdc45 loading at sites of initiation. This concept is consistent with the model 
proposed by Edwards et al. 2002, in which Cdc7 can interact with MCMs 
throughout broad regions of chromatin outside of the initiation sites.  
The activation of a caffeine-sensitive replication checkpoint that targets the 
chromatin binding of Cdc45 shares certain similarities with the DNA damage 
pathways previously reported in Xenopus cell-free extracts. Treatment with 
etoposide, an inhibitor of topoisomerase II, results in activation of ATR, which 
leads to disruption of the Dbf4-Cdc7 complex and inhibition of its kinase activity. 
This inhibition prevents the loading of Cdc45 and entry into S-phase (Costanzo et 
al., 2003). Interestingly, Dbf4 dissociates from chromatin under these conditions, 
but Cdc7 remains bound. In contrast, Drf1 remains associated with chromatin in 
the presence of etoposide, suggesting that its regulation in response to DNA 
damage differs from that of Dbf4.  
In the presence of aphidicolin, limited origin firing and elongation can occur 
before replication forks stall (Mahbubani et al., 1997; Walter and Newport, 2000). 
These arrested replication structures are known to activate a checkpoint pathway 
that activates ATR, Claspin, and Chk1 to inhibit entry into mitosis (Guo et al., 
58 
 
2000; Hekmat-Nejad et al., 2000; Kumagai and Dunphy, 2000; Liu et al., 2000; 
Zhao and Piwnica-Worms, 2001). However, results from yeast and mammalian 
systems have also identified an intra-S checkpoint pathway that functions to 
prevent the initiation of replication at late origins in the presence of stalled 
replication forks (Dimitrova and Gilbert, 2000; Santocanale and Diffley, 1998; 
Shirahige et al., 1998). This pathway is also caffeine sensitive and involves 
several components of the S-M checkpoint, suggesting that activation of the 
replication checkpoint has multiple cell cycle targets. Our data from XTC cells 
identified a similar caffeine-sensitive intra-S checkpoint that is activated by 
aphidicolin. Only very low levels of BrdUrd labeling could be detected when cells 
were treated with aphidicolin, but distinctly punctate BrdUrd labeling was 
observed when caffeine was also added. It is important to note that the overall 
intensity of the BrdUrd labeling was not nearly as high as in the untreated nuclei, 
consistent with continued inhibition of DNA polymerases. Nevertheless, these 
results suggest that some aspect of DNA unwinding is inhibited by the replication 
checkpoint pathway in the presence of incompletely replicated DNA.  
Using alkaline agarose gels, we have established a biochemical assay for the 
checkpoint-dependent block to replication in response to aphidicolin in egg 
extracts. Consistent with our observations in XTC cells, treatment with aphidicolin 
and caffeine allowed the synthesis of short nascent DNA strands. These results 
support the hypothesis that an intra-S checkpoint operates in egg extracts to 
prevent further initiation events in the presence of stalled replication forks. One 
attractive hypothesis is that, in response to aphidicolin, ATR and Claspin are 
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activated, leading to bifurcating signaling events. One pathway leads to activation 
of Chk1 and inhibition of Cdc2. The other pathway would lead to the 
accumulation of Drf1-Cdc7 kinase on chromatin. Abrogation of this pathway by 
caffeine would then allow Drf1-Cdc7 to participate in the loading of Cdc45 onto 
chromatin. This process could involve either new origin firing at unreplicated sites 
or resumption of replication within regions in which origins have already fired. 
Montagnoli et al. 2002 have proposed that the human Drf1 might be a specific 
activator of Cdc7 to fire late origins selectively. Although late origins have not 
been characterized in the Xenopus egg extract system, our results nonetheless 
are consistent with the possibility that Drf1 plays some role in origin utilization 
during a DNA replication block.  
Another related possibility is that Drf1-Cdc7 acts to ensure proper resumption of 
DNA replication upon recovery from the arrest. In fission yeast, dfp1 and hsk1 
mutants exhibit severe defects in recovery from hydroxyurea arrest, consistent 
with a role in restarting stalled replication forks (Snaith et al., 2000; Takeda et al., 
1999). In Xenopus, ATR and Claspin may participate in the recovery process by 
recruiting or stabilizing Drf1 and Cdc7 on chromatin. Chromatin-bound Cdc7 has 
been shown to be capable of supporting DNA replication (Jares and Blow, 2000). 
Thus, when the block to replication is removed, the kinase is poised to load 
significant amounts of Cdc45 either at origins or at stalled forks to quickly re-
initiate and complete DNA synthesis. In both egg extracts and XTC cells, 
abrogation of this checkpoint could lead to premature re-starting of replication 
forks and DNA unwinding even in the presence of aphidicolin. 
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Chapter 3 
 
Roles of Replication Fork-interacting and Chk1-
activating Domains from Claspin in a DNA Replication 
Checkpoint Response 
Joon Lee, Daniel A. Gold, Anna Shevchenko, Andrej Shevchenko, and William 
G. Dunphy 
 
Claspin is essential for the ATR-dependent activation of Chk1 in Xenopus egg 
extracts containing incompletely replicated DNA. Claspin associates with 
replication forks upon origin unwinding. We show that Claspin contains a 
replication fork-interacting domain (RFID, residues 265–605) that associates with 
Cdc45, DNA polymerase ε, replication protein A, and two replication factor C 
complexes on chromatin. The RFID contains two basic patches (BP1 and BP2) at 
amino acids 265–331 and 470–600, respectively. Deletion of either BP1 or BP2 
compromises optimal binding of Claspin to chromatin. Absence of BP1 has no 
effect on the ability of Claspin to mediate activation of Chk1. By contrast, removal 
of BP2 causes a large reduction in the Chk1-activating potency of Claspin. We 
also find that Claspin contains a small Chk1-activating domain (residues 776–
905) that does not bind stably to chromatin, but it is fully effective at high 
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concentrations for mediating activation of Chk1. These results indicate that stable 
retention of Claspin on chromatin is not necessary for activation of Chk1. Instead, 
our findings suggest that only transient interaction of Claspin with replication forks 
potentiates its Chk1-activating function. Another implication of this work is that 
stable binding of Claspin to chromatin may play a role in other functions besides 
the activation of Chk1. 
3.1 Introduction 
Checkpoint control mechanisms ensure the integrity of the genome by preventing 
the transmission of incompletely replicated or damaged DNA to progeny cells 
(McGowan and Russell, 2004; O'Connell and Cimprich, 2005; Osborn et al., 
2002; Sancar et al., 2004). For example, the DNA replication checkpoint monitors 
whether DNA synthesis occurs normally throughout S phase. When problems 
become evident, this regulatory network forestalls premature entry into mitosis 
and stabilizes aberrant replication forks until normal replication can resume and 
subsequently reach completion. The manifestation of this checkpoint is most 
obvious when DNA replication forks stall at sites of exogenously inflicted DNA 
damage. However, this pathway also operates when spontaneous errors arise 
during replication or the replication apparatus encounters difficult-to-replicate 
sequences.  
Checkpoint pathways contain a variety of regulatory proteins that detect the 
status of the genome and that relay this information to effector enzymes that 
regulate downstream processes (Melo and Toczyski, 2002; Osborn et al., 2002; 
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Sancar et al., 2004).  In the DNA replication checkpoint, ATR functions at or near 
the top of this regulatory hierarchy (Abraham, 2001). ATR is a member of the 
phosphoinositide kinase-related family of protein kinases that also includes ATM. 
One key function of ATR involves activation of the checkpoint effector kinase 
Chk1 (Guo et al., 2000; Hekmat-Nejad et al., 2000; Liu et al., 2000).  
Significantly, ATR cannot carry out this function alone but must cooperate with 
numerous other proteins. For example, ATR possesses a conserved binding 
partner called ATRIP (Cortez et al., 2001).  Other collaborating factors include the 
checkpoint clamp assembly of Rad9, Rad1, and Hus1 (the 9-1-1 complex) 
(Sancar et al., 2004).  A checkpoint clamp loader consisting of Rad17 and the 
four small subunits of replication factor C (RFC) is responsible for deposition of 
the 9-1-1 complex onto DNA. The checkpoint clamp loader and clamp proteins 
most likely interact with boundaries between single-stranded and double-
stranded regions of DNA that would be present in incompletely replicated or 
damaged DNA (Ellison and Stillman, 2003; Lee et al., 2003; You et al., 2002; Zou 
et al., 2003).  
ATR and ATM also work together with a class of proteins known as mediators 
(McGowan and Russell, 2004; O'Connell and Cimprich, 2005). In vertebrates, 
these proteins consist of Claspin and various BRCA1 C-terminal repeat (BRCT)-
containing proteins, including TopBP1, 53BP1, Mdc1, and BRCA1 itself 
(Canman, 2003; Chini and Chen, 2003; Kumagai and Dunphy, 2000). These 
mediators either have been shown to or are thought to serve as adaptors 
between ATR/ATM and the downstream kinases Chk1 and Chk2. In addition, 
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accumulating evidence has indicated that mediator proteins may function as 
sensors of chromatin structures. For example, in response to double-stranded 
DNA breaks, mammalian 53BP1 and its fission yeast relative Crb2 recognize 
methylated forms of lysine 79 in histone H3 and lysine 20 in histone H4, 
respectively (Huyen et al., 2004; Sanders et al., 2004). These histone 
methylations do not vary in response to DNA damage. Instead, modified histones 
may become inappropriately exposed at sites of damage. Furthermore, 53BP1, 
Crb2, and other BRCT-containing proteins respond to the phosphorylation of 
histone H2AX and H2A in mammals and fission yeast, respectively (Celeste et 
al., 2003; Nakamura et al., 2004). This type of histone phosphorylation is not 
required for initial recruitment of mediator proteins to sites of damage, but it is 
necessary for their stable incorporation into damage-induced foci. These 
observations suggest that the interaction of mediator proteins with chromatin is 
multifaceted and may fulfill multiple functions.  
We have been studying the DNA replication checkpoint in Xenopus egg extracts. 
In this system, the DNA replication inhibitor aphidicolin elicits the formation of 
stalled replication forks, which in turn trigger the activation of Xenopus Chk1 
(Xchk1) (Kumagai et al., 1998; Michael et al., 2000). The Xenopus homologue of 
ATR (Xatr) is responsible for the phosphorylation-dependent activation of Xchk1 
(Guo et al., 2000; Hekmat-Nejad et al., 2000). This process also requires the 
mediator protein Claspin in Xenopus egg extracts and human cells (Chini and 
Chen, 2003; Kumagai and Dunphy, 2000; Lin et al., 2004).  Claspin associates 
directly with Xchk1 and thereupon strongly enhances the ability of Xatr to 
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phosphorylate Xchk1 (Kumagai and Dunphy, 2003; Kumagai et al., 2004).  In 
addition, Claspin displays dynamic spatial localization by associating with 
replication forks during S phase (Lee et al., 2003). This binding requires Xcdc45 
and Cdk2 but not replication protein A (RPA), suggesting that Claspin associates 
with incipient replication forks at around the time of DNA unwinding (Lee et al., 
2003). The initial binding of Claspin occurs before Xatr-Xatrip and the replication 
factor C (RFC) proteins and therefore must involve, at least in part, chromatin 
structures that are distinct from those recognized by these proteins. The budding 
yeast homologue of Claspin called Mrc1 likewise associates specifically with 
replication forks (Katou et al., 2003; Osborn and Elledge, 2003). These 
observations imply that Claspin and its homologues may also function as 
checkpoint sensor proteins.  
In this study, we have explored the mechanism by which Claspin associates with 
the DNA replication apparatus to understand the purpose of this interaction. Our 
results indicate that Claspin uses a conserved domain to interact with key 
replication and checkpoint proteins, including Cdc45, DNA polymerase ε (Pol ε), 
RPA, and both the replicative and Rad17-containing RFC complexes. 
Interestingly, although a portion of this domain is required for optimal activation of 
Chk1, stable retention of Claspin on chromatin is not essential for its Chk1-
activating function. 
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3.2 Materials and Methods 
3.2.1 Xenopus Egg Extracts 
Extracts from Xenopus eggs were prepared as described previously (Lee et al., 
2003). The DNA replication checkpoint was induced by the addition of 
demembranated Xenopus sperm nuclei (3,000/µl) and aphidicolin (100 µg/ml). 
Caffeine (5 mM) was used to override this checkpoint response. Isolation of 
nuclear and chromatin fractions from egg extracts was described previously (Lee 
et al., 2003).  
3.2.2 Antibodies 
Antibodies against Xenopus Claspin, RPA70, Xorc2, phospho-Ser864 of Claspin, 
Xatr, Xatrip, Xchk1, Xrad17, and Xhus1 were described previously (Kumagai and 
Dunphy, 2003; Kumagai et al., 2004; Lee et al., 2003). Antibodies against 
Xenopus RFC40 and proliferating cell nuclear antigen (PCNA) were raised 
against bacterially expressed His6-tagged proteins containing either residues 1–
320 of RFC40 or full-length PCNA, respectively. The sequence of Xenopus 
RFC40 (expressed sequence tag database XGI TC34364) showed 89.6% identity 
at the amino acid level with human RFC40. Anti-Xcdc45 and anti-p60 of Pol ε 
antibodies were raised as described previously (Mimura and Takisawa, 1998; 
Waga et al., 2001). These antibodies were all affinity purified with their antigens. 
Antisera against Xenopus importin α, Xenopus Pol δ (p125 subunit), Xsld5, 
Xenopus cyclin E, and Xmcm7 were generously supplied by D. Görlich 
(Universität Heidelberg, Heidelberg, Germany), S. Waga (Osaka University, 
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Osaka, Japan), H. Takisawa (Osaka University, Osaka, Japan), P. Jackson 
(Stanford University, Stanford, CA), and J. Blow (University of Dundee, Dundee, 
Scotland, United Kingdom), respectively. Antisera against human RFC37 and 
Xenopus RFC140 were the kind gifts of J. Hurwitz (Memorial Sloan-Kettering 
Cancer Center, New York, NY) and S. Waga, respectively. Anti-human Chk1 
phospho-Ser345 antibody was purchased from Cell Signaling Technology 
(Beverly, MA). Purified control rabbit IgG and anti-FLAG monoclonal antibodies 
were obtained from Zymed Laboratories (South San Francisco, CA) and Sigma-
Aldrich (St. Louis, MO), respectively. Immunodepletion procedures for Claspin, 
Xcdc45, and RPA were described previously (Lee et al., 2003).  
3.2.3 Recombinant Proteins 
The pBluescript vector was engineered to encode a nuclear localization signal 
(NLS) (TPPKKKRKVEDP) (Moore et al., 2002) fused upstream of Claspin 
fragments for in vitro protein synthesis. The same NLS was inserted into pGEX-
4T-3 (GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom) to make 
glutathione S-transferase (GST)-NLS fusion constructs of Claspin. Baculoviruses 
encoding full-length or truncated His6-Claspin-FLAG proteins were generated 
with the Bac-to-Bac system with a His6 tag and FLAG epitope (DYKDDDDK) at 
the N-terminal and C-terminal ends, respectively. Various Claspin mutants 
(internal deletions or amino acid substitutions) were produced through PCR-
based mutagenesis by standard methods. Recombinant Claspin proteins were 
expressed and purified from baculovirus-infected insect cells or bacteria as 
described previously (Kumagai and Dunphy, 2003). 35S-labeled proteins were 
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synthesized in vitro with the TnT system (Promega, Madison, WI). Human GST-
p27 (gift from T. Hunter, Salk Institute, La Jolla, CA) was expressed in bacteria 
and purified with glutathione agarose.  
3.2.4 Identification of Claspin-binding Proteins from Egg Extracts 
Claspin was immunoprecipitated from 5 ml of interphase egg extract with 200 µg 
of anti-Claspin antibodies cross-linked to Affiprep protein-A beads (Bio-Rad, 
Hercules, CA). The beads were washed four times with immunoprecipitation (IP) 
buffer B (10 mM HEPES-KOH, pH 7.6, 0.5 M NaCl, 0.1% NP-40, and 20 mM β-
glycerolphosphate). Samples were boiled in SDS buffer, concentrated, separated 
by SDS-PAGE, transferred to nitrocellulose, and stained with Ponceau S. Protein 
bands containing p55 and p90 were excised and subjected to chemical 
sequencing and nanoelectrospray tandem mass spectrometry in the Howard 
Hughes Medical Institute protein sequencing facility at University of California 
(Berkeley, CA). Sequences from p55 (KXTQH/AP and KYFXGEEA) and p90 
(KFYAK and KTLATWATK) corresponded to importin α and β, respectively.  
3.2.5 Identification of Claspin-binding Proteins in Chromatin Eluates 
For analytical experiments, sperm nuclei reconstituted in interphase egg extract 
(1 ml) were collected through a sucrose cushion (Lee et al., 2003). Nuclei were 
resuspended in 100 µl of HEPES-buffered saline (10 mM HEPES-KOH, pH 7.6, 
and 150 mM NaCl) supplemented with 10% dimethyl sulfoxide and 5 mM 
caffeine, incubated at room temperature for 30 min, and cooled on ice for 20 min. 
An equal volume of elution buffer (10 mM HEPES-KOH, pH 7.6, 1 M NaCl, and 
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1% NP-40) was added, and the incubation was continued on ice for 20 min. After 
dilution with 200 µl of 10 mM HEPES-KOH, pH 7.6, soluble proteins were 
recovered by centrifugation at 14,000 rpm in an Eppendorf centrifuge for 10 min. 
Antibodies (2.5 µg) cross-linked to protein A beads were incubated with these 
preparations for 1 h at 4 °C, washed twice with IP buffer C (10 mM HEPES-KOH, 
pH 7.6, 150 mM NaCl, 0.1% CHAPS, 2.5 mM EGTA, and 20 mM β-
glycerolphosphate), and subjected to SDS-PAGE.  
For identification by protein sequencing, four batches of egg extract totaling 50 ml 
were used to reconstitute nuclei (3,000/µl) in the presence of aphidicolin and 
caffeine. Proteins were removed from chromatin by elution with 0.5 M NaCl and 
immunoprecipitated with anti-Claspin antibodies as described above. Bound 
proteins were concentrated, separated by SDS-PAGE, stained with Coomassie 
Blue, and subjected to in-gel trypsin digestion as described previously 
(Shevchenko et al., 1996). Methods for nanoelectrospray tandem mass 
spectrometry of tryptic peptides and analysis of the sequencing data were carried 
out exactly as described previously (Shevchenko et al., 2003; Shevchenko et al., 
2001; Yoo et al., 2004). The following protein identifications were obtained: p180 
(Claspin, 10 peptides), p150 (RFC140, 3 peptides), and p65 (RPA70, 3 peptides). 
p36-40 contained RFC36 (2 peptides), RFC37 (5 peptides), RFC38 (2 peptides), 
and RFC40 (5 peptides).  
3.2.6 Oligonucleotide Binding Assay 
Preparation of magnetic beads coated with DNA oligonucleotides and assay 
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conditions for binding of proteins in egg extracts to these beads were described 
previously (Lee et al., 2003). For the double-stranded template, annealed (dA)70-
(dT)70 was
 prepared as described previously (Kumagai and Dunphy, 2000). For 
the 30d-40s branched DNA, the following oligonucleotides were annealed: 5'-
ACTGATTACGGTGCTGCTTATCGATGGTTTGCAGTGCTCGCATGGAGCTGG
TTTCCGGCCTTGCTAATGG and 5'-biotin-
CCATTAGCAAGGCCGGAAACCAGCTCCATGATCATTGGCAATCATTGGCAC
AACGATCAGCCAACTAAAC. Oligonucleotides were added to egg extracts at a 
final concentration of 5.5 nM. 
3.3 Results 
3.3.1 Search for Claspin-interacting Proteins in Cytoplasmic Egg Extracts 
To probe the mechanism by which Claspin promotes the phosphorylation of 
Xchk1 in Xenopus egg extracts that contain incompletely replicated DNA, we 
attempted to find Claspin-interacting proteins. In particular, we wished to evaluate 
whether Claspin could recognize specific components of the DNA replication 
apparatus. We first searched for Claspin-interacting proteins by 
immunoprecipitating Claspin from whole cytoplasmic egg extracts (figure 3.1A). 
We identified two prominent binding proteins at 55 and 90 kDa as Xenopus 
importins α and β, respectively (see Materials and Methods). The binding of 
importin α was verified by immunoblotting with anti-importin α antibodies (figure 
3.1A). These proteins could not be found in anti-Claspin immunoprecipitates from 
nuclear extracts (see below), which is consistent with the fact that importins 
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dissociate from their cargo upon nuclear entry. In further studies, we found that 
importin α binds well to a GST peptide containing the C-terminal 56 amino acids 
of Claspin (residues 1230–1285), which contains sequences that closely 
resemble a NLS (our unpublished data).  
3.3.2 Claspin Interacts with Key Replication Proteins on Chromatin 
Because we could not identify any additional Claspin-binding proteins in 
cytoplasmic extracts, we examined whether Claspin associates specifically with 
other proteins upon binding to chromatin. To pursue these experiments, we first 
considered the richest potential source of Claspin-interacting, chromatin-binding 
proteins. Previously, we observed that Claspin accumulates on chromatin in 
aphidicolin-treated extracts. The binding of Claspin increases dramatically upon 
the further addition of caffeine. Recent studies have indicated that caffeine 
stimulates the firing of inhibited replication origins in aphidicolin-treated chromatin 
(Marheineke and Hyrien, 2004; Shechter et al., 2004; Yanow et al., 2003). 
Therefore, the increased binding of Claspin to chromatin in such extracts seems 
to reflect binding to numerous additional origins of replication. Under this 
condition, >80% of the nuclear Claspin is bound to chromatin. Hence, for the 
experiments described below, we have searched for Claspin-binding proteins on 
chromatin in extracts containing both aphidicolin and caffeine.
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Figure 3.1. Identification of Claspin-interacting proteins in cytoplasmic 
and chromatin fractions from Xenopus egg extracts. 
(A) Claspin-binding proteins from egg extracts. IP was performed with control (lane 1) or 
anti-Claspin antibodies (lane 2) from interphase egg extracts. Samples were analyzed 
by silver staining (top) and immunoblotted for Xenopus importin α (bottom). H, IgG 
heavy chain. (B) Interaction of Claspin with proteins on chromatin. Chromatin-binding 
proteins were eluted from reconstituted nuclei (derived from 250 µl of egg extract) with 
various concentrations of NaCl and immunoprecipitated with anti-Claspin antibodies 
(lanes 4–8). Chromatin fractions after salt elution were loaded in lanes 9–13. In parallel, 
whole egg extracts (50 µl) were immunoprecipitated with control (lane 2) and anti-
Claspin antibodies (lane 3). Lane 1 depicts 1 µl of egg extract. Samples were 
immunoblotted for the indicated proteins. (C) Silver staining of Claspin-binding proteins 
on chromatin. Interphase egg extracts were immunoprecipitated with control (lane 1) 
and anti-Claspin antibodies (lane 2). For lane 3, chromatin proteins from nuclei 
reconstituted in 1 ml of egg extract were eluted with 0.5 M NaCl and immunoprecipitated 
with anti-Claspin antibodies. Samples were subjected to SDS-PAGE and silver staining. 
Bands designated as Claspin (p180), p150, p140, p65, and p36–40 were prepared on a 
large scale for identification by mass spectrometry (see Materials and Methods). 
Asterisks in lane 2 denote importin α and β. H and L, IgG heavy and light chains. (D) 
Confirmation of Claspin-binding proteins by immunoblotting. Samples from C were 
immunoblotted for the indicated proteins (lanes 2–4). Lane 1 depicts 1 µl of egg extract. 
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 Next, we assessed different methods for immunoprecipitation of the chromatin-
derived form of Claspin. Some commonly used techniques, such as nuclease 
digestion or sonication of the chromatin before immunoprecipitation, resulted in 
anti-Claspin immunoprecipitates that were contaminated by general DNA binding 
proteins. We concluded that these methods yielded chromatin fragments that 
were large enough to bridge Claspin nonspecifically with other proteins during 
immunoprecipitation. As an alternative, we attempted to extract Claspin from 
chromatin by mild salt treatment under conditions that would maintain certain 
protein–protein interactions that had initially formed on the DNA. For this purpose, 
we exposed chromatin to increasing concentrations of NaCl (i.e., 0.25, 0.5, 0.75, 
and 1 M). As shown in figure 3.1B, treatment with 0.25 M NaCl led to a 
substantial decrease in chromatin-bound Claspin, and 0.5 M NaCl removed 
Claspin almost completely. Various replication and checkpoint regulatory 
proteins, including Xorc2, Xmcm7, Xcdc45, RPA70, RFC40, PCNA, Xatr, and 
Xhus1, each displayed their own characteristic salt elution profile.  
We immunoprecipitated Claspin from the salt eluates and immunoblotted for 
various key replication and checkpoint proteins. We could readily detect Xcdc45, 
RPA70, and RFC40 in the anti-Claspin immunoprecipitates from the 0.5 M NaCl 
eluate, and, to a lesser extent, in the 0.75 M eluate (figure 3.1B). The interaction 
between Claspin and RFC40 was very strong, remaining even in the presence of 
1 M NaCl. It has been established that Xcdc45, Claspin, and Pol ε load onto 
replication origins around the same time (Lee et al., 2003; Mimura et al., 2000). 
Therefore, we also immunoblotted the anti-Claspin immunoprecipitates with anti-
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Pol ε antibodies, but we could detect only a very faint signal for Pol ε in the 0.5 
and 0.75 M NaCl eluates (our unpublished data). However, we were able to 
demonstrate an interaction between Claspin and Pol ε by a different method (see 
below). We could not detect the specific presence of Pol α or Pol δ in anti-Claspin 
immunoprecipitates by immunoblotting with anti-Pol α or anti-Pol δ antibodies 
(our unpublished data). Finally, we could not find Xatr, Xhus1, Xorc2, Xmcm7, or 
PCNA in anti-Claspin immunoprecipitates from any of the salt eluates. These 
observations argue that our procedure detects specific protein–protein 
interactions that become established on chromatin. Furthermore, the absence of 
abundant DNA binding proteins such as Xorc2 indicates that these 
immunoprecipitates do not contain DNA fragments with contaminating proteins.  
To identify Claspin-binding proteins in a more general manner, we analyzed anti-
Claspin immunoprecipitates by silver staining (figure 3.1C). We observed 
specifically associated bands at 150, 140, and 65 kDa as well as a cluster of 
bands at 36–40 kDa. Analysis by nanoelectrospray tandem mass spectrometry 
indicated that p150 and p65 correspond to the largest subunits of RFC (RFC140) 
and RPA (RPA70), respectively. In addition, p36-40 contained all four small 
subunits of RFC (e.g., RFC36, RFC37, RFC38, and RFC40). p140 is still under 
investigation. We verified these associations by immunoblotting anti-Claspin 
immunoprecipitates with specific antibodies that recognize the Xenopus versions 
of RFC140 and RPA70 (figure 3.1D). We could also detect the presence of 
RFC37 and RFC40 by immunoblotting with antibodies against these proteins. 
Because the small RFC subunits are also present in other clamp loader 
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complexes, such as the one containing Rad17, we asked whether Claspin could 
also associate with Rad17.  As shown in figure 3.1D, Xrad17 could also be found 
in anti-Claspin immunoprecipitates from chromatin by immunoblotting with anti-
Xrad17 antibodies.  
3.3.3 Claspin Interacts Successively with Xcdc45 and RFC Complexes 
To corroborate these results, we carried out various reciprocal 
immunoprecipitation experiments. First, we asked whether complexes containing 
Xcdc45 and Claspin could also be identified by immunoprecipitation with anti-
Xcdc45 antibodies. As shown in figure 3.2A, we could clearly detect Claspin as 
well as RPA70, RFC40, and Xrad17 in anti-Xcdc45 immunoprecipitates from    
0.5 M NaCl eluates of chromatin. In addition, we could find Xmcm7 and Xsld5, 
components of the MCM and GINS complexes, respectively, in anti-Xcdc45 
immunoprecipitates of both 0.5 and 1 M NaCl chromatin eluates. Consistent with 
the results described above, we found Xcdc45, RPA70, RFC40, and Xrad17 in 
anti-Claspin immunoprecipitates that were prepared in parallel. However, we 
could not find either Xmcm7 or Xsld5 in anti-Claspin immunoprecipitates. 
Therefore, Claspin does not associate with Xcdc45 indirectly through either the 
MCM or GINS complexes.
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Figure 3.2. Binding relationships between Claspin and other proteins on 
chromatin. 
 (A) Immunoprecipitation with anti-Xcdc45 antibodies. Control (lanes 2–4), anti-Xcdc45 (lanes 5–
7), and anti-Claspin antibodies (lanes 8–10) were used for immunoprecipitation from egg 
extracts (lanes 2, 5, and 8) or chromatin eluates prepared with either 0.5 M (lanes 3, 6, and 9) or 
1 M NaCl (lanes 4, 7, and 10). The samples were immunoblotted for the indicated proteins. Lane 
1 depicts whole egg extract. (B) Association of Claspin with RFC40 and Xrad17. Egg extracts 
(lanes 2, 4, 6, 8, and 10) or 0.5 M NaCl chromatin eluates (lanes 3, 5, 7, 9, and 11) were 
immunoprecipitated with control (lanes 2 and 3), anti-Xenopus RPA70 (lanes 4 and 5), anti-
Xenopus RFC40 (lanes 6 and 7), anti-Xrad17 (lanes 8 and 9), and anti-Xhus1 antibodies (lanes 
10 and 11). Samples were immunoblotted for various proteins as indicated. (C) RPA-dependent 
association of RFC complexes with Claspin. Claspin was immunoprecipitated from egg extracts 
(lane 1) and from chromatin eluates obtained from either mock-depleted (lane 2) or RPA-
depleted extracts (lane 3). Samples were immunoblotted for the indicated proteins. (D) Xcdc45 
interacts with RFC independently of Claspin. Xcdc45 was immunoprecipitated from either egg 
extracts (lane 1) or chromatin eluates prepared from either mock-depleted (lane 2) or Claspin-
depleted extracts (lane 3). Samples were immunoblotted for the indicated proteins. 
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Next, we carried out immunoprecipitations with anti-RPA70, anti-RFC40, and 
anti-Xrad17 antibodies. We could find Claspin in anti-RFC40 and anti-Xrad17, but 
not in anti-RPA70 immunoprecipitates (figure 3.2B). We also performed 
immunoprecipitations of the chromatin eluates with antibodies against Xhus1, a 
component of the 9-1-1 complex. Consistent with the results obtained in the anti-
Claspin immunoprecipitation studies, we could not detect any Claspin in anti-
Xhus1 immunoprecipitates from chromatin eluates (figure 3.2B). On the other 
hand, we could observe RPA70, RFC40, and Xrad17 in these 
immunoprecipitates. It should be noted that these results do not rule out an 
interaction of Claspin with the 9-1-1 complex, because it is possible that the 
chromatin elution procedure could disrupt such an association.  
Previously, we reported that binding of Claspin to chromatin requires Xcdc45 but 
not RPA (Lee et al., 2003). Moreover, it is well established that the replicative and 
Rad17-containing RFC complexes associate with replication forks after RPA-
stabilized unwinding of the DNA (Ellison and Stillman, 2003; Lee et al., 2003; You 
et al., 2002; Zou et al., 2003). Therefore, we examined whether the association of 
Claspin with RFC proteins also requires RPA. We immunodepleted RPA from 
egg extracts, prepared salt eluates of chromatin fractions from these extracts, 
and then immunoprecipitated Claspin from these eluates. As depicted in figure 
3.2C, we could detect Xcdc45 but not RFC40 or Xrad17 in anti-Claspin 
immunoprecipitates from RPA-depleted chromatin.
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Figure 3.3 
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Figure 3.3. Identification and characterization of an RFID from Claspin.  
(A) Chromatin-binding fragments of Claspin. Various 35S-labeled fragments from the N-
terminal half of Claspin were incubated for 100 min in egg extracts containing sperm 
chromatin, aphidicolin, and caffeine. In this experiment, His6-Claspin(606-1285)-FLAG 
protein was used to represent the C-terminal half of the protein. Separate nuclear (lane 
1) and chromatin fractions were prepared (lanes 2 and 3). To assess dependency of 
chromatin binding on S-phase cyclin-dependent kinase activity, extracts were treated 
with p27 (lane 3). Fragments were visualized by SDS-PAGE and phosphorimaging, 
except for the 606-1285 fragment, which was detected by immunoblotting with anti-
FLAG antibodies. (B) The N-terminal domain of Claspin has very similar chromatin 
binding properties as full-length Claspin. Extracts were subjected to an immunodepletion 
procedure with control (lanes 1 and 2), anti-Xcdc45 (lane 3), or anti-RPA antibodies 
(lane 4). Extracts were incubated with 35S-NLS-Claspin(1-605) and the indicated drugs. 
Binding to chromatin was assessed by phosphorimaging or immunoblotting for 
endogenous proteins as indicated. (C) Interaction of N-terminal domain of Claspin with 
various proteins on chromatin. 35S-NLS-Claspin(1-605) was incubated in egg extracts as 
in A. Aliquots of chromatin eluates were immunoprecipitated with antibodies against the 
indicated proteins. The amount of bound 35S-fragment was detected by SDS-PAGE and 
phosphorimaging. Lane 1 depicts 15% of the input chromatin eluate for each lane. (D) 
Interaction of bacterially expressed RFID with chromatin. Mock-depleted (lanes 1–3) and 
Claspin-depleted extracts (lane 4) were incubated in the absence (lanes 1 and 2) or 
presence (lanes 3 and 4) of GST-NLS-Claspin(265-605). Chromatin fractions were 
prepared and immunoblotted with anti-Claspin (top) and anti-GST antibodies (bottom). 
(E) Contribution of the RFID to the binding of full-length Claspin to chromatin in 
undepleted extracts. 35S-Labeled versions of full-length Claspin containing no deletion or 
deletions of residues 265–331 (∆BP1), 566–605 (∆BP2'), or 376–425 (∆LK) were 
prepared. For the 6A mutant, the highly conserved residues Gln287, Arg288, Leu289, 
Pro298, Tyr299, and His300 were all changed to alanine. Nuclear accumulation (lane 1), 
chromatin binding (lane 2), and p27 sensitivity of chromatin binding (lane 3) were 
determined as described in A. (F) Interaction of the RFID with replication proteins on 
chromatin. GST-NLS-Claspin(265-605) ∆LK was incubated with egg extracts as in A. 
Aliquots of chromatin eluates were immunoprecipitated with the indicated antibodies and 
immunoblotted with anti-GST antibodies. Lane 1 depicts 15% of the input chromatin 
eluate for each sample. 
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To characterize these interactions further, we analyzed the binding partners of 
Xcdc45 in the absence of Claspin. As shown in figure 3.2D, Xcdc45 could bind 
well to RFC40 and Xrad17 even in Claspin-depleted extracts. From these results, 
we conclude that Claspin interacts first with Xcdc45 at replication forks and later 
associates with RFC complexes after RPA-stabilized unwinding of the DNA. At 
this juncture, Xcdc45 also forms connections with RFC proteins, but these 
interactions do not require the presence of Claspin. These results, along with the 
fact that the interactions of Claspin with Xcdc45 versus RFC40 display different 
salt sensitivities, imply that Xcdc45 and RFC complexes associate with Claspin 
independently.  
3.3.4 A Conserved N-Terminal Domain Mediates Interaction of Claspin with 
Chromatin 
To assess the functional significance of the interactions with other proteins on 
chromatin, we attempted to map the chromatin-binding region of Claspin. 
Because in vitro translated 35S-Claspin bound to chromatin as efficiently as 
endogenous Claspin, we used 35S-labeled fragments of Claspin for the initial 
phase of these experiments. We incubated various truncated forms of Claspin in 
extracts containing aphidicolin and caffeine and compared their ability to 
associate with chromatin. For any fragment that did not contain the last 56 amino 
acids of Claspin, which are essential for nuclear uptake, we incorporated an 
ectopic NLS into the polypeptide chain. Because expression of individual 
fragments was variable, we normalized the data by examining what percentage 
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of each fragment in nuclear fractions from the extracts could associate with 
chromatin.  
These studies indicated that a fragment containing residues 1–605 of Claspin 
binds exceptionally well to chromatin (figure 3.3A). By contrast, various fragments 
from the C-terminal end of Claspin (e.g., 606–1285) showed little, if any, stable 
interaction with chromatin. The binding of the 1–605 fragment to chromatin was 
sensitive to the Cdk inhibitor p27, which inhibits firing of replication origins and 
thus prevents binding of full-length Claspin to replication forks. Furthermore, the 
interaction of this fragment with chromatin depended on Xcdc45 but not on RPA 
(figure 3.3B), as for full-length Claspin. 
Next, we asked whether the 1–605 fragment could associate with the same 
replication and checkpoint proteins as full-length Claspin. As shown in figure 
3.3C, we could immunoprecipitate the 1–605 fragment from chromatin fractions 
with antibodies against Xcdc45, RPA70, RFC40, and Xrad17. For these 
experiments, we also examined binding to three major eukaryotic DNA 
polymerases, namely, Pol α, Pol β, and Pol ε. We could observe strong 
interaction of the 1–605 fragment with Pol ε, but no binding to either Pol α or Pol 
δ. Finally, we could detect little or no binding of this fragment to Xorc2, Xcut5, 
Xmcm7, PCNA, and Xhus1 in immunoprecipitations with antibodies against these 
respective proteins. From these observations, we conclude that the ability of 
Claspin to interact stably with chromatin resides in the 1–605 fragment. 
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Figure 3.4. Role of the BP1 region from the RFID in binding of Claspin to 
chromatin and activation of Xchk1 in extracts lacking endogenous Claspin.  
(A) Various His6-Claspin-FLAG proteins were prepared from baculovirus-infected insect cells 
and added directly into undepleted egg extracts containing sperm chromatin, aphidicolin, and 
caffeine. The proteins included full-length Claspin (WT) (lanes 1 and 2), a deletion of 
residues 150–331 (lanes 3 and 4), and a deletion of residues 265–331 (∆BP1, lanes 5 and 
6), and the 6A mutant (lanes 7 and 8). Nuclear (lanes 1, 3, 5, and 7) and chromatin fractions 
(lanes 2, 4, 6, and 8) were immunoblotted with anti-FLAG antibodies (top). Samples were 
also immunoblotted for Xorc2 as a loading control (bottom). (B) Mock-depleted (lanes 1 and 
2) and Claspin-depleted extracts (lanes 3–7) containing control buffer (lanes 1–3) or 
equivalent amounts of the indicated forms of His6-Claspin-FLAG (lanes 4–7) were incubated 
in the absence (lane 1) or presence (lanes 2–7) of aphidicolin. Chromatin fractions were 
immunoblotted for Claspin and Xorc2 (top two panels). Phosphorylation of 35S-Xchk1 in 
nuclear fractions was assessed by phosphorimaging (third panel from top). For quantitation 
(bottom), the amount of shifted 35S-Xchk1 was divided by the total 35S-Xchk1 in each lane 
and normalized to the signal in the absence of aphidicolin (lane 1). Results are the mean ± 
SD for two experiments. (C) Binding of the ∆BP1 mutant to chromatin is sensitive to p27. 
Mock-depleted (lanes 1–3) and Claspin-depleted extracts (lanes 4–6) containing control 
buffer (lanes 1–3) or the ∆BP1 mutant of His6-Claspin-FLAG were incubated with aphidicolin 
and caffeine. p27 was also added in lanes 3 and 6. Nuclear (lanes 1 and 4) and chromatin 
fractions (lanes 2, 3, 5, and 6) were immunoblotted for the indicated proteins. (D) Claspin 
does not bind detectably to branched DNA in egg extracts. Magnetic beads coated with no 
DNA (lanes 2 and 6), (dA)70-(dT)70 (lanes 3–5), or 30d–40s DNA (a branched structure that 
contains a 30-mer double-stranded region and two 40-mer single-stranded regions) (lanes 7–
9) were incubated in mock-depleted (lanes 3, 4, 7, and 8) or RPA-depleted egg extracts 
(lanes 5 and 9). Caffeine was included in some incubations (lanes 4 and 8). The beads were 
recovered, washed, and immunoblotted for the indicated proteins. Lane 1 shows 1 µl of egg 
extract. 
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In further mapping studies, we found that removal of the N-terminal 264 residues 
from the 1–605 fragment had no effect on chromatin-binding efficiency (figure 
3.3A). However, additional deletion of residues 265–331 abrogated binding. 
Similarly, removal of residues 566–605 from the opposite C-terminal end of this 
fragment also abolished interaction with chromatin. From these studies, we 
conclude that a region of Claspin stretching from residues 265–605 is involved in 
the interaction with chromatin. To corroborate these findings, we prepared a GST 
fusion protein containing residues 265–605 of Claspin as well as an ectopic NLS. 
The resulting GST-NLS-Claspin(265–605) protein could bind well to chromatin 
(figure 3.3D). The binding was much higher in Claspin-depleted extracts. 
However, binding also occurred in mock-depleted extracts, where inclusion of the 
fragment also reduced the binding of endogenous Claspin to chromatin. 
Therefore, the isolated 265–605 fragment of Claspin fragment seems to compete 
with endogenous Claspin for a finite number of binding sites in chromatin.  
We named the 265–605 region of Claspin the replication fork-interacting domain 
(RFID). Two recent studies have shown that human Claspin and its fission yeast 
homologue Mrc1 possess an in vitro DNA binding activity that is mediated by a 
DNA binding domain (DBD) (Sar et al., 2004; Zhao and Russell, 2004). The DBD 
in human Claspin (residues 149–340) corresponds closely to residues 150–331 
of Xenopus Claspin, which overlap partially with the RFID. During our studies, we 
noticed an interesting structural feature of Claspin. Overall, Claspin is a very 
acidic protein (pI = 4.5), but it does contain four patches of basic amino acids 
(residues 265–331, 470–600, 721–783, and 1157–1285) with a pI value >10 
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(figure 3.3A and supplemental figure S1). These segments, which we denoted 
BP1, BP2, BP3, and BP4, are highly conserved in metazoan Claspin, and the 
yeast Mrc1 proteins also possess similar basic segments. Notably, BP1 and BP2 
define the boundaries of the RFID.  
To evaluate directly whether the RFID can account for the chromatin-binding 
ability of full-length Claspin, we prepared various forms of full-length 35S-labeled 
Claspin with mutations in this domain. We first examined relatively large deletions 
in the protein. Initially, we deleted BP1 (α BP1, residues 265–331) and 40 amino 
acids encompassing the C-terminal end of BP2 (α BP2', residues 566–605). 
Moreover, we also produced a mutant (6A) in which six residues within BP1 that 
are highly conserved in metazoan Claspin proteins and conserved to some extent 
in the yeast Mrc1 proteins were changed to alanine. As shown in figure 3.3E, 
when we added 35S-labeled forms of the α BP1, α BP2', and 6A mutants to 
undepleted egg extracts that contain their full complement of endogenous 
Claspin, binding to chromatin was abrogated or greatly reduced. By contrast, 
deletion of a poorly conserved segment (residues 376–425) from the center of the 
RFID, which we named the linker region (LK), had negligible effect on binding to 
chromatin (figure 3.3E). Consistent with this observation, a bacterially expressed 
form of GST-NLS-Claspin(265-605) α LK bound well to chromatin (our 
unpublished data) and associated specifically with Xcdc45, Pol ε, RPA, and 
RFC40 in chromatin immunoprecipitation experiments (figure 3.3F).  
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3.3.5 The BP1 Region of Claspin Is Not Required for Activation of Chk1 
Next, we sought to replace endogenous Claspin in egg extracts with various 
RFID mutants to assess their abilities to function in checkpoint regulation. Toward 
this end, we created mutations in a baculovirus-expressed version of Claspin that 
contains His6 and FLAG tags at the N- and C-terminal ends, respectively (His6-
Claspin-FLAG). First, we focused on the BP1 region. We produced α BP1 and 6A 
mutants of the baculovirus-expressed protein. We also prepared a larger deletion 
(residues 150–331) that removes all of BP1 and a block of upstream conserved 
sequences. The deleted region in this latter mutant corresponds to the whole 
DBD that was identified in human Claspin (Sar et al., 2004). When we examined 
binding to chromatin in undepleted egg extracts, we observed that none of the 
α BP1, 6A, and α (150-331) mutants of baculovirus-expressed His6-Claspin-FLAG 
could bind to chromatin (figure 3.4A). 
We proceeded to immunodeplete endogenous Claspin from the extracts and to 
replace it with equivalent amounts of these three mutants. First, we monitored the 
binding of these mutants to chromatin in extracts that now lacked endogenous 
Claspin. Unexpectedly, we observed that these three mutants could now bind 
very well to chromatin (figure 3.4B). This observation indicates that, in the 
absence of competition from endogenous Claspin, these three mutants retain 
significant ability to interact with chromatin. Furthermore, binding of the α BP1 
mutant to chromatin displayed the same sensitivity to p27 as wild-type Claspin 
(figure 3.4C), which argues this mutant binds specifically to replication forks. We 
next examined the ability of these mutants to mediate the activation of Xchk1 in 
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response to treatment with aphidicolin. As shown in figure 3.4B, all three mutants 
did not show any obvious difference from wild-type Claspin in the ability to 
promote the phosphorylation of Xchk1. Together, these results indicate that 
neither BP1 nor the whole DBD region is required for activation of Xchk1. 
Deletion of BP1 or the DBD region does weaken the interaction of Claspin with 
chromatin. However, without competition from endogenous full-length Claspin, 
mutants lacking these sequences bind very well to chromatin, which implies that 
the remaining sequences of Claspin are sufficient for chromatin binding.  
We have previously shown that Claspin does not bind detectably to either single-
stranded or double-stranded DNA in egg extracts (Kumagai et al., 2004; Lee et 
al., 2003). More recently, it was reported that recombinant human Claspin seems 
to have a stronger in vitro binding activity toward branched DNA than single-
stranded or double-stranded DNA (Sar et al., 2004). Therefore, we tested directly 
whether endogenous Claspin in egg extracts can associate stably with branched 
DNA. As the template (30d-40s DNA), we annealed two 70-mers that are 
complementary for 30 nucleotides at one end. As shown in figure 3.4D, we could 
not detect any binding of Claspin to either the branched 30d–40s DNA or double-
stranded (dA)70-(dT)70. On the other hand, we
 could readily observe binding of 
RPA, Xatr, and Xatrip to both templates. Furthermore, addition of caffeine or 
immunodepletion of RPA, both of which greatly increase the binding of Claspin to 
chromatin in aphidicolin-containing egg extracts (Lee et al., 2003), did not result 
in any binding of Claspin to either template. The concentration of Claspin in egg 
extracts (240 nM) (Kumagai and Dunphy, 2000) is well over the observed Kd for 
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in vitro binding of recombinant human Claspin to branched DNA and thus should 
not be a limiting factor. Together, these results suggest that endogenous Claspin 
in egg extracts cannot bind stably to DNA alone in egg extracts and that 
interaction with proteins at the replication fork is necessary for stable association 
with chromatin.  
3.3.6 The BP2 Region of Claspin Potentiates Its Chk1-activating Function 
To study the role of the RFID more systematically, we prepared various mutant 
versions of Claspin containing serial N-terminal deletions and compared their 
chromatin binding properties in the absence of endogenous Claspin. We 
performed these experiments in the presence of aphidicolin and caffeine to 
maximize binding, but we obtained qualitatively similar binding in the presence of 
aphidicolin alone (our unpublished data). As shown in figure 3.5A, both 
Claspin(265–1285) and Claspin(332–1285), which lack part of or the entire DBD 
region, bind as well as full-length Claspin to chromatin. On the other hand, further 
deletions from the N-terminal end resulted in a dramatic drop in association with 
chromatin. In particular, binding of the Claspin(470–1285), Claspin(606–1285), 
and Claspin(774–1285) fragments was markedly reduced, although the 470–
1285 fragment did reproducibly bind somewhat better than the 606–1285 and 
774–1285 fragments.
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Figure 3.5. C-terminal fragments of Claspin display reduced potency in 
mediating activation of Xchk1.  
(A) Full-length (residues 1–1285) and N-terminally truncated forms of Claspin (residues 265–
1285, 332–1285, 470–1285, 606–1285, and 774–1285) were prepared as His6-Claspin-FLAG 
proteins in insect cells and added into Claspin-depleted extracts containing sperm chromatin, 
aphidicolin, and caffeine. Nuclear (lanes 1–6) and chromatin fractions (lanes 7–12) were 
prepared and immunoblotted with anti-FLAG (top) and anti-Xorc2 antibodies (bottom). The 
bars on right denote positions of the different recombinant Claspin proteins. (B) Mock-depleted 
(lanes 1 and 2) and Claspin-depleted extracts (lanes 3–13) containing control buffer (lanes 1–
3) or the indicated forms of His6-Claspin-FLAG (lanes 4–13) were incubated in the absence 
(lane 1) or presence (lanes 2–13) of aphidicolin. Recombinant Claspin proteins were added at 
a molar concentration equal to (1×) or one-fifth (0.2×) that of endogenous Claspin. 
Phosphorylation of 35S-Xchk1 in nuclear fractions from the extracts was assessed by 
phosphorimaging. (C) Wild-type His6-Claspin-FLAG (lanes 1 and 2) and a deletion mutant 
lacking residues 470–605 (∆BP2, lanes 3 and 4) were added into undepleted egg extracts 
containing sperm chromatin, aphidicolin, and caffeine. Nuclear (lanes 1 and 3) and chromatin 
fractions (lanes 2 and 4) were immunoblotted with anti-FLAG (top) and anti-Xorc2 antibodies 
(bottom). (D) Claspin-depleted extracts were prepared and incubated in the presence of 
aphidicolin with buffer alone (lane 1), wild-type His6-Claspin-FLAG (lane 2), or the ∆BP2 
mutant (lane 3). Chromatin fractions were immunoblotted for Claspin (top) and Xorc2 (bottom). 
(E) Phosphorylation of 35S-Xchk1 was compared in extracts containing the full-length, 470–
1285, and ∆BP2 versions of Claspin at the indicated concentrations as described in B. 
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We proceeded to compare the ability of the various truncation mutants to mediate 
the activation of Xchk1. For these experiments, we immunodepleted endogenous 
Claspin from egg extracts and then added back the various recombinant Claspin 
proteins at two different concentrations to compare their relative potencies. In 
particular, we used molar concentrations corresponding to the amount of 
endogenous Claspin (1×) and a fivefold dilution of this amount (0.2×), 
respectively. Finally, we added sperm chromatin and aphidicolin to the extracts 
and then monitored phosphorylation of Xchk1. We observed that the full-length, 
332–1285, and 470–1285 polypeptides all could restore phosphorylation of 
Xchk1 in Claspin-depleted extracts at the both 1× and 0.2× concentrations (figure 
3.5B). However, the shorter fragments of Claspin, namely, 606–1285 and 774–
1285 were significantly less potent at promoting the phosphorylation of Xchk1. 
This effect was most evident at the diluted concentration of these fragments. For 
example, an extract containing the 774–1285 mutant at the 0.2× concentration 
displayed little or no phosphorylation of Xchk1. These observations indicate that 
the C-terminal region of Claspin, which does not bind strongly to chromatin, 
shows reduced capacity to mediate the activation of Xchk1. However, the 470–
1285 fragment seemed similar to full-length Claspin in the ability to mediate 
phosphorylation of Xchk1, even though it did not display the stable chromatin-
binding capacity of full-length Claspin.  
These observations suggested that all or part of the BP2 region in Claspin 
(residues 470–600) might be important for checkpoint signaling. To pursue this 
possibility, we prepared a mutant of full-length His6-Claspin-FLAG with a deletion 
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of residues 470–605 (α BP2). Consistent with the results observed for the smaller 
deletion of residues 566–605, the α BP2 mutant could bind to chromatin in 
Claspin-depleted extracts but not in undepleted extracts containing endogenous 
Claspin (figure 3.5C and D). When we examined checkpoint regulation, we 
observed that aphidicolin-treated extracts containing a fivefold dilution of the 
α BP2 mutant showed significantly reduced phosphorylation of Xchk1 (figure 
3.5E). Therefore, deletion of BP2 seems to compromise the checkpoint-signaling 
potency of Claspin.  
3.3.7 The C-terminal Region of Claspin Contains a Small Chk1-activating 
Domain 
These observations suggested that the C-terminal domain of Claspin has a 
significantly reduced potency for activation of Xchk1. To pursue this issue, we 
systematically compared the potencies of full-length Claspin and the C-terminal 
774–1285 fragment for mediating the activation of Xchk1 (figure 3.6A and B). For 
this purpose, we immunodepleted endogenous Claspin from egg extracts and 
added back different dilutions of full-length Claspin and the 774–1285 fragment. 
This procedure enabled us to compare the relative potencies of the two proteins. 
Significantly, full-length Claspin was highly resistant to dilution, indicating that 
there is a large functional surplus of Claspin in egg extracts. For example, we 
observed half-maximal phosphorylation of Xchk1 in extracts containing a 
concentration of recombinant full-length Claspin ~0.055× the level of endogenous 
Claspin (figure 3.6B). By contrast, a molar concentration of the 774–1285 
fragment ~1.8-fold greater than that of endogenous full-length Claspin was 
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required to elicit a similar extent of phosphorylation. Therefore, the 774–1285 
fragment seems to be ~33-fold less potent than full-length Claspin. To evaluate 
whether the 774-1285 fragment acts by a similar mechanism as full-length 
Claspin, we examined phosphorylation of Claspin on Ser864, which is required 
for phosphorylation of Xchk1 (Kumagai and Dunphy, 2003). As shown in figure 
3.6C, the 774–1285 fragment became very efficiently phosphorylated on Ser864 
in aphidicolin-treated extracts.  
These results imply that the C-terminal region of Claspin should contain the 
minimal sequences necessary to carry out the biochemical process required for 
the ATR-dependent phosphorylation of Xchk1. To identify these sequences, we 
prepared various C-terminal fragments of Claspin as fusion proteins containing 
GST and an ectopic NLS. The fusion constructs were designed to contain the 
previously identified Chk1-binding domain of Claspin (CKBD, residues 847–903), 
in which serines 864 and 895 must be phosphorylated for binding to Xchk1 
(Kumagai and Dunphy, 2003).  We could observe phosphorylation of Xchk1 in the 
presence of a fragment from Claspin containing residues 776–956 but not an 
overlapping fragment containing residues 844–1170 (figure 3.6D). Further 
analysis indicated that a 130-amino acid fragment containing amino acids 776–
905 is sufficient for restoring phosphorylation of Xchk1 to Claspin-depleted 
extracts (figure 3.6E and F). We named this fragment the Chk1-activating domain 
(CKAD). The CKAD, as well as the longer 776–956 and 774–1285 fragments, 
displayed little or no binding to chromatin (figure 3.6G). Importantly, however, the 
CKAD is considerably less potent than full-length Claspin. For example, in figure 
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3.6E, we needed to add the CKAD fragment at a six-fold molar excess over the 
amount of endogenous Claspin, which is already in surplus, to observe a similar 
extent of Xchk1 phosphorylation.  
Overall, these findings indicate that the capacity of Claspin to mediate the 
activation of Xchk1 resides in a small C-terminal region containing no more than 
130 amino acids. However, sequences from the BP2 region greatly increase the 
overall potency of Claspin for activation of Xchk1. Deletion of BP2 weakens the 
interaction of Claspin with chromatin. On the other hand, a truncated form of 
Claspin (residues 470–1285) that contains BP2 does not bind stably to chromatin 
and nonetheless induces phosphorylation of Xchk1 as efficiently as full-length 
Claspin. These observations indicate that stable retention of Claspin on 
chromatin is not necessary for activation of Xchk1.
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Figure 3.6 
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Figure 3.6. A small fragment from the C-terminal end of Claspin is sufficient at 
high concentrations for mediating phosphorylation of Xchk1.  
(A) Mock-depleted (lanes 1 and 2) and Claspin-depleted extracts (lanes 3–12) were incubated 
with control buffer (lanes 1 and 2) and the indicated dilutions of full-length His6-Claspin-FLAG 
(lanes 3–7) or the His6-Claspin(774–1285)-FLAG fragment (lanes 8–12) in the absence (lane 
1) or presence (lanes 2–12) of aphidicolin. Nuclear fractions were prepared and 
immunoblotted with anti-Claspin antibodies (top), anti-FLAG antibodies to detect both full-
length Claspin (second panel from top) and the 774–1285 fragment (third panel from the top), 
and anti-PCNA antibodies (fourth panel from top). Note that the anti-Claspin antibodies do not 
detect the 774–1285 fragment. Phosphorylation of 35S-Xchk1 was assessed by 
phosphorimaging (bottom). (B) Quantitation of results from A for full-length Claspin (closed 
circles) and the 774–1285 fragment (closed squares). (C) Phosphorylation of the 774–1285 
fragment on Ser864. Mock-depleted (lanes 1 and 2) and Claspin-depleted extracts (lanes 3–
6) containing control buffer (lanes 1–3), full-length His6-Claspin-FLAG (lane 4), or His6-
Claspin(774–1285)-FLAG (lanes 5 and 6) at the indicated amounts relative to endogenous 
Claspin were incubated in the absence (lane 1) or presence (lanes 2–6) of aphidicolin. 
Nuclear fractions were immunoblotted with anti-Claspin, anti-P-Ser864 of Claspin, and anti-
FLAG antibodies as indicated. To examine phosphorylation of Xchk1, samples were 
immunoblotted with anti-P-Ser344 of Xchk1 and anti-Xchk1 antibodies (bottom two panels). 
(D) C-terminal fragments of Claspin fully rescue phosphorylation of Xchk1 at high 
concentrations. Mock-depleted (lanes 1 and 2) and Claspin-depleted extracts (lanes 3–9) 
containing control buffer (lanes 1–3), full-length His6-Claspin-FLAG (lane 4), His6-
Claspin(774–1285)-FLAG (lanes 5–7), GST-NLS-Claspin(776–956) (lane 8), and GST-NLS-
Claspin(844–1170) (lane 9) at the indicated concentrations relative to endogenous Claspin 
were incubated in the absence (lane 1) or presence (lanes 2–9) of aphidicolin. 
Phosphorylation of 35S-Xchk1 was detected with a phosphorimager (top) and quantitated 
(bottom). Results are mean ± SD for two experiments. (E) The 776–905 fragment of Claspin 
is sufficient at a high concentration for full phosphorylation of Xchk1. Mock-depleted (lanes 1 
and 2) and Claspin-depleted extracts (lanes 3 and 4) were incubated with control buffer (lanes 
1–3) or GST-NLS-Claspin(776–905) (lane 4) at a molar concentration sixfold higher than that 
of endogenous Claspin and examined for phosphorylation of 35S-Xchk1. (F) Summary for 
identification of the CKAD from Claspin. The CKBD is denoted with the shaded box. (G) 
Fragments from C-terminal half of Claspin display little or no stable binding to chromatin. 
Extracts were incubated with His6-Claspin(774–1285)-FLAG, GST-NLS-Claspin(776–956), or 
GST-NLS-Claspin(776–905) in the presence of aphidicolin (lane 2) or aphidicolin plus 
caffeine (lanes 1 and 3). Polypeptides were added at 4–6× the molar concentration of 
endogenous Claspin. Nuclear (lane 1) and chromatin fractions (lanes 2 and 3) were 
immunoblotted with anti-FLAG or anti-GST antibodies to detect recombinant Claspin proteins 
as appropriate. Samples were also immunoblotted for endogenous Claspin, Xrad17, and 
Xorc2. 
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3.4 Discussion 
One characteristic of the checkpoint mediator protein Claspin is that it interacts 
specifically with both normal and stalled DNA replication forks during S phase. In 
this report, we have investigated the mechanism and functional significance of 
this interaction. To this end, we have mapped the regions of Claspin that enable 
binding to chromatin and searched for chromatin-bound proteins that mediate this 
interaction. Our studies have indicated that Claspin contains a relatively large 
RFID that is responsible for interaction with chromatin. This domain associates 
with Xcdc45, RPA, and both the replicative and Rad17-containing RFC 
complexes (figure 3.7). We have also established that there is specific binding of 
Claspin to one of the major replicative DNA polymerases, namely, Pol ε. 
Therefore, Claspin interacts with both essential replication proteins and a key 
checkpoint regulator on chromatin. Consistent with these observations, it has 
been reported that budding yeast Mrc1 and Cdc45 can be coimmunoprecipitated 
from nuclease digests of chromatin (Katou et al., 2003). However, these studies 
did not resolve whether Mrc1 and Cdc45 associate by protein–protein 
interactions or simply bind near one another on the same digested DNA 
fragments.
96 
 
  
Figure 3.7. Model for the interaction of Claspin with stalled replication 
forks.  
(A) Diagram summarizes the protein–protein interactions of Claspin at replication 
forks. See text for discussion. (B) Summary of the different functional domains within 
Claspin. 
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3.4.1 Claspin Interacts Successively with Replication Fork Proteins 
We have found that Xcdc45 forms a complex with Claspin without loading of RPA 
or RFC onto chromatin. By contrast, RFC depends upon the loading of RPA to 
interact with Claspin. These dependencies reflect the hierarchy in which these 
proteins associate with chromatin. Therefore, our results indicate that upon 
binding to chromatin Claspin interacts first with Xcdc45. After unwinding of the 
DNA, loading of RPA, and synthesis of initiating primers, the replicative RFC 
complex would recognize the 3' recessed ends of nascent DNA strands. At this 
point, RFC would also become incorporated into a complex with Claspin. We also 
find that Claspin interacts with the Rad17-containing RFC complex. Recent 
evidence has indicated that the Rad17-containing complex interacts with the 5' 
recessed ends of DNA strands (Ellison and Stillman, 2003; Zou et al., 2003). 
Thus, Claspin would be in a position to participate in the detection of an array of 
different DNA replication intermediates (figure 3.7A).  
3.4.2 Role of Claspin as a Checkpoint Sensor Protein 
One important question in the cell cycle checkpoint field involves the issue of how 
cells detect the presence of incompletely replicated or damaged DNA. Numerous 
studies in recent years have suggested that cells use a combinatorial mechanism 
to detect and discriminate between arrays of checkpoint-triggering signals 
(Sancar et al., 2004). Mediator proteins such as Claspin and the BRCT-
containing proteins can provide additional modes of discrimination to checkpoint-
sensing mechanisms, and indeed they may be crucial for cells to distinguish 
between different checkpoint-inducing signals. The fact that Claspin associates 
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strongly with replication forks raised the possibility that this binding would be 
closely related with the ability of Claspin to mediate the activation of Xchk1. 
Interestingly, however, we find that certain fragments of Claspin retain the ability 
to mediate the activation of Xchk1 without being able to associate stably with 
chromatin. These fragments fall into two classes. Fragments from the C-terminal 
half of Claspin retain full efficacy for activation of Xchk1 but are significantly less 
potent. For example, the 774–1285 fragment is ~33-fold less potent than full-
length Claspin for half-maximal activation of Xchk1. By contrast, a fragment 
containing residues 470–1285 does not bind to chromatin stably but is 
nonetheless comparable to full-length Claspin in its potency for activation of 
Xchk1. Significantly, this fragment retains a substantial portion of the RFID, 
namely, BP2 (residues 470–600) (figure 3.7B). The presence of the BP2 region 
may allow the 470-1285 fragment to interact transiently with replication forks and 
thereby enhance the ability of Claspin to mediate the activation of Xchk1. 
Alternatively, it is possible that the BP2 region increases the activity of Claspin as 
a mediator by a mechanism that does not involve any interaction with chromatin. 
However, our mapping studies have clearly indicated that this region is important 
for optimal interaction with chromatin. For example, deletion of BP2 (residues 
470–600) from full-length Claspin impaired chromatin binding in egg extracts 
containing all of its endogenous Claspin, indicating that this mutant cannot 
compete effectively with normal Claspin. Furthermore, in Claspin-depleted 
extracts, the α BP2 mutant can bind to chromatin, but it displays significantly 
reduced ability to mediate the activation of Xchk1. Therefore, this mutant seems 
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to associate with chromatin in an aberrant manner that is not compatible with 
normal activation of Xchk1.  
Recently, it has been shown that human Claspin and its fission yeast relative 
Mrc1 possess a DBD (Sar et al., 2004; Zhao and Russell, 2004). The DBD in 
human Claspin (residues 149–340) is highly homologous to residues 150–331 in 
Xenopus Claspin and contains the BP1 region of the RFID that we have identified 
in this study. Our results indicate that the DBD region is not essential either for 
interaction with chromatin or for activation of Xchk1. We found that versions of 
Claspin that lack this region, such as the α (150–331) and 332–1285 constructs, 
bind very well to chromatin in Claspin-depleted extracts and display a 
comparable potency with full-length Claspin for mediating the activation of Xchk1. 
Nonetheless, these mutants do seem to have a lower affinity for replication forks 
in that they are unable to bind to chromatin in undepleted extracts containing the 
full complement of endogenous Claspin. The physiological role of the DBD in 
human Claspin is not known. Fission yeast harboring a version of Mrc1 with a 
mutated DBD displayed a modest increase in sensitivity to hydroxyurea and a 
partial defect in the DNA replication checkpoint. However, the abilities of this 
mutant to associate with chromatin in fission yeast cells and to mediate the 
activation of Cds1, the checkpoint effector kinase downstream of Mrc1, have not 
yet been described. We suspect that the DBD/BP1 region may have a role in 
some other function of Claspin besides mediating the activation of Xchk1.  
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3.4.3 Identification of a Minimal Chk1-activating Domain 
Another finding of this work is that a very small fragment of Claspin (the CKAD), 
only 130 amino acids long, is fully sufficient at high concentrations to sustain the 
Xatr-dependent activation of Xchk1 in aphidicolin-treated extracts. We can detect 
little or no association of the CKAD with chromatin, which reinforces the concept 
that stable binding of Claspin to chromatin is not obligatory for checkpoint 
activation. Nonetheless, even this small fragment presumably interacts transiently 
with sites of replication to collaborate with replication fork-associated Xatr in the 
phosphorylation of Xchk1. Similarly, we can never detect binding of Xchk1 to 
chromatin (our unpublished data), which implies that Xchk1 would also interact 
only transiently with Xatr-Xatrip and Claspin at replication forks. Consistent with 
this idea, Claspin has a low affinity for the fully activated form of Xchk1, which 
presumably dissociates from Claspin immediately upon kinase activation (Jeong 
et al., 2003). Together, these observations indicate that Xatr-Xatrip, Claspin, and 
Xchk1 associate evanescently with one another during the process that results in 
activation of Xchk1.  
3.4.4 Stable Chromatin Binding of Claspin May Reflect an Additional Function 
Our observations support the possibility that the RFID has another function in 
addition to initial activation of Xchk1. In the absence of Claspin, DNA replication 
in egg extracts occurs somewhat more slowly than normal (Lee et al., 2003). 
Interestingly, overexpression of Claspin in human cells enhances the rate of cell 
proliferation (Lin et al., 2004). Furthermore, it is well established that the budding 
yeast Mrc1 protein, the apparent functional counterpart of Claspin, has a role in 
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DNA replication. Yeast mutants lacking Mrc1 replicate their DNA more slowly, 
accumulate DNA damage in S phase, and exhibit defects in sister chromatid 
cohesion (Alcasabas et al., 2001; Osborn and Elledge, 2003; Xu et al., 2004). 
Although the exact role that Claspin/Mrc1 plays in S-phase regulation remains to 
be established, our data raise the possibility that the stable retention of Claspin 
on chromatin may be related to this function. 
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Chapter 4 
 
 
Drf1-Dependent Kinase (DDK) Interacts 
with Claspin through a Conserved 
Protein Motif  
Daniel A. Gold and William G. Dunphy 
 
The Drf1/Dbf4-dependent kinase (DDK) is required for the initiation of DNA 
replication in eukaryotes.  Another protein, Claspin, mediates the activation of a 
cellular checkpoint response to stalled replication forks and is also a regulator of 
replication.  In this study, we found that DDK phosphorylates Claspin in vitro and 
forms a nuclear complex containing Cdc7, Drf1, and Claspin in Xenopus egg 
extracts.  We identified a conserved binding site on Claspin required for its 
interaction with DDK.  This site corresponds to the first of two sequence repeats 
in the Chk1-binding domain (CKBD) of Claspin.  Furthermore, we have 
established that two amino acids in this motif, D861 and Q866, are essential for 
the interaction between Claspin and DDK.  Finally, we found that a mutant form 
of Claspin incapable of interacting with DDK is still able to associate with and 
activate Chk1 in response to replication blocks.  These findings suggest that the 
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interaction of DDK with Claspin mediates a checkpoint-independent function of 
Claspin, most likely related to DNA replication. 
4.1 Introduction 
The maintenance of genomic stability is of paramount importance to living 
organisms.  For example, proliferating cells must ensure the fidelity of 
chromosomal DNA replication.  To accomplish this task, eukaryotic organisms 
have evolved a highly ordered series of steps to carry out DNA replication as well 
as a system of checkpoints to monitor the integrity of this process.   
The stepwise process of eukaryotic DNA replication begins with the formation of 
pre-replication complexes (pre-RCs) at replication origins (Arias and Walter, 
2007; Takeda and Dutta, 2005).  The conversion of the pre-RCs into active 
replication forks is promoted by the action of two kinases, the S-phase cyclin-
dependent kinase (S-CDK) and the Drf1/Dbf4-dependent kinase Cdc7 (DDK).  In 
higher eukaryotes, the kinase activity of Cdc7 is dependent on the association 
with either of the regulatory subunits, Dbf4 or Drf1 (Jiang et al., 1999; Kumagai et 
al., 1999; Montagnoli et al., 2002).  However, Drf1 is the primary Cdc7-binding 
partner that drives replication in early Xenopus embryos (Takahashi and Walter, 
2005) (Silva et al., 2006).  The most well-established target of DDK activity is the 
MCM2-7 complex, the putative replicative helicase.  DDK phosphorylates 
multiple components of the MCM complex (Masai et al., 2006; Sheu and 
Stillman, 2006; Tsuji et al., 2006).  Moreover, the action of DDK is required for 
the recruitment of Cdc45 to chromatin (Walter, 2000; Zou and Stillman, 2000).  It 
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is thought that Cdc45 stimulates replicative helicase activity, which allows binding 
of DNA polymerases and other DNA replication elongation factors to origins 
(Aparicio et al., 2009; Gambus et al., 2006; Moyer et al., 2006; Pacek et al., 
2006).     
Cells frequently encounter barriers during the course of DNA replication.  Cells 
respond to the resulting stalled replication forks mainly by employing the ATR-
Chk1 checkpoint pathway (Kastan and Bartek, 2004; Melo and Toczyski, 2002).  
ATR is a sensor kinase that becomes activated in response to stalled replication 
forks and thereby transduces signals through the effector kinase Chk1.  These 
signaling steps lead to the prevention of the inappropriate entry into mitosis and 
the inhibition of late replication origin firing (Kastan and Bartek, 2004; Melo and 
Toczyski, 2002).  ATR directly phosphorylates Chk1 by a mechanism that 
depends on the checkpoint mediator protein Claspin (Chini and Chen, 2003; 
Kumagai and Dunphy, 2000; Kumagai et al., 2004).  Besides its well-established 
function in mediating the activation of Chk1 in response to replication stress, 
Claspin also has roles in the regulation of unperturbed DNA replication and in the 
stabilization of disrupted replication forks (Lee et al., 2005; Lee et al., 2003; Lin et 
al., 2004).  Claspin is a component of both normal and stalled replication forks.  It 
interacts with a number of replication factors, including Cdc45, RFC, RPA, and 
DNA polymerase ε (Pol ε), and is necessary for a normal rate of fork progression 
(Lee et al., 2005; Lee et al., 2003; Lin et al., 2004; Petermann et al., 2008; Sar et 
al., 2004).  The association of Claspin with chromatin depends on Cdc45 and 
occurs at about the same time as Pol ε (Lee et al., 2003).  Likewise, the yeast 
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ortholog of Claspin, Mrc1, moves with the replication fork and is necessary for a 
normal rate of DNA replication (Hodgson et al., 2007; Katou et al., 2003; Lou et 
al., 2008; Osborn and Elledge, 2003; Szyjka et al., 2005; Tourriere et al., 2005).     
Despite the inhibition of late origin firing under conditions of checkpoint-inducing 
replication stress, the Cdc7/Drf1 kinase remains active (Tenca et al., 2007; Tsuji 
et al., 2008; Yanow et al., 2003).  Several lines of evidence indicate that DDK 
may play a role in the regulation of checkpoint responses in metazoan systems.  
Drf1 accumulates on replication-arrested chromatin in an ATR- and Claspin-
dependent manner in Xenopus egg extracts (Yanow et al., 2003).  Also, human 
Cdc7 has been shown to phosphorylate and interact with human Claspin in HeLa 
cells (Kim et al., 2008).  Moreover, when Cdc7 is knocked down by siRNA, 
mammalian cells are more sensitive to agents that elicit replication stresses such 
as hydroxyurea (HU).  These Cdc7-ablated cells are defective in the checkpoint-
associated phosphorylation of Chk1 and Claspin (Kim et al., 2008).  Finally, 
ectopic addition of excess Dbf4-Cdc7 to Xenopus egg extracts or overexpression 
of Dbf4 in HeLa cells is able to down-regulate the ATR-Chk1 pathway signaling 
elicited by agents that induce replication stress (Tsuji et al., 2008). 
For these reasons, we sought to examine the potential role of DDK in response 
to replication stress by further examining the relationship between DDK and the 
replication-monitoring protein, Claspin.  In this study, we established that DDK 
phosphorylates and interacts with Claspin in Xenopus egg extracts.  
Furthermore, we precisely mapped the site of this interaction to an evolutionarily 
conserved protein motif on Claspin.  We found that two amino acids located 
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within the region of Claspin shown to be essential for binding and activating Chk1 
were required for the interaction with DDK.  Interestingly, however, we 
demonstrate that this interaction is not required for Claspin to mediate activation 
of Chk1.  These findings suggest that interaction with DDK reflects a checkpoint-
independent function of Claspin.  
4.2 Experimental Procedures 
4.2.1 Xenopus egg extracts- Interphase egg extracts were treated with 50 µg/ml 
annealed (dA)70-(dT)70 (pA-pT) to activate checkpoint responses as described 
previously (Kumagai and Dunphy, 2000).  To produce chromatin containing DNA 
replication blocks, extracts were incubated with demembranated sperm nuclei 
(3000–4000/µL) and 50 µg/ml aphidicolin. 
4.2.2 Antibodies- Immunodepletion and immunoblotting of Claspin were 
performed with antibodies raised against residues 232–606 of Claspin (Yoo et 
al., 2006).  The anti-Claspin immunoprecipitations (IPs) in this chapter were 
carried out with antibodies generated against residues 1–464 of Claspin 
(Kumagai and Dunphy, 2000).  Anti-Drf1, anti-Cdc7, anti-Plx1, anti-RPA70, and 
anti-Chk1 antibodies were described previously (Kumagai and Dunphy, 1996; 
Kumagai et al., 1998; Lee et al., 2003; Yanow et al., 2003).  Anti-GST (Santa 
Cruz Biotechnology), anti-FLAG M2 (Sigma), and antibodies that detect 
phosphorylated Ser344 of Xenopus Chk1 (Cell Signaling Technology) were 
purchased from commercial sources.  Anti-Scc2 serum (Takahashi et al., 2008) 
was a generous gift of T. Takahashi (Osaka University). 
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4.2.3 Recombinant Proteins- Glutathione-S-transferase (GST)-fused Claspin 
fragments 847–903 and 847–903(2AG) were described previously (Kumagai and 
Dunphy, 2003).  DNA sequences for additional GST-fused Claspin fragments 
(amino acids 1–258, 258–518, 518–775 776–851, 847–962, 961–1078, 1076–
1285, 776–877, 776–867, 776–856, 847–877, 856–903, 868–903, 878–903, 
902–961, 776–1078, and 878–961) were cloned into the pGEX-2T expression 
vector using PCR-based methods.  Sequences encoding the minimal DDK 
binding site (residues 856-867) and point mutants thereof (Q866K, D861E, and 
Q866K/D861E) were cloned into pGEX-2T by producing oligonucleotide linkers 
that create 5′ BamHI and 3′ EcoRI cohesive ends upon annealing.  These 
oligonucleotides were subsequently ligated into the linearized vector prepared 
with the appropriate restriction sites.  Constructs for fragments of human Claspin 
(HuCKBD1, residues 908–919; HuCKBD2, residues 937–948; and HuCKBD3, 
residues 974–985) were prepared in a similar manner.  The above GST-fused 
peptides were expressed in E. coli BL21 CodonPlus (RIL) cells and purified with 
glutathione-agarose beads.  Site-directed mutagenesis using the QuikChange kit 
(Stratagene) was performed to create the D861E, Q866K, and D861E/Q866K 
mutants with the pFastBac-His6-Claspin-FLAG (full-length) and pGEX-2T(776–
1078) as templates.  Recombinant baculoviruses were created using the Bac-to-
Bac method (Invitrogen).  Wild-type Chk1-GST-His6 protein was expressed and 
purified in Sf9 insect cells as previously described (Kumagai and Dunphy, 2000).  
Full-length Claspin proteins were expressed in Sf9 insect cells and purified with 
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M2 anti-FLAG agarose beads (Sigma) and eluted with 3×FLAG peptide (Sigma) 
in HEPES-buffered saline (HBS).   
4.2.4 Immunoprecipitations, immunodepletions, and GST pulldowns- Interphase 
immunoprecipitations were carried out according to previously defined methods 
(Yanow et al., 2003).  Immunodepletions of Claspin from extracts as well as GST 
pulldowns from extracts were performed as in earlier work (Kumagai and 
Dunphy, 2000). 
4.2.5 Immunoprecipitation from nuclear lysates and isolation of soluble nuclear 
lysates- Nuclear immunoprecipitations (IPs) were performed by incubating 100 
µL (per IP reaction) of extracts lacking or containing aphidicolin (4,000 nuclei/µl) 
for 65 minutes at room temperature and subsequently centrifuging them through 
1 ml of ice-cold sucrose cushion (20 mM HEPES-KOH, pH 7.5, 1 M sucrose, 80 
mM KCl, 2.5 mM K-gluconate, and 10 mM Mg-gluconate) at 6,100 × g for 5 
minutes at 4ºC.  The supernatant was removed, leaving a loose pellet, to which 
another 500 µL of sucrose cushion was added.  The sample was centrifuged 
again as above.  The supernatant was removed and 25 µL of high-salt lysis 
buffer (10 mM HEPES-KOH, pH 7.5, 300 mM NaCl, 2.5 mM EGTA, 0.1% 
CHAPS, and 0.5% NP-40) was added to resuspend the pellets.  The samples 
were incubated for 10 minutes at 4ºC, diluted 4-fold with 75 µL of 20 mM 
HEPES-KOH (pH 7.5) to reduce the salt concentration, and subsequently 
centrifuged at 10,000 rpm for 10 minutes at 4ºC.  For immunoprecipitations, the 
supernatant was incubated with agitation at 4ºC for 1 hour with Affiprep Protein A 
beads (BioRad) that had been coated with the appropriate antibodies.  The 
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beads were then washed 4 times with a buffer containing 10 mM HEPES-KOH 
(pH 7.5), 80 mM NaCl, 2.5 mM EGTA, 20 mM β -glycerolphosphate, and 0.1% 
NP-40 and finally boiled in SDS-PAGE sample buffer. 
The nuclear soluble fraction was obtained by centrifuging 25 µL of extracts (mock 
or Claspin-immunodepleted) twice through a 500 µL sucrose cushion as 
described above and then resuspending the pellets in 30 µL of chromatin 
isolation buffer (Lee et al., 2003) on ice for 10 minutes.  The lysates were then 
centrifuged at 6,100 × g for 5 minutes at 4ºC.  The supernatant was collected and 
boiled in SDS-PAGE sample buffer.   
4.3 Results 
4.3.1 DDK forms a stable complex with Claspin in S-phase egg extracts.  An 
active form of the Cdc7 kinase can be isolated from interphase Xenopus egg 
extracts by immunoprecipitating the Drf1 protein (Yanow et al., 2003).  In the 
course of testing substrates for this kinase activity, we observed that Cdc7 was 
able to phosphorylate recombinant full-length His6-Claspin-FLAG protein in vitro 
(figure 4.S.1, lane 3).  This result led us to ask whether Drf1 and Claspin can 
interact with one another in egg extracts.  To this end, we subjected interphase 
egg extracts to immunoprecipitation with either anti-Drf1 or anti-Claspin 
antibodies and then immunoblotted the immunoprecipitates for Claspin and Drf1, 
respectively.  These extracts were also incubated in the absence or presence of 
the checkpoint-inducing DNA oligonucleotides (dA)70-(dT)70.  We could easily 
detect Claspin in anti-Drf1 immunoprecipitates and vice versa.  These 
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interactions were not affected by the presence of (dA)70-(dT)70 (figure 4.1A).  
These results are consistent with studies on human Claspin (Kim et al., 2008).    
To examine this finding in greater detail, we also prepared lysates of replicating 
nuclei from interphase egg extracts in which we had eluted proteins from 
chromatin by salt treatment.  We immunoprecipitated these lysates with anti-
Claspin, anti-Drf1, and anti-Cdc7 antibodies and then immunoblotted for all three 
proteins.  In these experiments, we also found that Claspin, Cdc7, and Drf1 
formed a specific complex (figure 4.1B).  In addition, we observed that the 
formation of this complex was not affected by aphidicolin, a drug that causes the 
formation of stalled DNA replication forks in egg extracts.  Recently, Cdc7 and 
Drf1 have been shown to form a stable complex with the cohesin loading protein 
Scc2 in Xenopus egg extracts.  Moreover, this interaction is required for the 
loading of the cohesin complex onto chromatin during replication (Takahashi et 
al., 2008).  In our experiments, we observed that Scc2 and Claspin also 
associate with each other in egg extracts in both the absence and presence of 
aphidicolin (figure 4.1B).  
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Figure 4.S.1  DDK isolated from egg extracts can phosphorylate 
Claspin in vitro. 
Interphase egg extracts were immunoprecipitated with either anti-Drf1 or mock 
control antibodies.  The immunoprecipitates were added to in vitro kinase 
reactions containing bacterially expressed GST-Mcm2 (lanes 6 and 7), His6-
Claspin-FLAG (lanes 3 and 4), or no recombinant protein (lanes 1 and 2) in the 
presence of [α -32P]ATP.  The reaction in lane 5 contains His6-Claspin-FLAG 
and [α -32P]ATP but no immunoprecipitates samples.  The reactions were 
subjected to SDS-PAGE, stained with Coomassie Brilliant Blue (CBB) (top 
panel), and analyzed by autoradiography (bottom panel).  Kinase assays were 
carried out as described (Yanow et al., 2003). 
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Figure 4.1   Claspin forms a nuclear interphase complex with Cdc7 
and Drf1 (DDK) in Xenopus egg extracts. 
(A) Mock, anti-Drf1 and anti-Claspin immunoprecipitates (IPs) were prepared from 
nuclei-free interphase egg extracts lacking or containing (dA)70-(dT)70 (pA-pT) and 
immunoblotted for Claspin, Drf1, Cdc7, and Plx1.  Lanes 1 and 2 depict aliquots of 
pre-IP extracts. 
(B) Nuclear lysates were prepared by isolating nuclei from with and without 
aphidicolin (APH) treated interphase extracts supplemented with 4,000/µL 
demembranated sperm DNA. The nuclei were lysed and salt-extracted with 300 mM 
NaCl diluted back to physiological salt levels after centrifugation.  The nuclear lysates 
were immunoprecipitated with control (mock), anti-Drf1, anti-Claspin, and anti-Cdc7 
antibodies and immunoblotted for Scc2, Claspin, Drf1, and Cdc7.  The Claspin 
immunoblots are presented as both long and short film exposures.  Lane 1 is an 
aliquot of interphase egg extract, and lanes 2 and 3 are aliquots of pre-IP nuclear 
lysate lacking or containing aphidicolin. 
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4.3.2 Mapping a DDK-binding site on Claspin.  In order to characterize further the 
interaction between DDK and Claspin, we sought to identify the minimal region of 
Claspin that is required for this binding.  For this purpose, we first constructed a 
series of seven GST-fused Claspin fragments that spanned the entirety of the 
protein.  Immunoprecipitations of Drf1 were carried out with interphase extracts 
that had been supplemented with these GST-Claspin protein fragments.  We 
found that Drf1 strongly interacted with the Claspin fragment containing amino 
acids 847–962 (figure 4.2A, lane 11, and figure 4.S.2A).  There was also a weak 
interaction of Drf1 with the fragment containing amino acids 258–518 (figure 
4.2A, lane 5).   
Subsequently, we focused on the 847–962 fragment both because this 
interaction was very strong and because this fragment contains the Chk1-binding 
domain (CKBD), a region required for the binding and activation of Chk1 
(Kumagai and Dunphy, 2003).  The CKBD of Claspin is composed of two repeat 
sequences, each containing serines that are phosphorylated during a replication 
checkpoint response.  In order to map more finely the sequence that is required 
for Claspin to associate with Drf1, we prepared a series of overlapping GST-
fused Claspin peptide fragments ranging from amino acids 776 to 903.  We found 
that peptide fragments starting at position 776 and ending at or before amino 
acid 856 could not interact with Drf1 (figure 4.2B, D, and figure 4.S.2B).  
Conversely, Claspin fragments starting at before residue 857 could associate 
with Drf1, while there was no binding of the 868–903 and 878–903 fragments 
(figure 4.2B, D, and figure 4.S.3).  Thus, the region comprising amino acids 856 
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through 867 of Claspin is required for this interaction (figure 4.2D).  Interestingly, 
this region corresponds to the first repeat of the CKBD (856–867).  Notably, 
fragments containing the second CKBD repeat (887–898) failed to bind to Drf1.  
In order to ascertain whether this minimal region was sufficient to for the 
interaction with DDK, we constructed a GST fusion protein containing only 
residues 856–867 from Claspin.  When we tested this fragment in the binding 
assay, we could readily observe binding to Drf1 (figure 4.2C, lane 7).  Thus, 
residues 856–867 of Claspin are both necessary and sufficient for recognition of 
Drf1. 
It is striking that only the first CKBD repeat and not the second one could interact 
with Drf1, given that only two amino acids (namely, aspartate 861 and glutamine 
866) are different between the repeats (figure 4.3C).  Some Claspin homologs, 
including human Claspin, have three repeats instead of the two found in Xenopus 
laevis (Chini and Chen, 2006; Clarke and Clarke, 2005).  When we compared 
CKBD repeat sequences across a selection of metazoan Claspin homologs, we 
noticed that these two positions displayed the most variability (figure 4.3C).  We 
initially focused on the position containing glutamine 866, which changes from a 
glutamine to a lysine in the second Xenopus repeat sequence.  This variation 
represents a difference in charge.  By contrast, the position corresponding 
aspartate 861 contains a similar acid residue (glutamate) in the second CKBD 
repeat. 
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Figure 4.2  The region of Claspin required for interaction with DDK 
maps to the first repeat sequence of the CKBD. 
(A) Interphase egg extracts containing the indicated GST-Claspin fragments or GST 
alone were immunoprecipitated with anti-Drf1 (D) or mock (M) control antibodies and 
immunoblotted for Drf1 and GST.  The arrow denotes a cross-reacting IgG band.  
Lane 1 depicts an aliquot of pre-IP extract.  Input levels for the recombinant peptides 
are shown in figure 4.S.2A. 
(B) Interphase nuclei-free egg extracts containing the indicated GST-Claspin 
fragments or no recombinant protein were immunoprecipitated with anti-Drf1 (D) or 
mock (M) control antibodies and immunoblotted for Drf1 and GST.  Lane 19 depicts 
an aliquot of pre-IP extract.  Input levels for the recombinant peptides are shown in 
figure 4.S.2B. 
(C) Interphase nuclei-free egg extracts containing GST-Claspin(776–856), GST-
Claspin(776–867), GST-Claspin(856–867), GST-Claspin(856–867)-Q866K or no 
recombinant protein were immunoprecipitated with anti-Drf1 (D) or mock (M) control 
antibodies and immunoblotted for Drf1 and GST (lanes 2–11).  Lane 1 is depicts an 
aliquot of the initial extract of cytostatic factor.  Lanes 12–16 represent aliquots of pre-
IP extracts containing the recombinant peptides listed above. 
(D) (Top) A schematic depiction of several known domains of Claspin.  The domains 
are the replication-fork interacting domain (RFID), the first and second repeats of the 
Chk1-binding domain (CKBD), and the nuclear localization sequence (NLS).  (Bottom) 
A summary of the abilities of Claspin peptide fragments’ ability to bind DDK. 
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Figure 4.S.2  Loading controls for figure 4.2A and B. 
 (A) Aliquots of extracts containing recombinant proteins from figure 2A (lanes 2–17) 
were taken prior to immunoprecipitation.  Lane 1 is an aliquot of extract with no 
recombinant proteins.  Samples were immunoblotted with Drf1 and GST. 
(B) Aliquots of extracts with the recombinant proteins from figure 4.2B (lanes 1–8) were 
taken prior to immunoprecipitation.  Lane 9 is an aliquot of extract with no recombinant 
proteins.  Samples were immunoblotted for Claspin and GST. 
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Figure 4.S.3  Additional structure-function studies of the DDK-
Claspin interaction. 
Interphase, nuclei-free egg extracts containing GST-Claspin(847–903), GST-
Claspin(847–877), GST-Claspin(878–903), GST-Claspin(902–961), GST-
Claspin(776–851), or no recombinant protein (lanes 2 and 3) were 
immunoprecipitated with anti-Drf1 (D) or mock (M) control antibodies and 
immunoblotted for Drf1 and GST.  Lanes 1, 4, 7, 10, 13, and 16 are aliquots 
(taken before immunoprecipitation) of extracts containing recombinant 
proteins, and lane 19 is an aliquot of the initial extract.   
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We constructed a version of the GST-fused 856-867 Claspin in which glutamine 
866 was changed to lysine (hereafter referred to as the Q866K mutant).  Upon 
testing this mutated fragment, we observed that binding to Drf1 was significantly 
reduced but not completely abolished relative to the original fragment (figure 
4.2C, lane 9, and figure 4.S.4A).  Next, we proceeded to change aspartate 861 to 
glutamate (to generate the D861E mutant).  We also prepared the D861E 
/Q866K double mutant (referred to as E/K).  In the context of the 856–867 
fragment, the D861E mutant displayed a more marked reduction of binding to 
Drf1 in comparison with Q866K mutant.  Moreover, the double E/K mutation 
essentially abolished the interaction with Drf1 (figure 4.S.4A).  We observed 
similar results in a larger Claspin GST-fused fragment (776–1078) that contains 
the entire CKBD and is by itself sufficient to rescue Chk1 activation in a Claspin-
depleted extracts (figure 4.S.4B) (Lee et al., 2005).  Finally, we decided to test 
the capacity of these mutants to interact with DDK in the context of the full-length 
Claspin protein.  We expressed and purified FLAG-tagged recombinant versions 
of wild-type, D861E, Q866K, and E/K full-length Claspin proteins from insect cells 
using a baculovirus protein expression system.  The full-length proteins followed 
the same pattern as the smaller Claspin fragments in that binding of the Q866K 
mutant to Drf1 was reduced, while binding of the D861E single mutant and the 
double E/K binding was nearly eliminated (figure 4.3A).
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Figure 4.3  Identification of conserved sites in Claspin required for interaction 
with DDK. 
(A) Interphase, nuclei-free egg extracts containing full-length, wild-type His6-Claspin-FLAG, 
His6-Claspin-FLAG-Q866K, His6-Claspin-FLAG-D861E, His6-Claspin-FLAG-E/K, or no 
recombinant protein were immunoprecipitated with anti-Drf1 antibodies (lanes 7–11).  Extracts 
containing wild-type His6-Claspin-FLAG were mock immunoprecipitated with control antibodies 
(lane 12).  Lanes 2–6 depict pre-IP aliquots of extracts supplemented with the recombinant 
proteins listed above.  Lane 1 shows an aliquot of interphase extract alone.  The 
immunoprecipitates were immunoblotted for the FLAG epitope and Drf1. 
(B) Interphase, nuclei-free egg extracts containing GST-XeClaspin(856–67), GST-HuClaspin-
CKBD1, GST-HuClaspin-CKBD2, GST-HuClaspin-CKBD3, and GST were immunoprecipitated 
with anti-Drf1 antibodies (lanes 7–11).  Extracts containing GST-Claspin(856–867) and GST-
HuCKBD1 were mock immunoprecipitated with control antibodies (lanes 12 and 13).  Lane 1 
contains an aliquot of pre-IP interphase extract, and lanes 2–6 contain pre-IP aliquots of extracts 
supplemented with the recombinant proteins listed above.  The immunoprecipitates were 
immunoblotted for Drf1, Cdc7, and GST. 
(C) A sequence alignment of the Chk1-binding domain (CKBD) repeat sequences across a 
selection of metazoan Claspin homologs.  The organisms represented here are Xenopus laevis 
(South African claw-toed frog), Gallus gallus (domestic chicken), Drosophila melanogaster (fruit 
fly), Homo sapiens (human), Bos taurus (domestic cow), Canis familiaris (domestic dog), 
Monodelphis domestica (gray short-tailed opossum), Rattus norvegicus (Norway rat), Mus 
musculus (house mouse), and Danio rerio (zebrafish).  The dark arrows point to the X. laevis 
Claspin CKBD repeats and the light arrows point to the H. sapiens CKBD repeats.  Asterisks (*) 
indicate the peptides that were immunoprecipitated by anti-Drf1 antibodies. 
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Figure 4.S.4  Characterization of point mutations in the DDK-interacting 
region of Claspin. 
(A) Interphase, nuclei-free egg extracts containing wild-type GST-Claspin(856–867), GST- 
Claspin(856–867)-Q866K, GST-Claspin(856–867)-D861E, GST-Claspin(856–67)-E/K, and 
GST were immunoprecipitated with anti-Drf1 antibodies (lanes 7–11).  Extract containing wild-
type GST-Claspin(856–67)-wild type was also mock immunoprecipitated with control 
antibodies (lane 12).  Lane 1 contains an aliquot of pre-IP interphase extract prior to 
immunoprecipitation, and lanes 2–6 contain pre-IP aliquots of extracts supplemented with the 
recombinant proteins listed above.  The immunoprecipitates were immunoblotted for Drf1 and 
GST. 
(B) Interphase nuclei-free egg extracts containing wild-type GST-Claspin(776–1078), GST- 
Claspin(776–1078)-Q866K, GST-Claspin(776–1078)-D861E, GST-Claspin(776–1078)-E/K, 
and GST were immunoprecipitated with anti-Drf1 antibody (lanes 7-11).  Extract containing 
GST-Claspin(776–1078)-wild type was mock immunoprecipitated with control antibodies (lane 
12).  Lane 1 contains an aliquot of pre-IP interphase extract, and lanes 2–6 contain pre-IP 
aliquots of extracts supplemented with the recombinant proteins listed above.  The 
immunoprecipitates were immunoblotted for Drf1 and GST. 
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Since the Claspin CKBD sequences are well conserved across metazoans, we 
decided to test whether these amino acid sites were important in the human 
ortholog of Claspin.  At the amino acid position equivalent to aspartate 861 in 
Xenopus Claspin, the human Claspin CKBD repeats contain the residues 
aspartate, asparagine, and alanine in the first, second, and third repeat, 
respectively.  Accordingly, we expressed and purified the three human Claspin 
CKBD repeats as GST-fused peptides, added them to Xenopus egg extracts, 
and assayed binding to Drf1 by immunoprecipitating with anti-Drf1 antibodies as 
above.  We observed that the first human Claspin CKBD repeat (HuCKBD1) 
bound efficiently to Drf1, whereas the second and third repeats (HuCKBD2 and 
HuCKBD3) did not bind at all (figure 4.3B, lanes 8–10).  These findings suggest 
that the DDK-binding domain of Claspin may be conserved across metazoan 
species.
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Figure 4.4  Interactions of Claspin with DDK and Chk1 have distinct 
requirements. 
(A) Interphase extracts, lacking or containing (dA)70-(dT)70 (pA-pT), were supplemented with 
wild-type GST-Claspin(776–1078), GST-Claspin(776–1078)-Q866K, GST-Claspin(776–1078)-
D861E, GST-Claspin(776–1078)-E/K), and GST.  Extracts were subjected to pulldowns with 
glutathione agarose beads (lanes 3–12).  Lanes 13–17 are aliquots of pre-pulldown extracts 
supplemented with the above recombinant peptides.  Lanes 1 and 2 depict extracts without and 
with oligonucleotides, but with no added recombinant proteins.  The pulldown fractions were 
immunoblotted for Claspin, Chk1, and GST. 
(B) Interphase extracts, lacking or containing (dA)70-(dT)70 (pA-pT), were supplemented with 
recombinant Chk1-GST-His6.  Extracts were also supplemented with the indicated versions of 
recombinant His6-Claspin-FLAG or no recombinant Claspin.  Extracts were subjected to 
pulldowns with glutathione agarose beads (lanes 3–12).  Lanes 13–17 depict aliquots of 
extracts prior to the pulldowns. Lanes 1 and 2 depict extracts without and with oligonucleotides, 
but with no added recombinant proteins.  The samples were immunoblotted for the FLAG 
epitope and GST. 
(C) Interphase extracts containing GST-Claspin(776–851), wild-type GST-Claspin(847–903), 
GST-Claspin(847–903)-2AG, and GST-Claspin(847–962) were incubated in the absence or 
presence of checkpoint-inducing oligonucleotides and immunoprecipitated with anti-Drf1 
antibodies (D) or mock (M) control antibodies.  The immunoprecipitates were immunoblotted for 
Drf1 and GST. 
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Figure 4.S.5  Loading control for figure 4.4C. 
Aliquots of extracts with the recombinant proteins from figure 4.4C (lanes 1–7) 
prior to immunoprecipitation.  Lanes 8 and 9 are aliquots of extract with no 
recombinant proteins.  Samples were immunoblotted for Claspin and GST. 
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4.3.3 The interaction of Claspin with DDK is separable from its role in mediating 
the activation of Chk1.  Since we have determined that the region of Claspin that 
interacts with DDK also encompasses a key portion of its binding domain for 
Chk1, we decided to test whether the interaction with DDK affects the role of 
Claspin in binding to and activating Chk1.  We first tested whether or not Chk1 
could bind to mutants that were defective for the interaction with DDK.  To this 
end, we performed GST pulldowns with our array of DDK-interaction mutations in 
the context of the GST-fused 776–1078 Claspin peptide fragment mentioned 
above.  This peptide fragment of Claspin contains both the CKBD and sequences 
capable of rescuing Chk1 activation in Claspin-depleted extracts (Lee et al., 
2005).   
When we used glutathione beads to isolate the wild type, D861E, Q866K, and 
E/K mutant Claspin (776–1078) fragments from nuclei-free interphase extracts, 
we found that all of these proteins could bind Chk1 in extracts that had been 
treated those extracts that were treated with the checkpoint-inducing (dA)70-
(dT)70 oligonucleotides (figure 4.4A).  Notably, the mutant Claspin fragments 
displayed an equivalent reduction in electrophoretic mobility as the wild-type 
fragment in extracts treated with (dA)70-(dT)70 (figure 4.4A).  This electrophoretic 
shift is characteristic of Claspin peptides containing the CKBD and is mediated 
by phosphorylation in response to checkpoint activation (Kumagai and Dunphy, 
2003; Lee et al., 2005). 
Next, we tested the Claspin-Chk1 interaction in a reciprocal manner by 
incubating glutathione beads in extracts supplemented with both a GST-tagged 
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version of Chk1 (Chk1-GST-His6) and the different versions of the full-length 
His6-Claspin-FLAG protein.  By this methodology, we also observed that D861E, 
Q866K, and E/K mutants could associate normally with Chk1 (figure 4.4B).  
Taken together, these results indicate that elimination of the ability of Claspin to 
associate with DDK has virtually no effect on binding to Chk1. 
Subsequently, we endeavored to test whether Claspin fragments that are unable 
to bind to Chk1 were still competent to interact with DDK.  Chk1 interacts with 
Claspin through two phosphoserines (S864 and S895) that become 
phosphorylated in response to the activation of the DNA replication checkpoint 
(Kumagai and Dunphy, 2003).  We performed anti-Drf1 immunoprecipitations 
with interphase extracts supplemented with CKBD-containing GST-fused Claspin 
fragments (847–903) that were either wild type or had the ser864 and ser895 
mutated to alanines (2AG).  The wild-type and 2AG fragments were found at 
equivalent levels in the Drf1 immunoprecipitates, regardless of whether the 
extracts contained checkpoint inducing (dA)70-(dT)70 oligonucleotides (figure 4.4C 
and figure 4.S.5).  Thus, the binding of Chk1 to Claspin is distinct from the 
interaction of Claspin with DDK.  
Next, we tested whether the DDK-binding compromised Claspin mutants were 
competent to activate Chk1 in response to replication arrest.  To address this 
question, we immunodepleted Claspin from extracts and then added back wild-
type or mutant full-length His6-Claspin-FLAG proteins to approximately 
endogenous levels.  The extracts were incubated with demembranated sperm 
chromatin in the absence or presence of aphidicolin.  The activation of Chk1 was 
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monitored with anti-phosphopeptide antibodies that detect phosphorylation of 
Chk1 on Ser344, a well established marker for activation of this kinase.  As 
expected, activation of Chk1 activation in response to aphidicolin was ablated in 
the absence of Claspin, and recombinant wild-type Claspin could reverse this 
defect (figure 4.5A, lane 7).  Significantly, the both the D861E and the E/K mutant 
Claspin proteins were also fully able to rescue the activation of Chk1 (figure 
4.5A).  These results are fully consistent with the fact that these mutants can still 
bind Chk1 normally. 
Claspin loads onto chromatin during S-phase in a manner that depends on both 
the pre-RC and Cdc45 (Lee et al., 2003).  The most important known kinase 
target of DDK is the MCM2-7 complex, and this phosphorylation leads to the 
recruitment of Cdc45 (Masai et al., 2006; Sheu and Stillman, 2006; Tsuji et al., 
2006).  Accordingly, we examined the ability of the DDK-interaction mutants of 
Claspin to associate with chromatin that is undergoing replication in egg extracts.  
For this purpose, we isolated chromatin from extracts in which we had 
immunodepleted the endogenous Claspin and replaced it with wild-type 
recombinant Claspin or various DDK-interaction mutants.  For these 
experiments, we also incubated the various extracts in the absence or presence 
of aphidicolin.  We observed that, in the absence of aphidicolin, both the D861E 
and E/K mutants, bound to chromatin with an efficiency similar to that of wild-type 
Claspin (figure 4.5B).  In the presence of aphidicolin, Claspin binds in elevated 
amounts to chromatin and undergoes an electrophoretic shift due to checkpoint-
dependent phosphorylation.  We found that both the D861E and E/K mutants, 
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like wild-type Claspin, associated in higher amounts with aphidicolin-treated 
chromatin and displayed a checkpoint-dependent shift in electrophoretic mobility 
(figure 4.5B).  Finally, our laboratory observed previously that Cdc45 
accumulates in higher amounts on chromatin in the absence of Claspin (Lee et 
al., 2003; Yanow et al., 2003).  Addition of recombinant wild-type Claspin 
reduced the binding of Cdc45 to normal levels (figure 4.5.B).  Likewise, both the 
D861E and E/K mutant Claspin proteins could elicit the normal binding pattern of 
Cdc45.  Taken together, these results indicate that Claspin can associate 
normally with chromatin under a variety of different conditions even if it has lost 
the ability to interact with DDK.
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Figure 4.5 DDK-interaction mutants of Claspin can still mediate activation of Chk1 
and associate with replicating chromatin.   
(A) Nuclear soluble fractions were obtained from interphase egg extracts that were either 
immunodepleted with anti-Claspin antibodies (lanes 2–5 and 7–10) or mock control antibodies (lanes 
6 and 11).  The extracts were supplemented with full-length versions of wild-type His6-Claspin-FLAG 
(lanes 3 and 8), His6-Claspin-FLAG-D861E (lanes 4 and 9), His6-Claspin-FLAG-E/K (lanes 5 and 
10), or no recombinant protein (lanes 2 and 7).  Lane 1 contains an aliquot extract with no 
recombinant protein.  The fractions were immunoblotted for Claspin, Drf1, RPA70, phosphoserine-
344 of Chk1, and Chk1. 
(B) Chromatin was isolated from interphase extracts supplemented with 3,000 sperm nuclei/µl and 
incubated in the absence (lanes 4–8) or presence of aphidicolin (lanes 9–13).  Extracts were 
immunodepleted with either anti-Claspin (lanes 4–7 and 9–12) or mock control antibodies (lanes 8 
and 13).  Extracts were also supplemented with the indicated versions of the His6-Claspin-FLAG 
protein (lanes 5–7 and 10–12) or buffer alone (lanes 4, 8, 9, and 13).  Lanes 14–18 depict aliquots of 
extract taken before isolation of chromatin.  Aliquots of extract were taken before (lane 1) and after 
immunodepletion (lanes 2 and 3).  Samples were immunoblotted for Claspin, Cdc45, and Orc2. 
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4.4 Discussion 
The role of Claspin as a mediator in the activation of Chk1 in response to 
replication stress has been well studied.  On the other hand, the role of Claspin 
as a regulator of replication is still being elucidated.  In this study, we have 
confirmed that Claspin associates specifically with the replication initiating kinase 
DDK in Xenopus egg extracts.  A similar finding has been made in human cells 
(Kim et al., 2008).  Moreover, this complex includes Claspin, Cdc7, Drf1, and the 
cohesin-loading protein Scc2.  The discovery that Claspin can be co-
immunoprecipitated with Scc2 coincides with the finding that the Drf1-Cdc7 
complex interacts with Scc2 and is necessary for the loading of Scc2 onto 
chromatin during S-phase (Takahashi et al., 2008).  Even though we did not see 
a observe a defect in the loading of Scc2 loading onto chromatin in Claspin-
depleted extracts with no perturbation of replication (data not shown), it remains 
possible that Claspin may play a role in regulating the increased loading of the 
cohesin complex onto chromatin in the presence of stalled replication forks 
(Strom et al., 2007).    
We found that the most minimal sequence of Claspin required for binding to DDK 
was the first repeat of the CKBD.  By comparing CKBD repeat sequences both 
within Xenopus Claspin and between other metazoan Claspin homologs, we 
identified two amino acid positions of maximum variability within the repeats.  By 
changing aspartate 861 to glutamate and glutamine 866 to lysine (thereby 
converting the first Xenopus CKBD repeat into the second), we were able to 
abolish almost completely the ability of Claspin to interact with Drf1.  We 
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examined the evolutionary conservation of this binding by testing the ability of 
GST-fused human CKBD minimal repeat peptides to interact with Xenopus Drf1.  
There are three human CKBD repeats, but only the first two are required for 
activation of Chk1 (Chini and Chen, 2006; Clarke and Clarke, 2005).  The first 
human CKBD repeat, which has an aspartate at the position equivalent to 
aspartate 861 of Xenopus Claspin, was the only fragment that could interact with 
Xenopus Drf1 in egg extracts.  While this is an admittedly heterologous 
interaction, there is a high degree of sequence identity between CKBD repeats 
across metazoan species.  The first repeat seems to contain aspartic acid at this 
position in nearly every case (except zebrafish), whereas the other repeats have 
a higher variability of residues and none contain aspartic acid.   Therefore, it 
seems reasonable to speculate that there is a high degree of conservation 
across metazoan Claspin molecules in order for this site to interact with DDK. 
The mechanism by which Claspin activates Chk1 has been well described in 
Xenopus egg extracts.  In response to replication stress, serines 864 and 895 are 
phosphorylated in an ATR-dependent manner by an unidentified kinase.  These 
phosphoserines associate with the kinase domain of Chk1 during a process that 
ultimately leads to the activation of Chk1 (Jeong et al., 2003; Kumagai and 
Dunphy, 2003; Kumagai et al., 2004).  The proximity of the aspartate 861 and 
glutamine 866 to serine 864 was striking and led us to test whether the D861E or 
E/K mutants would affect the ability of Claspin to activate Chk1.  Subsequently, 
we found that these mutants were fully competent to associate with Chk1 and 
mediate its activation of Chk1 in response to replication stress.  Additionally, a 
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2AG mutant version of Claspin fragment that is incapable of binding to Chk1 
(owing to mutations in serines 864 and 895) was still able to interact with Drf1, 
suggesting that the role of DDK interaction with Claspin is distinct from that of 
activating Chk1.  It has been reported that the ablation of Cdc7 by siRNA leads to 
reduced activation of the ATR-Chk1 pathway in mammalian cells (Kim et al., 
2008).  However, this effect may be the result of a reduced number of replication 
forks the absence of Cdc7 rather than a direct modulation of Claspin.  Other work 
has shown that overexpression or ectopic addition of excess Dbf4-Cdc7 can lead 
to an attenuation of Chk1 signaling upon the addition of etoposide in mammalian 
cells and Xenopus egg extracts (Tsuji et al., 2008).  While we observed no defect 
in the ability of the DDK-interaction mutants to activate Chk1 in response to 
aphidicolin, it remains possible that there could be a defect in recovery from 
damage as a result of the loss of interaction with DDK.  Additionally, there could 
be differences between the Dbf4-Cdc7 and Drf1-Cdc7 complexes or in 
responses to different types of damage. 
Our preliminary experiments suggest that addition of the D861E and E/K mutants 
of Claspin to Claspin-depleted extracts may result in a modestly slower rate of 
DNA replication in comparison with Claspin-depleted extracts (Lee et al., 2003).  
This preliminary work also hints that there is a modest delay in mitosis in the 
presence of these mutants, which would be consistent with delayed replication.  
However, these effects were relatively subtle.  Nonetheless, DDK is an important 
regulator of replication.  Although Claspin and its yeast homolog Mrc1 are not 
absolutely required for replication, these proteins are involved in the control of 
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replication-related processes.  Hence, it seems likely the Claspin-DDK interaction 
may be important for some aspect of DNA replication in metazoans. 
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Chapter 5 
Concluding Remarks 
5.1 Checkpoint-regulated Drf1 chromatin binding dynamics 
DDK (Drf1/Dbf4-dependent kinase) is one of two evolutionarily conserved 
kinases required to facilitate the conversion of inactive replication origins into 
initiated replication forks in S-phase (Arias and Walter, 2007; Bell and Dutta, 
2002; Takeda and Dutta, 2005). Drf1 and Dbf4 are cell-cycle-regulated proteins 
that are required for the activation of the kinase Cdc7.  Dbf4 and Drf1 exist in 
distinct complexes with Cdc7.  DDK phosphorylates the MCM2-7 complex, 
recruiting the replication fork unwinding complex of Cdc45 and GINS to the 
MCM2-7 complex, leading to the activation of the MCM2-7 helicase, fork 
unwinding and recruitment of replication fork elongation factors (e.g., DNA 
Polymerases) and replication monitoring proteins (e.g., Claspin). 
5.1.1 Summary of results 
The Xenopus homologue of the Cdc7 adaptor protein, Drf1, was cloned.  Drf1 
forms an active, stable complex that is recruited to replicating chromatin in 
Xenopus egg extracts.  Both Drf1 and Cdc7 remain stably bound to chromatin in 
the presence of the replication inhibitor etoposide. The DDK kinase activity is 
unaffected by the DNA polymerase inhibitor aphidicolin, which activates the 
replication checkpoint.  Immunodepletions of either Cdc7 or Drf1 from the extract 
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demonstrate that each protein is required for the other to associate with 
chromatin.  Drf1 hyper-accumulates on chromatin treated with aphidicolin and 
this hyper-accumulation is dependent on the replication checkpoint proteins 
Claspin and ATR and it is sensitive to the ATR inhibitor caffeine.  However, the 
effect is independent of the downstream replication checkpoint effector kinase 
Chk1.  In contrast to the effect on Drf1, treatment of the extract with caffeine and 
aphidicolin leads to chromatin hyper-accumulation of Cdc45.  Depletion of 
Claspin or ATR in the presence of caffeine also leads to Cdc45 hyper-
accumulation on chromatin.  A small amount DNA replication was found to occur 
after treatment of aphidicolin and caffeine in Xenopus tissue culture (XTC) cells. 
Likewise, nascent DNA replication was also detected under the same conditions 
in the egg extract.   In keeping with this, DDK was found to be active in the 
presence of aphidicolin and caffeine in the extract. 
5.1.2 Significance of results 
These results are of relevance to both the fields of DNA replication initiation and 
replication checkpoint control.  Providing evidence that Drf1-Cdc7 is an active 
kinase that remains stably associated to both each other and chromatin in the 
presence of arrested replication has been an important contribution to a 
controversial subject.  Additionally, describing the dependency of Drf1 hyper-
accumulation on ATR and Claspin and not Chk1 demonstrates regulation by the 
replication checkpoint but it is not a downstream effect of the checkpoint.  
Similarly, the presence of some limited replication initiation in the presence of 
aphidicolin when the replication checkpoint has been down-regulated by caffeine 
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suggests an underlying activity of some replication machinery, such as DDK, 
despite the blockage to replication.   
5.2 Investigating the role of Claspin at the replication fork  
Claspin is a protein required to mediate activation of the replication checkpoint 
effector kinase, Chk1, in response to arrested replication (Kumagai and Dunphy, 
2000).  Previous studies of Claspin in Xenopus egg extracts have described the 
mechanism by which Claspin activates Chk1.  Claspin binds to Chk1 through a 
conserved motif comprised of repeat sequences where a key serine in each 
repeat is phosphorylated in response to arrested replication by an unknown 
kinase in an ATR-dependent manner (Kumagai and Dunphy, 2003).  These 
phosphoserines bind to the catalytic domain of Chk1, coordinating activation by 
ATR/ATRIP, and culminates in the release of activated Chk1 from this complex 
(Jeong et al., 2003; Kumagai et al., 2004).  Claspin was also identified as a 
component of the replication fork, loading onto chromatin in a Cdc45 and S-CDK-
dependent manner (Lee et al., 2003). 
5.2.1 Summary of Results 
Claspin associates with the replication fork proteins Cdc45, DNA polymerase ε 
(Pol ε), Replication Protein A (RPA), and two Replication Factor C complexes 
(RFCs) on chromatin in Xenopus egg extracts.  Using a differential 
immunoprecipitation approach, we verified that Claspin does not interact with 
Cdc45 indirectly through other members of the CMG complex, GINS and MCM2-
7.  Claspin interaction with the RFC is dependent on the presence of RPA but the 
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Cdc45 interaction is independent of RPA, suggesting that Claspin interacts with 
Cdc45 before origin unwinding and the RFC after this event.  An N-terminal 
region of Claspin comprising amino acids 265–605 was found to be required for 
the association of Claspin with chromatin and the replication fork proteins 
Xcdc45, RPA70, RFC40, Xrad17, and Pol ε.  This region was named the 
replication fork-interacting domain (RFID) as it is essential for Claspin association 
with the replication fork.  This region is composed of two well-conserved basic 
patches in what is an otherwise very acidic protein that are required for efficient 
association of Claspin with chromatin.  The first basic patch is not required for 
Claspin to mediate Chk1 activation but the second basic patch is required for 
efficient activation.  A small fragment of Claspin (amino acids 776-905) that 
contains the previously characterized CKBD is the most minimal fragment found 
to be able to complement Claspin-depleted Xenopus egg extracts (Kumagai and 
Dunphy, 2003).  This fragment, termed the Chk1 activating domain (CKAD), is 
unable to associate with chromatin and is significantly less efficient in mediating 
Chk1 activation than endogenous Claspin, which is already in excess abundance 
in the egg extract.  Therefore, Claspin association with chromatin is not strictly 
required for its ability to mediate Chk1 activation but the association is required 
for full efficiency of this process. 
5.2.2 Significance of Results 
This work is of significance to the fields of both replication control and replication 
checkpoint regulation.  A key question that this work answers is the spatial 
requirement for the activation of the replication checkpoint in response to 
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replication arrest.  Chk1 is a dynamic, nucleoplasmic protein whereas Claspin is 
both nucleoplasmic and associated with replication forks, where it accumulates 
upon replication arrest (Bekker-Jensen et al., 2006; Liu et al., 2006).  These 
studies show that Claspin is not strictly required to be localized to the replication 
fork in order to mediate Chk1 activation.  However, the spatial localization of 
Claspin to the replication fork is required for a high efficiency of Chk1 activation 
relative to non-chromatin associated Claspin molecules. 
5.3 Identification of a DDK interaction motif on Claspin 
Claspin has been shown to have two broad functions, one as a mediator of Chk1 
activation and the other as a component of the replication fork (Kumagai and 
Dunphy, 2000; Lee et al., 2003).  Claspin mediates Chk1 activation through a 
conserved motif comprised of amino acid repeat sequences (Kumagai and 
Dunphy, 2003).  Several studies have provided evidence that Claspin is required 
for normal replication fork progression (Lee et al., 2003; Lin et al., 2004; 
Petermann et al., 2008).  A recent study has demonstrated that Cdc7 interacts 
with and phosphorylates Claspin in mammalian cells but neither the mechanism 
nor physiological implications of these findings are clear (Kim et al., 2008). 
5.3.1 Summary of results 
We confirmed that Xenopus Claspin is phosphorylated by DDK in vitro.  We 
found that Claspin forms a nuclear complex with Cdc7 and Drf1, irrespective of 
the activation state of the replication checkpoint.  Claspin also 
coimmunoprecipitated the cohesin loading protein Scc2, a finding that coincides 
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with a recent study demonstrating that DDK binds to and is required for Scc2 
chromatin loading (Takahashi et al., 2008).  We prepared a series of Claspin 
peptide fragments and identified the most minimal amino acid sequence in 
Claspin required for interacting with DDK.  Surprisingly, this region turned out to 
be the first, but not the second, repeat sequence of the CKBD.  There are only 
two amino acid positions that vary between the two repeats and we mutated the 
first repeat both singly and combinatorially at those positions (residues D861E, 
Q866K and E/K).  We found that the D861 and E/K mutations conferred the 
largest reduction of interaction with DDK when these mutations were expressed 
in successively larger Claspin peptide fragments and eventually the full-length 
protein.  The CKBD sequence repeats are well conserved in higher eukaryotes 
and the presence of an aspartate residue in the first repeat — as well as its 
absence in the downstream repeat(s) — is almost completely conserved as well.  
We were able to confirm that human CKBD fragments follow the same pattern of 
interaction when tested for interaction with DDK in Xenopus egg extracts.  Since 
the main described function of the CKBD is binding to and mediating activation of 
Chk1, we tested whether the loss of interaction with DDK would impact this role 
of Claspin.  CKBD peptide fragments mutated to be incapable of binding Chk1 
were still able to interact with DDK.  CKAD peptide fragments containing the 
D861E and E/K mutations were capable of reciprocally binding to Chk1 in 
replication checkpoint stimulated Xenopus egg extracts.  Moreover, both the 
D861E and E/K full-length recombinant mutants of Claspin were capable of 
successfully rescuing Chk1 activation in replication arrested Claspin-depleted 
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extracts.  The mutant full-length Claspin proteins interact with chromatin under 
both unperturbed and replication-arrested conditions in an equivalent manner to 
wild-type and endogenous Claspin molecules.  The mutant Claspin proteins were 
also capable of rescuing a chromatin binding defect of Cdc45 from replication-
arrested Claspin-depleted extracts. 
5.3.2 Significance of results 
This work provides a molecular characterization of the interaction between the 
essential replication kinase DDK and the replication checkpoint mediator Claspin.  
The most intriguing aspect of this study is the finding that the Claspin interacts 
with DDK through part of the highly conserved region previously identified as the 
Chk1 binding domain (CKBD).  Based on both the pattern of sequence 
conservation of the key amino acid position mediating DDK binding and the 
binding pattern of the human CKBD peptides, the DDK interaction motif on 
Claspin may be a highly conserved sequence element.  There are two other 
highly significant results from this study.  One is that the Claspin mutants 
incapable of binding DDK are still able to mediate Chk1 activation in response to 
replication arrest.  The other is that interaction with DDK is not required for 
Claspin chromatin loading.  
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Appendix A 
Physiological effects of Claspin DDK 
interaction mutants 
A.1 Introduction 
In chapter 4, we demonstrated that the S-phase kinase DDK (Drf1/Dbf4-
dependent kinase) interacts with the replication checkpoint protein Claspin 
through a conserved protein motif.  In that study, we identified the first repeat 
sequence of the Chk1 binding domain (CKBD) on Claspin as being essential for 
DDK interaction and furthermore showed that the amino acid positions D861 and 
Q866 in particular were required for this interaction (Figs. 4.2C and 4.3A) .  In 
addition, we demonstrated that the Claspin interaction with DDK was distinct 
from the ability of Claspin to bind to Chk1 and mediate Chk1 activation in 
response to replication blocks (Figs. 4.4A, 4.4B and 4.5A).   We also provided 
evidence that the Claspin mutants deficient in DDK binding (D861E and E/K) 
displayed a normal ability to load onto replicating chromatin as well as a typical 
hyper-accumulation on replication arrested chromatin.  Here we describe 
preliminary data providing several physiological implications resulting from 
adding the Claspin mutants that are deficient in DDK interaction to Claspin-
depleted extracts. 
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A.2 Results  
Claspin is a regulator of replication in mammalian cells and is required for a 
normal rate of DNA replication, even under unperturbed conditions (Lee et al., 
2005; Lee et al., 2003; Petermann et al., 2008; Sar et al., 2004).  However, in 
Xenopus egg extracts, immunodepletion of Claspin yields only a very modest 
decrease in DNA replication (Lee et al., 2003).  Since the primary role 
established for DDK is as an S-phase kinase required for the initiation of 
replication forks, we wanted to see if Claspin mutant proteins with a reduced 
ability to interact with DDK (described in chapter 4) would have an equal or 
greater impairment of DNA replication in extracts.  To this end, we 
immunodepleted Claspin from interphase extracts and added back either buffer 
alone or recombinant insect cell-expressed His6-Claspin-FLAG proteins.  We 
measured DNA replication by adding 32P-dATP before the onset of replication 
and took samples at selected time points until replication is typically completed in 
interphase extracts.  Replication characteristically starts at approximately 45 
minutes after entry into interphase in Xenopus egg extracts.   We found that 
Claspin-depleted extracts with no recombinant protein added did not result in a 
consistent decrease in replication compared to mock-depleted or recombinant 
wild-type Claspin rescued extracts (figure A.1A).  In contrast, when the D861E 
and E/K mutants were added back to Claspin depleted extracts, there was a 
~30% decrease in replication as compared to the wild type or mock-depleted 
conditions (Fig A.1A). The different rates of replication are apparent at the 
second time point, 60 minutes, implying that there is an early role for Claspin in 
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DNA replication. These results are consistent with Claspin involvement in 
maintaining a normal basal replication rate in other systems (Lee et al., 2003; Lin 
et al., 2004; Petermann et al., 2008) and suggest that DDK may play a part in 
this regulation.   
The S- and M-phases of Xenopus early extracts are tightly linked as there is no 
G2 phase in this system (reviewed in (Arias and Walter, 2007)).  Since the 
Claspin mutants D861E and E/K seem to result in slower replication when 
complementing Claspin-depleted conditions in interphase extracts, we wondered 
whether there might be a concomitant delay in mitosis. Previous work has not 
established a delay in entry into mitosis upon the depletion of Claspin in Xenopus 
egg extracts.  We decided to complement Claspin-depleted extracts with mutant 
and wild-type recombinant proteins or buffer alone as above.  We used the super 
gel-shifted form of the protein Cdc25, which is a key positive regulator of the M-
phase Cdk, as a marker for M-phase in these extracts (Kumagai and Dunphy, 
1992).  Typically, extracts enter M-phase around 90 minutes after entry into 
interphase following fertilization signals.  As such, the mock-depleted extract and 
Claspin-depleted extract rescued with wild-type Claspin displayed a 
characteristic supershift of Cdc25 at the 90 minute time point (figure A.1B, lanes 
10 and 17).  Surprisingly, the Claspin-depleted extract containing buffer alone 
had a slightly accelerated mitosis with a super-shifted Cdc25 band visible at 75 
minutes but still present at 90 minutes (figure A.1B, lanes 4 and 5).  However, the 
Claspin-depleted extracts rescued with the D861E or E/K Claspin recombinant 
proteins resulted in the super-shifted form of Cdc25 appearing at 105 minutes, a 
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15 minute delay in mitosis (figure A.1B, lanes 23 and 28).  This suggests that the 
delay in replication may be linked to a longer S-phase in the usually rapidly 
oscillating system of the Xenopus early embryo. 
Claspin is loaded onto chromatin during S-phase in a pre-RC and Cdc45 
dependent manner (Lee et al., 2003).  The most important known kinase target of 
DDK is the MCM2-7 complex and this phosphorylation leads to the recruitment of 
the replication fork unwinding factor, Cdc45 (Masai et al., 2006; Sheu and 
Stillman, 2006; Tsuji et al., 2006).  Given this information we wondered whether 
the DDK interaction mutants would be deficient in chromatin loading.  We 
isolated chromatin from extracts where we immunodepleted Claspin and added 
back various Claspin recombinant proteins.  In both the cases of unperturbed 
and aphidicolin-treated extracts, the mutant Claspin proteins, D861E and E/K, 
were loaded onto chromatin in a fashion comparable to wild-type rescued and 
mock-depleted Claspin (figure A.2, lanes 5–8 and 10–13).  In the case of the 
aphidicolin-treated extracts, the mutant Claspin proteins hyper-accumulated on 
chromatin and displayed a characteristic gel shift, both hallmarks of a replication 
checkpoint response (figure A.2, lanes 10–13).  The replication fork protein 
Cdc45 hyper-accumulates onto aphidicolin-treated chromatin after Claspin has 
been immunodepleted and this can be reversed by wild-type recombinant 
Claspin (chapter 2) (Yanow et al., 2003).  Here we found that the D861E and E/K 
Claspin mutants can reverse the hyper-accumulation of Cdc45, Pol ε, Pol α, and 
RFC40 seen in the Claspin-depleted extract with no recombinant protein added-
back equally as well as wild-type (Fig A.2, lanes 9–13) (J.Lee and W.G. Dunphy, 
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unpublished data).  Orc2 serves here as a loading control since the loading onto 
chromatin is unchanged in these conditions. 
Previous work in our lab found that Drf1 accumulated onto chromatin in 
aphidicolin treated extracts and that this increase was dependent upon Claspin 
(Yanow et al., 2003).  We have confirmed that finding, and have also found that 
the D861E and E/K Claspin mutants have lesser potency in rescuing this 
accumulation defect relative to wild-type and mock-depleted extracts (figure A.2, 
lanes 9–13).  The fact that the accumulation of Drf1 is not completely abrogated 
as in the buffer-only extract (Fig A.2) implies that either the D861E and E/K 
mutants still retain some DDK binding capacity or that there are other proteins 
that can compensate for this defect.
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Figure A.1  Claspin mutant proteins result in delayed replication 
progression and mitosis when complementing Claspin-depleted extracts. 
(A) Replication assays were carried out by incubating 32P-dATP in either mock (Mock) or 
Claspin-immunodepleted Xenopus egg extracts.  The extracts were complemented 
with recombinant Wild-type (Wt), D861E, or E/K His6-Claspin-FLAG proteins or buffer 
alone.  Aliquots were taken at 35, 55, 75, and 95 minutes, treated with replication stop 
buffer, digested with proteinase K for 60 minutes, the products were subjected to 
electrophoresis on an agarose gel and analyzed by autoradiography.  The data was 
detected by Phosphorimage analysis and were normalized to the Mock (95 minute) 
sample.    
(B) Mitosis assays were performed by taking aliquots from either mock (Mock) (lanes 8-
12) or Claspin-immunodepleted extracts. The extracts were complemented with 
recombinant Wild-type (Wt) (lanes 15–19), D861E (lanes 20–24), or E/K His6-Claspin-
FLAG (lanes 25–29) proteins or buffer alone (lanes 3–7).  Lanes1 and 13 are aliquots 
of CSF (cytostatic factor) arrested extracts and lanes 2 and 14 are aliquots of 
interphase extracts.  The extracts were western blotted with anti-Claspin and anti-
Cdc25 antibodies. 
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Figure A.2  Claspin mutant proteins partially rescue replication chromatin 
loading defects 
Chromatin was isolated from interphase extracts supplemented with 3,000 sperm nuclei/µl and 
incubated in the absence (lanes 4–8) or presence of aphidicolin (lanes 9–13).  Extracts were 
immunodepleted with either anti-Claspin (lanes 4–7 and 9–12) or mock control antibodies (lanes 
8 and 13).  Extracts were also supplemented with the indicated versions of the His6-Claspin-
FLAG protein (lanes 5–7 and 10–12) or buffer alone (lanes 4, 8, 9, and 13).  Lanes 14–18 depict 
aliquots of extract taken before isolation of chromatin.  Aliquots of extract were taken before 
(lane 1) and after immunodepletion (lanes 2 and 3).  Samples were immunoblotted for Claspin, 
Drf1, Cdc45, RFC40, Pol ε, Pol α,Orc2, and Scc2. 
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A.3 Discussion 
We have described several physiological effects resulting from the 
complementation of Claspin-depleted extracts with Claspin mutant proteins 
deficient in their ability to interact with DDK.  To begin, there is a slower rate of 
replication in extracts containing the D861E and E/K Claspin mutants relative to 
wild-type Claspin-rescued or mock-depleted extracts.  There could be several 
explanations for this reduction in replication.  One possibility could be the 
inappropriate activation of the intra-S-phase replication checkpoint where the 
mutant Claspin proteins would behave in a hyperactive manner with respect to 
mediating Chk1 activation.  However, this is unlikely based on the evidence in 
figure 4.5A where neither of the Claspin mutants display higher levels of the 
phospho-serine 344 Chk1 signal nor a slower gel-migrating form of Chk1 relative 
to wild-type recombinant Claspin when complementing Claspin-depleted extracts 
during unperturbed replication.  If the slower replication rate is the result of a 
replication initiation defect, there would be either a delay in the firing of 
replication origins or an overall reduced number of origins firing.  Alternatively, 
this delay could be the result of a slower rate in the elongation phase of DNA 
synthesis.  We see differences between the rates of DNA replication between 
wild-type and mutant-complemented Claspin-depleted extracts as early as the 
60-minute time point (figure A.1.A), suggesting that perhaps there is a defect in 
initiation.  However, this is by no means conclusive.  Considering that DDK is 
required for replication origin firing through its phosphorylation of the MCM2-7 
complex, which leads to the recruitment of the unwinding factor Cdc45, it is 
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possible that Claspin may have a role in the substrate targeting of DDK or the 
efficiency of DDK activity in this role (Masai et al., 2006; Sheu and Stillman, 
2006; Tsuji et al., 2008).  Also supporting the initiation hypothesis, Claspin is 
known to bind to Cdc45, although Claspin is not required for Cdc45 recruitment 
to chromatin (Lee et al., 2005; Lee et al., 2003; Yanow et al., 2003).  However, 
Claspin also interacts with proteins involved in DNA replication elongation such 
as Pol ε and the RFC complex as has the yeast Claspin homologue MRC1 so a 
defect in elongation cannot be completely ruled out (Lee et al., 2005; Lee et al., 
2003; Lou et al., 2008).  Whereas in mammalian systems the deletion or 
knockdown of Claspin has had a significant reduction in the rate of replication 
(Lin et al., 2004; Petermann et al., 2008; Sar et al., 2004), in Xenopus egg 
extracts the reduction in replication rate has been decidedly modest (Lee et al., 
2003).   The reduction in replication rate seen when complementing Claspin-
depleted extracts with Claspin D861E and E/K is more similar to the phenotype 
of Claspin-depleted mammalian cells (Lin et al., 2004; Petermann et al., 2008; 
Sar et al., 2004).  Further investigation will be required to determine the cause of 
the Claspin mutant replication defect from amongst the scenarios we have 
depicted. 
The second physiological effect of adding the mutant Claspin proteins to Claspin-
depleted extracts was a subtle delay in mitosis (Fig A.1B).  This approximately 
15-minute delay could, like the replication defect, result from the inappropriate 
activation of the Claspin-mediated G2/M checkpoint.  However, as detailed 
above, we did not observe abnormal activation of Chk1 under unperturbed 
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conditions (Fig 3.5A).  Another possibility is that the mitotic delay may be the 
direct result of the delayed replication observed with the same mutant Claspin 
proteins and that the onset of entry into M-phase is concomitant with the later 
end of replication.  We view this as the most likely possibility but further work in 
dissecting the mutant Claspin proteins role in delaying replication will also help to 
elucidate the mitotic delay.  
The final physiological effect of the Claspin D861E and E/K mutant 
complementation experiments that we observed was the incomplete rescue of 
Drf1 aphidicolin-induced chromatin hyper-accumulation.  Claspin loading onto 
chromatin is S-CDK (as determined by use of the S-Cdk inhibitor p27) and 
Cdc45-dependent (Lee et al., 2003).  We noted in chapter 4 that the mutant 
Claspin proteins associate with unperturbed and replication-arrested chromatin to 
an equivalent extent and dynamics as wild-type and endogenous Claspin 
proteins.  This provides evidence that a strong DDK interaction is not required for 
loading Claspin onto chromatin.  We have described in chapter 2 that the Drf1 
hyper-accumulation onto aphidicolin-treated chromatin is ATR, Claspin, and 
caffeine-dependent (Yanow et al., 2003).  Therefore, the incomplete rescue of 
the Claspin-depleted Drf1 hyper-accumulation defect by the Claspin DDK 
association mutants fits well with a model of Claspin regulating the recruitment or 
retention of DDK at stalled replication forks.  The physiological implication of the 
DDK hyper-accumulation at stalled forks is not currently known.  Moreover, there 
is still significant controversy in the field as to not only whether Drf1 hyper-
accumulates on replication-arrested chromatin but the regulation of DDK as a 
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whole under these conditions (extensively discussed in chapter 1.3.2).  The most 
recent work on this subject suggests that Drf1-Cdc7 remains in a stable, active 
complex in response to replication fork arrest and is localized to the arrested 
chromatin (Kim et al., 2008; Silva et al., 2006; Tenca et al., 2007; Tsuji et al., 
2008).  Assuming that this is the case, one result of DDK accumulation on stalled 
replication forks may be to stabilize these damaged forks against fork collapse 
and possibly prepare them for replication restart after adaptation or repair.  Some 
modest replication initiation is observed after replication arrest following 
treatment of caffeine, which inhibits the replication checkpoint, suggesting the 
presence of active DDK at these structures (chapter 2) (Yanow et al., 2003).  A 
possible scenario is that DDK attenuates the replication checkpoint at certain late 
time points after replication arrest.  One piece of data supporting this model is 
that the DDK interaction mutants do not impinge on the ability of Claspin to 
mediate Chk1 activation under these conditions, suggesting that the DDK 
association with Claspin is not a stimulatory one (chapter 4).  Another argument 
to support this is that the overexpression or addition of ectopic excess of DDK 
inhibits the replication checkpoint (Tsuji et al., 2008).  Replication is required for 
the activation of the replication checkpoint in response to replication stresses 
such as UV and HU (Lupardus et al., 2002; Michael et al., 2000; Stokes et al., 
2002).  The inhibition of the replication checkpoint in response to Cdc7 depletion 
in mammalian cells (Kim et al., 2008) may be a result of the reduction in the 
number of initiated replication forks as a consequence of the loss of DDK activity 
rather than direct inhibition of Claspin by DDK.  Clearly, more study into the 
152 
 
effects of DDK phosphorylation and interaction with Claspin, especially at later 
time-points following replication arrest. 
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